Document:

REGISTRATION RIGHTS

  
 EXHIBIT 4.1 
 Execution 
 Version 
  
 PSS World Medical, Inc. 
  
 2.25% Convertible Senior Notes due March 15, 2024 
  
 Registration Rights Agreement 
  
 March 8, 2004 
  
 Goldman, Sachs & Co., 
 As representative of the several Purchasers 
     named in
Schedule I to the Purchase Agreement 
 c/o Goldman, Sachs & Co. 
 85 Broad Street 
 New York, New York 10004 
  
 Ladies and Gentlemen: 
  
 PSS WORLD MEDICAL, INC., a Florida corporation (the “Company”), proposes to issue and sell to the Purchasers (as defined herein) upon the terms
set forth in the Purchase Agreement (as defined herein) its 2.25% Convertible Senior Notes due 2024 (the “Securities”). As an inducement to the Purchasers to enter into the Purchase Agreement and in satisfaction of a condition to the
obligations of the Purchasers thereunder, the Company agrees with the Purchasers for the benefit of Holders (as defined herein) from time to time of the Registrable Securities (as defined herein) as follows: 
  
 1. Definitions. 
  
 (a) Capitalized terms used herein without definition shall have the meanings
ascribed to them in the Purchase Agreement. As used in this Agreement, the following defined terms shall have the following meanings: 
  
 “Affiliate” of any specified person means any other person which, directly or indirectly, is in control of, is controlled by, or is under
common control with such specified person. For purposes of this definition, control of a person means the power, direct or indirect, to direct or cause the direction of the management and policies of such person whether by contract or otherwise; and
the terms “controlling” and “controlled” have meanings correlative to the foregoing. 
  
 “Closing Date” means the First Time of Delivery as defined in the Purchase Agreement. 
  
 “Commission” means the United States Securities and Exchange
Commission, or any other federal agency at the time administering the Exchange Act or the Securities Act, whichever is the relevant statute for the particular purpose. 
  

 1 

 “Common Stock” means the Company’s common stock, par value $0.01 per share together
with any associated preferred share purchase rights. 
  
 “DTC” means The Depository Trust Company. 
  
 “Effective Date” has the meaning assigned thereto in Section 2(b)(i) hereof. 
  
 “Effective Failure” has the meaning assigned thereto in Section 7(b) hereof. 
  
 “Effectiveness Period” has the meaning assigned thereto in
Section 2(b)(i) hereof. 
  
 “Effective Time”
means the time at which the Commission declares the Shelf Registration Statement effective or at which the Shelf Registration Statement otherwise becomes effective. 
  
 “Electing Holder” has the meaning assigned thereto in Section 3(a)(iii) hereof. 
  
 “Exchange Act” means the United States Securities Exchange
Act of 1934, as amended. 
  
 “Holder” means any
person that is the record owner of Registrable Securities (and includes any person that has a beneficial interest in any Registrable Security in book-entry form). 
  
 “Indenture” means the Indenture, dated as of March 8, 2004, between the Company and Wachovia Bank,
N.A., as amended and supplemented from time to time in accordance with its terms. 
  
 “Liquidated Damages” has the meaning assigned thereto in Section 7(a) hereof. 
  
 “Managing Underwriters” means the investment banker or investment bankers and manager or managers that shall administer an underwritten
offering, if any, conducted pursuant to Section 6 hereof. 
  
 “NASD Rules” means the Rules of the National Association of Securities Dealers, Inc., as amended from time to time. 
  
 “Notice and Questionnaire” means a Notice of Registration Statement and Selling Securityholder Questionnaire substantially in the form of
Appendix A hereto. 
  
 The term “person” means an
individual, partnership, corporation, trust or unincorporated organization, or a government or agency or political subdivision thereof. 
  
 “Prospectus” means the prospectus (including, without limitation, any preliminary prospectus, any final prospectus and any prospectus
that discloses information previously omitted from a prospectus filed as part of an effective registration statement in reliance upon Rule 430A under the Securities Act) included in the Shelf Registration Statement, as amended or supplemented by any
prospectus supplement with respect to the terms of the offering of any portion of the Registrable Securities covered by the Shelf Registration Statement and by all other amendments and supplements to such prospectus, including all material
incorporated by reference in such prospectus and all documents filed after the date of such prospectus by the Company under the Exchange Act and incorporated by reference therein. 
  

 2 

 “Purchase Agreement” means the purchase agreement, dated as of March 2, 2004, between
the Purchasers and the Company relating to the Securities. 
  
 “Purchasers” means the Purchasers named in Schedule I to the Purchase Agreement. 
  
 “Registrable Securities” means all or any portion of the Securities issued from time to time under the Indenture in registered form and
the shares of Common Stock issuable upon conversion of such Securities; provided, however, that a security ceases to be a Registrable Security when it is no longer a Restricted Security. 
  
 “Registration Default” has the meaning assigned thereto in
Section 7(a) hereof. 
  
 “Restricted Security”
means any Security or share of Common Stock issuable upon conversion thereof except any such Security or share of Common Stock that (i) has been effectively registered under the Securities Act and sold in a manner contemplated by the Shelf
Registration Statement, (ii) has been transferred in compliance with Rule 144 under the Securities Act (or any successor provision thereto) or is transferable pursuant to paragraph (k) of such Rule 144 (or any successor provision thereto) or (iii)
has otherwise been transferred and a new Security or share of Common Stock not subject to transfer restrictions under the Securities Act has been delivered by or on behalf of the Company in accordance with Section 2.1 of the Indenture. 

 
 “Rules and Regulations” means the published rules and
regulations of the Commission promulgated under the Securities Act or the Exchange Act, as in effect at any relevant time. 
  
 “Securities Act” means the United States Securities Act of 1933, as amended. 
  
 “Shelf Registration” means a registration effected pursuant
to Section 2 hereof. 
  
 “Shelf Registration
Statement” means a registration statement filed under the Securities Act providing for the registration of, and the sale on a continuous or delayed basis by the Holders of, all of the Registrable Securities pursuant to Rule 415 under the
Securities Act and/or any similar rule that may be adopted by the Commission, filed by the Company pursuant to the provisions of Section 2 of this Agreement, including the Prospectus contained therein, any amendments and supplements to such
registration statement, including post-effective amendments, and all exhibits and all material incorporated by reference in such registration statement. 
  
 “Suspension Period” has the meaning assigned thereto in Section 2(c) hereof. 
  
 “Trust Indenture Act” means the Trust Indenture Act of 1939,
or any successor thereto, and the rules, regulations and forms promulgated thereunder, as the same shall be amended from time to time. 
  
 The term “underwriter” means any underwriter of Registrable Securities in connection with an offering thereof under a Shelf Registration
Statement. 
  
 (b) Wherever there is a reference in this Agreement
to a percentage of the “principal amount” of Registrable Securities or to a percentage of Registrable Securities, Common Stock shall be treated as representing the principal amount of Securities that was surrendered for conversion or
exchange in order to receive such number of shares of Common Stock. 
  

 3 

 2. Shelf Registration. 
  
 (a) The Company shall, no later than 120 calendar days following the Closing Date, file with the Commission a Shelf
Registration Statement relating to the offer and sale of the Registrable Securities by the Holders from time to time in accordance with the methods of distribution elected by such Holders and set forth in such Shelf Registration Statement and,
thereafter, shall use its reasonable best efforts to cause such Shelf Registration Statement to be declared effective under the Securities Act no later than 180 calendar days following the Closing Date; provided, however, that the
Company may, upon written notice to all Holders, postpone having the Shelf Registration Statement declared effective for a reasonable period not to exceed 90 days if the Company possesses material non-public information, the disclosure of which
would have a material adverse effect on the Company and its subsidiaries taken as a whole or if a pending transaction that would be material to the Company and its subsidiaries, taken as a whole, could be materially adversely affected as a result;
provided, further, however, that no Holder shall be entitled to be named as a selling securityholder in the Shelf Registration Statement or to use the Prospectus forming a part thereof for resales of Registrable Securities unless such Holder is an
Electing Holder. 
  
 (b) The Company shall use its reasonable best
efforts: 
  
 (i) to keep the Shelf Registration
Statement continuously effective under the Securities Act in order to permit the Prospectus forming a part thereof to be usable by Holders until the earliest of (1) the sale of all Registrable Securities registered under the Shelf Registration
Statement; (2) the expiration of the period referred to in Rule 144(k) of the Securities with respect to all Registrable Securities held by Persons that are not Affiliates of the Company; and (3) two years from the date (the “Effective
Date”) such Shelf Registration Statement is declared effective (such period being referred to herein as the “Effectiveness Period”); 
  
 (ii) after the Effective Time of the Shelf Registration Statement, promptly upon the request of any Holder of Registrable Securities that
is not then an Electing Holder, to take any action reasonably necessary to enable such Holder to use the Prospectus forming a part thereof for resales of Registrable Securities, including, without limitation, any action necessary to identify such
Holder as a selling securityholder in the Shelf Registration Statement; provided, however, that nothing in this subparagraph shall relieve such Holder of the obligation to return a completed and signed Notice and Questionnaire to the Company
in accordance with Section 3(a)(ii) hereof; and 
  
 (iii) if at any time the Securities, pursuant to Section 4.2 of the Indenture, are convertible into securities other than Common Stock, to cause, or to cause any successor under the Indenture to cause, such securities to be included in the
Shelf Registration Statement no later than the date on which the Securities may then be convertible into such securities. 
  
 The Company shall be deemed not to have used its reasonable best efforts to keep the Shelf Registration Statement effective during the Effectiveness period if the Company
voluntarily takes any action that would result in Holders of Registrable Securities covered thereby not being able to offer and sell any of such Registrable Securities during such period, unless such action is (A) required by applicable law and the
Company thereafter promptly complies with the requirements of paragraph 3(j) below or (B) permitted pursuant to Section 2(c) below. 
  

 4 

 (c) The Company may suspend the use of the Prospectus for a period not to exceed 30 days in any 90-day
period or an aggregate of 90 days in any 12-month period (each, a “Suspension Period”) if the Board of Directors of the Company shall have determined in good faith that because of valid business reasons (not including avoidance of the
Company’s obligations hereunder), including the acquisition or divestiture of assets, pending corporate developments and similar events, it is in the best interests of the Company to suspend such use, and prior to suspending such use the
Company provides the Holders with written notice of such suspension, which notice need not specify the nature of the event giving rise to such suspension. 
  
 3. Registration Procedures. In connection with the Shelf Registration Statement, the following provisions shall apply: 
  
 (a) (i) Not less than 30 calendar days prior to the Effective Time of the
Shelf Registration Statement, the Company shall mail the Notice and Questionnaire to the Holders of Registrable Securities. No Holder shall be entitled to be named as a selling securityholder in the Shelf Registration Statement as of the Effective
Time, and no Holder shall be entitled to use the Prospectus forming a part thereof for resales of Registrable Securities until such Holder has returned a completed and signed Notice and Questionnaire to the Company; provided, however, to be
included in the Registration Statement as of the Effective Time, Holders of Registrable Securities shall have at least 28 calendar days from the date on which the Notice and Questionnaire is first mailed to such Holders to return a completed and
signed Notice and Questionnaire to the Company. 
  
 (ii) After the Effective Time of the Shelf Registration Statement, the Company shall, upon the request of any Holder of Registrable Securities that is not then an Electing Holder, promptly send a Notice and Questionnaire to such Holder.
From and after the Effective Time of the Shelf Registration Statement, the Company shall (A) as promptly as is practicable after the date a completed and signed Notice and Questionnaire is delivered to the Company, and in any event within ten
Business Days after such date, prepare and file with the Commission (x) a supplement to the Prospectus or, if required by applicable law, a post-effective amendment to the Shelf Registration Statement and (y) any other document required by
applicable law, so that the Holder delivering such Notice and Questionnaire is named as a selling securityholder in the Shelf Registration Statement and is permitted to deliver the Prospectus to purchasers of such Holder’s Registrable
Securities in accordance with applicable law, and (B) if the Company shall file a post-effective amendment to the Shelf Registration Statement, use its reasonable best efforts to cause such post-effective amendment to become effective under the
Securities Act as promptly as is practicable; provided, however, that if a Notice and Questionnaire is delivered to the Company during a Suspension Period, the Company shall not be obligated to take the actions set forth in this clause (ii)
until the termination of such Suspension Period. 
  
 (iii) The term “Electing Holder” shall mean any Holder of Registrable Securities that has returned a completed and signed Notice and Questionnaire to the Company in accordance with Section 3(a)(i) or 3(a)(ii) hereof. 

 
 (b) The Company shall furnish to each Electing Holder, prior to the
Effective Time, a copy of the Shelf Registration Statement initially filed with the Commission, and shall furnish to such Holders, prior to the filing thereof with the Commission, copies of each amendment 

  

 5 

 
thereto and each amendment or supplement, if any, to the Prospectus included therein, and shall use its reasonable best efforts to reflect in each such
document, at the Effective Time or when so filed with the Commission, as the case may be, such comments as such Holders and their respective counsel reasonably may propose. 
  
 (c) The Company shall promptly take such action as may be necessary so that (i) each of the Shelf Registration Statement and
any amendment thereto and the Prospectus forming a part thereof and any amendment or supplement thereto (and each report or other document incorporated therein by reference in each case) complies in all material respects with the Securities Act and
the Exchange Act and the respective rules and regulations thereunder, (ii) each of the Shelf Registration Statement and any amendment thereto does not, when it becomes effective, contain an untrue statement of a material fact or omit to state a
material fact required to be stated therein or necessary to make the statements therein not misleading and (iii) each of the Prospectus forming a part of the Shelf Registration Statement, and any amendment or supplement to such Prospectus, does not
at any time during the Effectiveness Period include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not
misleading. 
  
 (d) The Company shall promptly advise each
Electing Holder, and shall confirm such advice in writing if so requested by any such Electing Holder: 
  
 (i) when a Shelf Registration Statement and any amendment thereto has been filed with the Commission and when a Shelf Registration
Statement or any post-effective amendment thereto has become effective, in each case making a public announcement thereof by release made to Reuters Economic Services and Bloomberg Business News; 
  
 (ii) of any request by the Commission for post-effective
amendments or supplements to the Shelf Registration Statement or the Prospectus included therein or for additional information; 
  
 (iii) of the issuance by the Commission of any stop order suspending the effectiveness of the Shelf Registration Statement or the
initiation of any proceedings for such purpose; 
  
 (iv) of the receipt by the Company of any notification with respect to the suspension of the qualification of the securities included in the Shelf Registration Statement for sale in any jurisdiction or the initiation of any proceeding for
such purpose; and 
  
 (v) subject to the
limitations of Section 2(c) above, of the occurrence of any event or the existence of any state of facts that requires the making of any changes in the Shelf Registration Statement or the Prospectus included therein so that, as of such date, such
Shelf Registration Statement and Prospectus do not contain an untrue statement of a material fact and do not omit to state a material fact required to be stated therein or necessary to make the statements therein (in the case of the Prospectus, in
light of the circumstances under which they were made) not misleading (which advice shall be accompanied by an instruction to such Holders to suspend the use of the Prospectus until the requisite changes have been made). 
  

 6 

 (e) The Company shall use its reasonable best efforts to prevent the issuance, and if issued to obtain
the withdrawal at the earliest possible time, of any order suspending the effectiveness of the Shelf Registration Statement. 
  
 (f) The Company shall furnish (i) to each Electing Holder, without charge, at least one copy of the Shelf Registration Statement and all post-effective
amendments thereto, including financial statements and schedules and (ii) if such Electing Holder so requests in writing, all reports, other documents and exhibits that are filed with or incorporated by reference in the Shelf Registration Statement
(such obligation to be satisfied by publicly available filings with the Commission if the Company is then subject to Section 13 or 15(d) of the Exchange Act). 
  

(g) The Company shall, during the Effectiveness Period, deliver to each Electing Holder, without charge, as many copies of the Prospectus (including
each preliminary Prospectus) included in the Shelf Registration Statement and any amendment or supplement thereto as such Electing Holder may reasonably request; and the Company consents (except during the periods specified in Section 2(c) above or
during the continuance of any event or the existence of any state of facts described in Section 3(d)(v) above) to the use of the Prospectus and any amendment or supplement thereto by each of the Electing Holders in connection with the offering and
sale of the Registrable Securities covered by the Prospectus and any amendment or supplement thereto during the Effectiveness Period. 
  
 (h) Prior to any offering of Registrable Securities pursuant to the Shelf Registration Statement, the Company shall (i) register or qualify or cooperate
with the Electing Holders and their respective counsel in connection with the registration or qualification of such Registrable Securities for offer and sale under the securities or “blue sky” laws of such jurisdictions within the United
States as any Electing Holder may reasonably request, (ii) keep such registrations or qualifications in effect and comply with such laws so as to permit the continuance of offers and sales in such jurisdictions for so long as may be necessary to
enable any Electing Holder or underwriter, if any, to complete its distribution of Registrable Securities pursuant to the Shelf Registration Statement, and (iii) take any and all other actions necessary or advisable to enable the disposition in such
jurisdictions of such Registrable Securities; provided, however, that in no event shall the Company be obligated to (A) qualify as a foreign corporation or as a dealer in securities in any jurisdiction where it would not otherwise be
required to so qualify but for this Section 3(h) or (B) file any general consent to service of process in any jurisdiction where it is not as of the date hereof so subject. 
  
 (i) Unless any Registrable Securities shall be in book-entry only form, the Company shall cooperate with the Electing
Holders to facilitate the timely preparation and delivery of certificates representing Registrable Securities to be sold pursuant to the Shelf Registration Statement, which certificates, if so required by any securities exchange upon which any
Registrable Securities are listed, shall be penned, lithographed or engraved, or produced by any combination of such methods, on steel engraved borders, and which certificates shall be free of any restrictive legends and in such permitted
denominations and registered in such names as Electing Holders may request in connection with the sale of Registrable Securities pursuant to the Shelf Registration Statement. 
  
 (j) Upon the occurrence of any event or the existence of any state of facts contemplated by paragraph 3(d)(v) above, the
Company shall promptly prepare a post-effective amendment to any Shelf Registration Statement or an amendment or supplement to the related Prospectus or file any other required document so that, as thereafter delivered to purchasers of 

  

 7 

 
the Registrable Securities included therein, the Prospectus will not include an untrue statement of a material fact or omit to state any material fact
necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading. If the Company notifies the Electing Holders of the occurrence of any event or the existence of any state of facts contemplated
by paragraph 3(d)(v) above, the Electing Holder shall suspend the use of the Prospectus until the requisite changes to the Prospectus have been made. 
  
 (k) Not later than the Effective Time of the Shelf Registration Statement, the Company shall provide a CUSIP number for the Registrable Securities that
are debt securities. 
  
 (l) The Company shall use its reasonable
best efforts to comply with all applicable Rules and Regulations, and to make generally available to its securityholders as soon as practicable, but in any event not later than eighteen months after (i) the effective date (as defined in Rule 158(c)
under the Securities Act) of the Shelf Registration Statement, (ii) the effective date of each post-effective amendment to the Shelf Registration Statement, and (iii) the date of each filing by the Company with the Commission of an Annual Report on
Form 10-K that is incorporated by reference in the Shelf Registration Statement, an earnings statement of the Company and its subsidiaries complying with Section 11(a) of the Securities Act and the rules and regulations of the Commission thereunder
(including, at the option of the Company, Rule 158). 
  
 (m) Not
later than the Effective Time of the Shelf Registration Statement, the Company shall cause the Indenture to be qualified under the Trust Indenture Act; in connection with such qualification, the Company shall cooperate with the Trustee under the
Indenture and the Holders (as defined in the Indenture) to effect such changes to the Indenture as may be required for such Indenture to be so qualified in accordance with the terms of the Trust Indenture Act; and the Company shall execute, and
shall use all reasonable efforts to cause the Trustee to execute, all documents that may be required to effect such changes and all other forms and documents required to be filed with the Commission to enable such Indenture to be so qualified in a
timely manner. In the event that any such amendment or modification referred to in this Section 3(m) involves the appointment of a new trustee under the Indenture, the Company shall appoint a new trustee thereunder pursuant to the applicable
provisions of the Indenture. 
  
 (n) In the event of an
underwritten offering conducted pursuant to Section 6 hereof, the Company shall, if requested, promptly include or incorporate in a Prospectus supplement or post-effective amendment to the Shelf Registration Statement such information as the
Managing Underwriters reasonably agree should be included therein and to which the Company does not reasonably object and shall make all required filings of such Prospectus supplement or post-effective amendment as soon as practicable after it is
notified of the matters to be included or incorporated in such Prospectus supplement or post-effective amendment. 
  
 (o) The Company shall enter into such customary agreements (including an underwriting agreement in customary form in the event of an underwritten offering
conducted pursuant to Section 6 hereof) and take all other appropriate action in order to expedite and facilitate the registration and disposition of the Registrable Securities, and in connection therewith, if an underwriting agreement is entered
into, cause the same to contain indemnification provisions and procedures substantially identical to those set forth in Section 5 hereof with respect to all parties to be indemnified pursuant to Section 5 hereof. 
  

 8 

 (p) The Company shall: 
  
 (i)(A) make reasonably available for inspection by the Electing Holders, any underwriter participating in
any disposition pursuant to the Shelf Registration Statement, and any attorney, accountant or other agent retained by such Electing Holders or any such underwriter all relevant financial and other records, pertinent corporate documents and
properties of the Company and its subsidiaries, and (B) cause the Company’s officers, directors and employees to supply all information reasonably requested by such Electing Holders or any such underwriter, attorney, accountant or agent in
connection with the Shelf Registration Statement, in each case, as is customary for similar due diligence examinations; provided, however, that all records, information and documents that are designated in writing by the Company, in
good faith, as confidential shall be kept confidential by such Electing Holders and any such underwriter, attorney, accountant or agent, unless such disclosure is made in connection with a court proceeding or required by law, or such records,
information or documents become available to the public generally or through a third party without an accompanying obligation of confidentiality; and provided further that, if the foregoing inspection and information gathering would otherwise
disrupt the Company’s conduct of its business, such inspection and information gathering shall, to the greatest extent possible, be coordinated on behalf of the Electing Holders and the other parties entitled thereto by one counsel designated
by and on behalf of the Electing Holders and other parties; 
  
 (ii) in connection with any underwritten offering conducted pursuant to Section 6 hereof, make such representations and warranties to the Electing Holders participating in such underwritten offering and to the
Managing Underwriters, in form, substance and scope as are customarily made by the Company to underwriters in primary underwritten offerings of equity and convertible debt securities and covering matters set forth in the Purchase Agreement, it being
understood and agreed that representations and warranties comparable to those contemplated by the Purchase Agreement, as amended to reflect a registered offering, shall be satisfactory; 
  
 (iii) in connection with any underwritten offering conducted pursuant to Section 6 hereof, obtain opinions
of counsel to the Company (which counsel and opinions in form, scope and substance shall be reasonably satisfactory to the Managing Underwriters, it being understood and agreed that opinions comparable to those contemplated by the Purchase
Agreement, as amended to reflect a registered offering, shall be satisfactory) addressed to each Electing Holder participating in such underwritten offering and the underwriters, covering such matters as are customarily covered in opinions requested
in primary underwritten offerings of equity and convertible debt securities (it being agreed that the matters to be covered by such opinions shall include opinions in form, scope and substance comparable to the opinions contemplated by the Purchase
Agreement, as amended to reflect a registered offering, as of the date of the opinion and as of the Effective Time of the Shelf Registration Statement or most recent post-effective amendment thereto, as the case may be, the absence from the Shelf
Registration Statement and the Prospectus, including the documents incorporated by reference therein, of an untrue statement of a material fact or the omission of a material fact required to be stated therein or necessary to make the statements
therein not misleading); 
  
 (iv) in connection
with any underwritten offering conducted pursuant to Section 6 hereof, obtain “cold comfort” letters and updates thereof from the independent public accountants of the Company (and, if necessary, from the independent public accountants of
any subsidiary of the Company or of any business acquired by the 

  

 9 

 
Company for which financial statements and financial data are, or are required to be, included in the Shelf Registration Statement), addressed to each
Electing Holder participating in such underwritten offering (if such Electing Holder has provided such letter, representations or documentation, if any, required for such cold comfort letter to be so addressed) and the underwriters, in customary
form and covering matters of the type customarily covered in “cold comfort” letters in connection with primary underwritten offerings by the Company of equity and convertible debt securities, it being understood and agreed that “cold
comfort” letters comparable to those contemplated by the Purchase Agreement, as amended to reflect a registered offering, shall be satisfactory; 
  
 (v) in connection with any underwritten offering conducted pursuant to Section 6 hereof, deliver such documents and certificates as may be
reasonably requested by any Electing Holders participating in such underwritten offering and the Managing Underwriters, if any, including, without limitation, certificates to evidence compliance with Section 3(j) hereof and with any conditions
contained in the underwriting agreement or other agreements entered into by the Company. 
  
 (q) The Company will use its reasonable best efforts to cause the Common Stock issuable upon conversion of the Securities to be quoted on The Nasdaq National Market System or other stock exchange or trading system on
which the Common Stock primarily trades on or prior to the Effective Time of the Shelf Registration Statement hereunder. 
  
 (r) In the event that any broker-dealer registered under the Exchange Act shall be an “affiliate” (as defined in Rule 2720(b)(1) of the NASD
Rules (or any successor provision thereto)) of the Company or has a “conflict of interest” (as defined in Rule 2720(b)(7) of the NASD Rules (or any successor provision thereto)) and such broker-dealer shall underwrite, participate as a
member of an underwriting syndicate or selling group or assist in the distribution of any Registrable Securities covered by the Shelf Registration Statement, whether as a Holder of such Registrable Securities or as an underwriter, a placement or
sales agent or a broker or dealer in respect thereof, or otherwise, the Company shall assist such broker-dealer in complying with the requirements of the NASD Rules, including, without limitation, by (A) engaging a “qualified independent
underwriter” (as defined in Rule 2720(b)(15) of the NASD Rules (or any successor provision thereto)) to participate in the preparation of the registration statement relating to such Registrable Securities, to exercise usual standards of due
diligence in respect thereto and to recommend the public offering price of such Registrable Securities, (B) indemnifying such qualified independent underwriter to the extent of the indemnification of underwriters provided in Section 5 hereof, and
(C) providing such information to such broker-dealer as may be required in order for such broker-dealer to comply with the requirements of the NASD Rules. 
  
 (s) The Company shall use its reasonable best efforts to take all other steps necessary to effect the registration, offering and sale of the Registrable
Securities covered by the Shelf Registration Statement contemplated hereby. 
  
 4. Registration Expenses. Except as otherwise provided in Section 3, the Company shall bear all fees and expenses incurred in connection with the performance of its obligations under Sections 2, 3 and 6 hereof
and shall bear or reimburse the Electing Holders for the fees and disbursements of a single counsel selected by a plurality of all Electing Holders who own an aggregate of not less than 25% of the Registrable Securities covered by the Shelf
Registration Statement to act as counsel therefore in connection therewith. Each Electing 

  

 10 

 
Holder shall pay all underwriting discounts and commissions and transfer taxes, if any, relating to the sale or disposition of such Electing Holder’s
Registrable Securities pursuant to the Shelf Registration Statement. 
  
 5. Indemnification and Contribution. 
  
 (a)
Indemnification by the Company. Upon the registration of the Registrable Securities pursuant to Section 2 hereof, the Company shall indemnify and hold harmless each Electing Holder and each underwriter, selling agent or other securities
professional, if any, which facilitates the disposition of Registrable Securities, and each of their respective officers and directors and each person who controls such Electing Holder, underwriter, selling agent or other securities professional
within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act (each such person being sometimes referred to as an “Indemnified Person”) against any losses, claims, damages or liabilities, joint or several, to
which such Indemnified Person may become subject under the Securities Act or otherwise, insofar as such losses, claims, damages or liabilities (or actions in respect thereof) arise out of or are based upon an untrue statement or alleged untrue
statement of a material fact contained in any Shelf Registration Statement under which such Registrable Securities are to be registered under the Securities Act, or any Prospectus contained therein or furnished by the Company to any Indemnified
Person, or any amendment or supplement thereto, or arise out of or are based upon the omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, and the
Company hereby agrees to reimburse such Indemnified Person for any legal or other expenses reasonably incurred by them in connection with investigating or defending any such action or claim as such expenses are incurred; provided,
however, that the Company shall not be liable to any such Indemnified Person in any such case to the extent that any such loss, claim, damage or liability arises out of or is based upon an untrue statement or alleged untrue statement or
omission or alleged omission made in such Shelf Registration Statement or Prospectus, or amendment or supplement, in reliance upon and in conformity with written information furnished to the Company by such Indemnified Person expressly for use
therein. 
  
 (b) Indemnification by the Electing Holders and
any Agents and Underwriters. Each Electing Holder agrees, as a consequence of the inclusion of any of such Electing Holder’s Registrable Securities in such Shelf Registration Statement, and each underwriter, selling agent or other
securities professional, if any, which facilitates the disposition of Registrable Securities shall agree, as a consequence of facilitating such disposition of Registrable Securities, severally and not jointly, to (i) indemnify and hold harmless the
Company, its directors, officers who sign any Shelf Registration Statement and each person, if any, who controls the Company within the meaning of either Section 15 of the Securities Act or Section 20 of the Exchange Act, against any losses, claims,
damages or liabilities to which the Company or such other persons may become subject, under the Securities Act or otherwise, insofar as such losses, claims, damages or liabilities (or actions in respect thereof) arise out of or are based upon an
untrue statement or alleged untrue statement of a material fact contained in such Shelf Registration Statement or Prospectus, or any amendment or supplement, or arise out of or are based upon the omission or alleged omission to state therein a
material fact required to be stated therein or necessary to make the statements therein not misleading, in each case to the extent, but only to the extent, that such untrue statement or alleged untrue statement or omission or alleged omission was
made in reliance upon and in conformity with written information furnished to the Company by such Electing Holder, underwriter, selling agent or other securities professional expressly for use therein, and (ii) reimburse the Company for any legal or
other expenses 

  

 11 

 
reasonably incurred by the Company in connection with investigating or defending any such action or claim as such expenses are incurred. 
  
 (c) Notices of Claims, Etc. Promptly after receipt by an indemnified
party under subsection (a) or (b) above of notice of the commencement of any action, such indemnified party shall, if a claim in respect thereof is to be made against an indemnifying party under this Section 5, notify such indemnifying party in
writing of the commencement thereof; but the omission so to notify the indemnifying party shall not relieve it from any liability which it may have to any indemnified party otherwise than under the indemnification provisions of or contemplated by
subsection (a) or (b) above. In case any such action shall be brought against any indemnified party and it shall notify an indemnifying party of the commencement thereof, such indemnifying party shall be entitled to participate therein and, to the
extent that it shall wish, jointly with any other indemnifying party similarly notified, to assume the defense thereof, with counsel satisfactory to such indemnified party (who shall not, except with the consent of the indemnified party, be counsel
to the indemnifying party), and, after notice from the indemnifying party to such indemnified party of its election so to assume the defense thereof, such indemnifying party shall not be liable to such indemnified party under this Section 5 for any
legal expenses of other counsel or any other expenses, in each case subsequently incurred by such indemnified party, in connection with the defense thereof other than reasonable costs of investigation. No indemnifying party shall, without the
written consent of the indemnified party, effect the settlement or compromise of, or consent to the entry of any judgment with respect to, any pending or threatened action or claim in respect of which indemnification or contribution may be sought
hereunder (whether or not the indemnified party is an actual or potential party to such action or claim) unless such settlement, compromise or judgment (i) includes an unconditional release of the indemnified party from all liability arising out of
such action or claim and (ii) does not include a statement as to, or an admission of, fault, culpability or a failure to act, by or on behalf of any indemnified party. 
  
 (d) Contribution. If the indemnification provided for in this Section 5 is unavailable to or insufficient to hold
harmless an indemnified party under subsection (a) or (b) above in respect of any losses, claims, damages or liabilities (or actions in respect thereof) referred to therein, then each indemnifying party shall contribute to the amount paid or payable
by such indemnified party as a result of such losses, claims, damages or liabilities (or actions in respect thereof) in such proportion as is appropriate to reflect the relative fault of the indemnifying party and the indemnified party in connection
with the statements or omissions which resulted in such losses, claims, damages or liabilities (or actions in respect thereof), as well as any other relevant equitable considerations. The relative fault of such indemnifying party and indemnified
party shall be determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or omission or alleged omission to state a material fact relates to information supplied by such indemnifying party or
by such indemnified party, and the parties’ relative intent, knowledge, access to information and opportunity to correct or prevent such statement or omission. The parties hereto agree that it would not be just and equitable if contribution
pursuant to this Section 5(d) were determined by pro rata allocation (even if the Electing Holders or any underwriters, selling agents or other securities professionals or all of them were treated as one entity for such purpose) or by any other
method of allocation which does not take account of the equitable considerations referred to in this Section 5(d). The amount paid or payable by an indemnified party as a result of the losses, claims, damages or liabilities (or actions in respect
thereof) referred to above shall be deemed to include any legal or other fees or expenses reasonably incurred by such indemnified party in connection with investigating or defending any such action or claim. No person guilty of fraudulent
misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to 

  

 12 

 
contribution from any person who was not guilty of such fraudulent misrepresentation. The obligations of the Electing Holders and any underwriters, selling
agents or other securities professionals in this Section 5(d) to contribute shall be several in proportion to the percentage of principal amount of Registrable Securities registered or underwritten, as the case may be, by them and not joint.

  
 (e) Notwithstanding any other provision of this Section 5, in
no event will any (i) Electing Holder be required to undertake liability to any person under this Section 5 for any amounts in excess of the dollar amount of the proceeds to be received by such Holder from the sale of such Holder’s Registrable
Securities (after deducting any fees, discounts and commissions applicable thereto) pursuant to any Shelf Registration Statement under which such Registrable Securities are to be registered under the Securities Act and (ii) underwriter, selling
agent or other securities professional be required to undertake liability to any person hereunder for any amounts in excess of the discount, commission or other compensation payable to such underwriter, selling agent or other securities professional
with respect to the Registrable Securities underwritten by it and distributed to the public. 
  
 (f) The obligations of the Company under this Section 5 shall be in addition to any liability which the Company may otherwise have to any Indemnified Person and the obligations of any Indemnified Person under this
Section 5 shall be in addition to any liability which such Indemnified Person may otherwise have to the Company. The remedies provided in this Section 5 are not exclusive and shall not limit any rights or remedies which may otherwise be available to
an indemnified party at law or in equity. 
  
 6. Underwritten
Offering. Any Holder of Registrable Securities who desires to do so may sell Registrable Securities (in whole or in part) in an underwritten offering; provided that (i) the Electing Holders of at least 33-1/3% in aggregate principal
amount of the Registrable Securities then covered by the Shelf Registration Statement shall request such an offering and (ii) at least such aggregate principal amount of such Registrable Securities shall be included in such offering; and provided
further that the Company shall not be obligated to cooperate with more than one underwritten offering during the Effectiveness Period. Upon receipt of such a request, the Company shall provide all Holders of Registrable Securities written notice
of the request, which notice shall inform such Holders that they have the opportunity to participate in the offering. In any such underwritten offering, the investment banker or bankers and manager or managers that will administer the offering will
be selected by, and the underwriting arrangements with respect thereto (including the size of the offering) will be approved by, the holders of a majority of the Registrable Securities to be included in such offering; provided,
however, that such investment bankers and managers and underwriting arrangements must be reasonably satisfactory to the Company. No Holder may participate in any underwritten offering contemplated hereby unless (a) such Holder agrees to sell
such Holder’s Registrable Securities to be included in the underwritten offering in accordance with any approved underwriting arrangements, (b) such Holder completes and executes all reasonable questionnaires, powers of attorney, indemnities,
underwriting agreements, lock-up letters and other documents required under the terms of such approved underwriting arrangements, and (c) if such Holder is not then an Electing Holder, such Holder returns a completed and signed Notice and
Questionnaire to the Company in accordance with Section 3(a)(ii) hereof within a reasonable amount of time before such underwritten offering. The Holders participating in any underwritten offering shall be responsible for any underwriting discounts
and commissions and fees and, subject to Section 4 hereof, expenses of their own counsel. The Company shall pay all expenses customarily borne by issuers in an underwritten offering, including but not limited to filing fees, the fees and
disbursements of its counsel and independent public accountants and any printing 

  

 13 

 
expenses incurred in connection with such underwritten offering. Notwithstanding the foregoing or the provisions of Section 3(n) hereof, upon receipt of a
request from the Managing Underwriter or a representative of holders of a majority of the Registrable Securities to be included in an underwritten offering to prepare and file an amendment or supplement to the Shelf Registration Statement and
Prospectus in connection with an underwritten offering, the Company may delay the filing of any such amendment or supplement for up to 90 days if the Board of Directors of the Company shall have determined in good faith that the Company has a bona
fide business reason for such delay. 
  
 7. Liquidated
Damages. 
  
 (a) Notwithstanding any postponement of
effectiveness permitted by Section 2(a) hereof, if (i) on or prior to the 120th day following the Closing Date, a Shelf Registration Statement has not been filed with the Commission or (ii) on or prior to the 180th day following the Closing Date,
such Shelf Registration Statement is not declared effective by the Commission (each, a “Registration Default”), the Company shall be required to pay liquidated damages (“Liquidated Damages”), from and including the day following
such Registration Default until and including the day immediately prior to the day such Shelf Registration Statement is either (i) filed or (ii) declared effective, as applicable, at a rate per annum equal to an additional one-quarter of one percent
(0.25%) of the principal amount of the Securities, to and including the 90th day following such Registration Default and one-half of one percent (0.50%) thereof from and after the 91st day following such Registration Default. 
  
 (b) In the event that (i) the Shelf Registration Statement ceases to be
effective, (ii) the Company suspends the use of the Prospectus pursuant to Section 2(c) or 3(j) hereof, (iii) the Holders are not authorized to use the Prospectus pursuant to Section 3(g) hereto or (iv) the Holders are otherwise prevented or
restricted by the Company from effecting sales pursuant to the Shelf Registration Statement (an “Effective Failure”) for more than 30 days, whether or not consecutive, in any 90-day period, or for more than 90 days, whether or not
consecutive, during any 12-month period, then the Company shall pay Liquidated Damages at a rate per annum equal to an additional one-half of one percent (0.50%) of the principal amount of the Securities from the 31st day of the applicable 90-day period or the 91st day of the applicable 12-month period, as the case may be, that any such
Effective Failure has existed until the earlier of (1) the time (i) the Shelf Registration Statement again becomes effective or (ii) the Holders of Registrable Securities are again able to make sales under the Shelf Registration Statement or (2) the
expiration of the Effectiveness Period. 
  
 (c) Any amounts to be
paid as Liquidated Damages pursuant to paragraphs (a) or (b) of this Section 7 shall be paid in cash semi-annually in arrears, with the first semi-annual payment due on the first Interest Payment Date (as defined in the Indenture), as applicable,
following the date of such Registration Default or Effective Failure, as applicable. Such Liquidated Damages will accrue in respect of the Securities at the rates set forth in paragraphs (a) or (b) of this Section 7, as applicable, on the principal
amount of the Securities. 
  
 (d) Except as provided in Section
8(b) hereof, the Liquidated Damages as set forth in this Section 7 shall be the exclusive monetary remedy available to the Holders of Registrable Securities for such Registration Default or Effective Failure. In no event shall the Company be
required to pay Liquidated Damages in excess of the applicable maximum amount of one-half of one percent (0.50%) set forth above, regardless of whether one or multiple Registration Defaults or Effective Failures exist. 
  

 14 

 8. Miscellaneous. 
  
 (a) Other Registration Rights. The Company may grant registration rights that would permit any person that is a third
party the right to piggy-back on any Shelf Registration Statement, provided that if the Managing Underwriter of any underwritten offering conducted pursuant to Section 6 hereof notifies the Company and the Electing Holders that the total
amount of securities which the Electing Holders and the holders of such piggy-back rights intend to include in any Shelf Registration Statement is so large as to materially threaten the success of such offering (including the price at which such
securities can be sold), then the amount, number or kind of securities to be offered for the account of holders of such piggy-back rights will be reduced to the extent necessary to reduce the total amount of securities to be included in such
offering to the amount, number and kind recommended by the Managing Underwriter prior to any reduction in the amount of Registrable Securities to be included in such Shelf Registration Statement. 
  
 (b) Specific Performance. The parties hereto acknowledge that there
would be no adequate remedy at law if the Company fails to perform any of its obligations hereunder and that the Purchasers and the Holders from time to time may be irreparably harmed by any such failure, and accordingly agree that the Purchasers
and such Holders, in addition to any other remedy to which they may be entitled at law or in equity and without limiting the remedies available to the Electing Holders under Section 7 hereof, shall be entitled to compel specific performance of the
obligations of the Company under this Registration Rights Agreement in accordance with the terms and conditions of this Registration Rights Agreement, in any court of the United States or any State thereof having jurisdiction. 
  
 (c) Amendments and Waivers. This Agreement, including this Section
8(c), may be amended, and waivers or consents to departures from the provisions hereof may be given, only by a written instrument duly executed by the Company and the holders of a majority in aggregate principal amount of Registrable Securities then
outstanding. Each Holder of Registrable Securities outstanding at the time of any such amendment, waiver or consent or thereafter shall be bound by any amendment, waiver or consent effected pursuant to this Section 8(c), whether or not any notice,
writing or marking indicating such amendment, waiver or consent appears on the Registrable Securities or is delivered to such Holder. 
  
 (d) Notices. All notices and other communications provided for or permitted hereunder shall be given as provided in the Indenture. 
  
 (e) Parties in Interest. The parties to this Agreement intend that all
Holders of Registrable Securities shall be entitled to receive the benefits of this Agreement and that any Electing Holder shall be bound by the terms and provisions of this Agreement by reason of such election with respect to the Registrable
Securities which are included in a Shelf Registration Statement. All the terms and provisions of this Agreement shall be binding upon, shall inure to the benefit of and shall be enforceable by the respective successors and assigns of the parties
hereto and any Holder from time to time of the Registrable Securities to the aforesaid extent. In the event that any transferee of any Holder of Registrable Securities shall acquire Registrable Securities, in any manner, whether by gift, bequest,
purchase, operation of law or otherwise, such transferee shall, without any further writing or action of any kind, be entitled to receive the benefits of and, if an Electing Holder, be conclusively deemed to have agreed to be bound by and to perform
all of the terms and provisions of this Agreement to the aforesaid extent. 
  

 15 

 (f) Counterparts. This Agreement may be executed in any number of counterparts and by the parties
hereto in separate counterparts, each of which when so executed shall be deemed to be an original and all of which taken together shall constitute one and the same agreement. 
  
 (g) Headings. The headings in this Agreement are for convenience of reference only and shall not limit or otherwise
affect the meaning hereof. 
  
 (h) Governing Law. This
Agreement shall be governed by and construed in accordance with the laws of the State of New York. 
  
 (i) Severability. In the event that any one or more of the provisions contained herein, or the application thereof in any circumstances, is held
invalid, illegal or unenforceable in any respect for any reason, the validity, legality and enforceability of any such provision in every other respect and of the remaining provisions hereof shall not be in any way impaired or affected thereby, it
being intended that all of the rights and privileges of the parties hereto shall be enforceable to the fullest extent permitted by law. 
  
 (j) Survival. The respective indemnities, agreements, representations, warranties and other provisions set forth in this Agreement or made pursuant
hereto shall remain in full force and effect, regardless of any investigation (or any statement as to the results thereof) made by or on behalf of any Electing Holder, any director, officer or partner of such Holder, any agent or underwriter, any
director, officer or partner of such agent or underwriter, or any controlling person of any of the foregoing, and shall survive the transfer and registration of the Registrable Securities of such Holder. 
  

 16 

 Please confirm that the foregoing correctly sets forth the agreement between the Company and you.

  

			
	 Very truly yours,

	
	 PSS WORLD MEDICAL, INC.

		
	By:	 	/s/    DAVID D. KLARNER        
	 	 	

	 Name:
	 	David D. Klarner
	 Title:
	 	Vice President

  
 Accepted as of the date hereof:

 Goldman, Sachs & Co. 
  

	
	
	/s/    Goldman, Sachs & Co.        
	

	(Goldman, Sachs & Co.)
	On behalf of each of the Purchasers

  

 17 

 Appendix A 
  

PSS WORLD MEDICAL, INC. 
  
 Notice of Registration Statement 
 and

 Selling Securityholder Questionnaire 
  
 [Date] 
  
 PSS WORLD MEDICAL, INC. (the “Company”) has filed with the United States Securities and Exchange Commission (the “Commission”)
a registration statement on Form S-3 (the “Shelf Registration Statement”) for the registration and resale under Rule 415 of the United States Securities Act of 1933, as amended (the “Securities Act”), of the
Company’s 2.25 % Convertible Senior Notes due March 15, 2024 (the “Securities”) and the shares of common stock, par value $0.01 per share (the “Common Stock”), issuable upon conversion thereof, in accordance with the
Registration Rights Agreement, dated as of March 8, 2004 (the “Registration Rights Agreement”), between the Company and the purchasers named therein. A copy of the Registration Rights Agreement is attached hereto. All capitalized
terms not otherwise defined herein shall have the meanings ascribed thereto in the Registration Rights Agreement. 
  
 In order to have Registrable Securities included in the Shelf Registration Statement (or a supplement or amendment thereto), this Notice of Registration
Statement and Selling Securityholder Questionnaire (“Notice and Questionnaire”) must be completed, executed and delivered to the Company at the address set forth herein for receipt ON OR BEFORE [DEADLINE FOR
RESPONSE]. No holder of Registrable Securities will be entitled: 
  

	 	•	to be named as a selling security holder in the Shelf Registration Statement as of the date the Shelf Registration Statement is declared effective; or 

  

	 	•	to use the prospectus forming a part of the Shelf Registration Statement for offers and resales of Registrable Securities at any time, 

  
 unless such holder has returned a completed and signed Notice and Questionnaire to the
Company. Holders of Registrable Securities who have not returned a Notice and Questionnaire by the deadline specified above will be included in the Shelf Registration Statement through a prospectus supplement or a post-effective amendment to the
Shelf Registration Statement, subject to restrictions on timing provided in the Registration Rights Agreement. 
  
 Certain legal consequences arise from being named as a selling securityholder in the Shelf Registration Statement and related Prospectus. Accordingly,
holders and beneficial owners of Registrable Securities are advised to consult their own securities law counsel regarding the consequences of being named or not being named as a selling securityholder in the Shelf Registration Statement and related
Prospectus. 
  
 The term “Registrable
Securities” is defined in the Registration Rights Agreement to mean all or any portion of the Securities issued from time to time under the Indenture in registered form and the shares of Common Stock issuable upon conversion of such
Securities; provided, however, that a security ceases to be a Registrable Security when it is no longer a Restricted Security. 
  
 The term “Restricted Security” is defined in the Registration Rights Agreement to mean any Security or share of Common Stock
issuable upon conversion thereof except any such Security or share of Common Stock that (i) has been effectively registered under the Securities Act and sold in a manner contemplated by the Shelf Registration Statement, (ii) has been transferred in
compliance with Rule 144 under the Securities Act (or any successor provision thereto) or is transferable pursuant to paragraph (k) of such Rule 144 (or any successor provision thereto), or (iii) has otherwise been transferred and a new 

  

 18 

 
Security or share of Common Stock not subject to transfer restrictions under the Securities Act has been delivered by or on behalf of the Company in
accordance with the Indenture. 
  
 ELECTION 
  
 The undersigned holder (the “Selling Securityholder”) of
Registrable Securities hereby elects to include in the Shelf Registration Statement the Registrable Securities beneficially owned by it and listed below in Item (3). The undersigned, by signing and returning this Notice and Questionnaire, agrees to
be bound with respect to such Registrable Securities by the terms and conditions of this Notice and Questionnaire and the Registration Rights Agreement, including, without limitation, Section 6 of the Registration Rights Agreement, as if the
undersigned Selling Securityholder were an original party thereto. 
  
 Upon any sale of Registrable Securities pursuant to the Shelf Registration Statement, the Selling Securityholder will be required to deliver to the Company and the Trustee the Notice of Transfer (completed and signed) set forth in Exhibit 1
to this Notice and Questionnaire. 
  

 19 

 The Selling Securityholder hereby provides the following information to the Company and represents and
warrants that such information is accurate and complete: 
  
 QUESTIONNAIRE 
  

					
	(1)	 	(a)	 	Full Legal Name of Selling Securityholder:
			
	 	 	 	 	 
	 	 	 	 	

	 	 	(b)	 	Full Legal Name of Registered Holder (if not the same as in (a) above) of Registrable Securities Listed in Item (3) Below:
			
	 	 	 	 	 
	 	 	 	 	

	 	 	(c)	 	Full Legal Name of DTC Participant (if applicable and if not the same as (b) above) Through Which Registrable Securities Listed in Item (3) Below are Held:
			
	 	 	 	 	 
	 	 	 	 	

			
	(2)	 	 	 	Address for Notices to Selling Securityholder:
			
	 	 	 	 	 
	 	 	 	 	

			
	 	 	 	 	 
	 	 	 	 	

			
	 	 	 	 	 
	 	 	 	 	

							
	 	 	 	 	Telephone:	 	 
	 	 	 	 	 	 	

							
	 	 	 	 	Fax:	 	 
	 	 	 	 	 	 	

							
	 	 	 	 	Contact Person:	 	 
	 	 	 	 	 	 	

					
			
	(3)	 	 	 	Beneficial Ownership of the Securities:
	 	 	 	 	Except as set forth below in this Item (3), the undersigned Selling Securityholder does not beneficially own any Registerable Securities or shares of Common Stock issued upon conversion,
repurchase or redemption of any Registerable Securities.
			
	 	 	(a)	 	Principal amount of Registrable Securities (as defined in the Registration Rights Agreement) beneficially owned:
			
	 	 	 	 	 
	 	 	 	 	

	 	 	 	 	CUSIP No(s). of such Registrable Securities:
			
	 	 	 	 	 
	 	 	 	 	

	 	 	 	 	Number of shares of Common Stock (if any) issued upon conversion, repurchase or redemption of Registrable Securities:
			
	 	 	 	 	 
	 	 	 	 	

			
	 	 	(b)	 	Principal amount of Securities other than Registrable Securities beneficially owned:
	 	 	 	 	 
	 	 	 	 	

							
	 	 	 	 	CUSIP No(s). of such other Securities:	 	 
	 	 	 	 	 	 	

					
	 	 	 	 	Number of shares of Common Stock (if any) issued upon conversion of such other Securities:
	 	 	 	 	 
	 	 	 	 	

	 	 	(c)	 	Principal amount of Registrable Securities which the undersigned wishes to be included in the Shelf Registration Statement:
			
	 	 	 	 	 
	 	 	 	 	

  

 20 

					
	 	 	 	 	CUSIP No(s). of such Registrable Securities to be included in the Shelf Registration Statement:
			
	 	 	 	 	 
	 	 	 	 	

	 	 	 	 	Number of shares of Common Stock (if any) issued upon conversion of Registrable Securities which are to be included in the Shelf Registration Statement:
			
	 	 	 	 	 
	 	 	 	 	

	(4)	 	 	 	Beneficial Ownership of Other Securities of the Company:
			
	 	 	 	 	Except as set forth below in this Item (4), the undersigned Selling Securityholder is not the beneficial or registered owner of any shares of Common Stock or any other securities of the
Company, other than the Securities and shares of Common Stock listed above in Item (3).
			
	 	 	 	 	State any exceptions here:
			
	(5)	 	 	 	Relationships with the Company:
			
	 	 	 	 	Except as set forth below, neither the Selling Securityholder nor any of its affiliates, officers, directors or principal equity holders (5% or more) has held any position or office or has
had any other material relationship with the Company (or its predecessors or affiliates) during the past three years.
			
	 	 	 	 	State any exceptions here:
			
	(6)	 	 	 	Nature of the Selling Securityholder:
			
	 	 	(a)	 	Is the selling Securityholder a reporting company under the Securities Exchange Act, a majority owned subsidiary of a reporting company under the Securities Exchange Act or a registered
investment company under the Investment Company Act? If so, please state which one.
			
	 	 	 	 	If the entity is a majority owned subsidiary of a reporting company, identify the majority stockholder that is a reporting company.
			
	 	 	 	 	If the entity is not any of the above, identify the natural person or persons having voting and investment control over the Company’s securities that the entity owns.
			
	 	 	(b)	 	Is the Selling Securityholder a registered broker-dealer? Yes        No
			
	 	 	 	 	State whether the Selling Securityholder received the Registrable Securities as compensation for underwriting activities and, if so, provide a brief description of the transaction(s)
involved.

  

 21 

					
	 	 	 	 	State whether the Selling Securityholder is an affiliate of a broker-dealer and if so, list the name(s) of the broker-dealer affiliate(s).
Yes        No
			
	 	 	 	 	If the answer is “Yes,” you must answer the following:
			
	 	 	 	 	If the Selling Securityholder is an affiliate of a registered broker-dealer, the Selling Securityholder purchased, the Registrable Securities (i) in the ordinary course of business and (ii) at
the time of the purchase of the Registrable Securities, had no agreements or understandings, directly or indirectly, with any person to distribute the Registrable Securities.
			
	 	 	 	 	Yes                 No
			
	 	 	 	 	If the answer is “No”, state any exceptions here:
			
	 	 	 	 	If the answer is “No,” this may affect your ability to be included in the registration statement.
			
	(7)	 	 	 	Plan of Distribution:
			
	 	 	 	 	Except as set forth below, the undersigned Selling Securityholder intends to distribute the Registrable Securities listed above in Item (3) only as follows (if at all): Such Registrable
Securities may be sold from time to time directly by the undersigned Selling Securityholder or, alternatively, through underwriters, broker-dealers or agents. Such Registrable Securities may be sold in one or more transactions at fixed prices, at
prevailing market prices at the time of sale, at varying prices determined at the time of sale or at negotiated prices. Such sales may be effected in transactions (which may involve crosses or block transactions) (i) on any national securities
exchange or quotation service on which the Registrable Securities may be listed or quoted at the time of sale, (ii) in the over-the-counter market, (iii) in transactions otherwise than on such exchanges or services or in the over-the-counter market
or (iv) through the writing of options. In connection with sales of the Registrable Securities or otherwise, the Selling Securityholder may enter into transactions with broker-dealers, which may in turn engage in short sales of the Registrable
Securities in the course of hedging the positions they assume. The Selling Securityholder may also sell Registrable Securities short and deliver Registrable Securities to close out such short positions, or loan or pledge Registrable Securities to
broker-dealers that in turn may sell such securities.
			
	 	 	 	 	State any exceptions here:
			
	 	 	 	 	By signing below, the Selling Securityholder acknowledges that it understands its obligation to comply, and agrees that it will comply, with the prospectus delivery and other provisions of the
Securities Act and the Exchange Act and the rules and regulations thereunder, particularly Regulation M.
			
	 	 	 	 	In the event that the Selling Securityholder transfers all or any portion of the Registrable Securities listed in Item (3) above after the date on which such information is provided to the
Company, the Selling Securityholder agrees to notify the transferee(s) at the time of the transfer of its rights and obligations under this Notice and Questionnaire and the Registration Rights Agreement.

  

 22 

					
			
	 	 	 	 	By signing below, the Selling Securityholder consents to the disclosure of the information contained herein in its answers to Items (1) through (6) above and the inclusion of such information in
the Shelf Registration Statement and related Prospectus. The Selling Securityholder understands that such information will be relied upon by the Company in connection with the preparation of the Shelf Registration Statement and related
Prospectus.
			
	 	 	 	 	In accordance with the Selling Securityholder’s obligation under Section 3(a) of the Registration Rights Agreement to provide such information as may be required by law for inclusion in the
Shelf Registration Statement, the Selling Securityholder agrees to promptly notify the Company of any inaccuracies or changes in the information provided herein which may occur subsequent to the date hereof at any time while the Shelf Registration
Statement remains in effect. All notices hereunder and pursuant to the Registration Rights Agreement shall be made in writing, by hand-delivery, first-class mail or air courier guaranteeing overnight delivery as follows:
			
	 	 	 	 	 (i)     To the Company:

			
	 	 	 	 	 PSS World Medical, Inc.
 4345 Southport Boulevard
 Jacksonville, Florida 32216
 Attn: David D. Klarner

			
	 	 	 	 	 (ii)    With a copy to:

			
	 	 	 	 	 Alston & Bird LLP
 601 Pennsylvania Avenue., N.W.
 North Building, 10th Floor
 Washington, D.C. 2004
 Attn: David E. Brown, Jr.

			
	 	 	 	 	Once this Notice and Questionnaire is executed by the Selling Securityholder and received by the Company, the terms of this Notice and Questionnaire, and the representations and warranties
contained herein, shall be binding on, shall inure to the benefit of and shall be enforceable by the respective successors, heirs, personal representatives, and assigns of the Company and the Selling Securityholder (with respect to the Registrable
Securities beneficially owned by such Selling Securityholder and listed in Item (3) above). This Agreement shall be governed in all respects by the laws of the State of New York.

  
 IN WITNESS WHEREOF,
the undersigned, by authority duly given, has caused this Notice and Questionnaire to be executed and delivered either in person or by its duly authorized agent. 
  

			
	Dated:	  	_________________________________________

			
	
	    ________________________________________________________________________________________________________
	 Selling Securityholder
 (Print/type full legal name of beneficial owner of Registrable Securities)

	 	  	 

  

			
		
	By:	 	 
	 	 	

	 Name:
	 	 
	 Title:
	 	 

  

 23 

 PLEASE RETURN THE COMPLETED AND EXECUTED NOTICE AND QUESTIONNAIRE FOR RECEIPT ON OR BEFORE [DEADLINE FOR RESPONSE]
TO THE COMPANY AT: 
  
 PSS World Medical, Inc. 
 4345 Southport Boulevard 
 Jacksonville,
Florida 32216 
  

 24 

 Exhibit 1 
 to Appendix A 
  
 NOTICE OF
TRANSFER PURSUANT TO REGISTRATION STATEMENT 
  
 PSS World Medical, Inc.

 4345 Southpoint Blvd. 
 Jacksonville, Florida 32216 

 
 Attention: [General Counsel] 
  
 [Wachovia Bank N.A.] 
 [Address of Trustee]

  
 Attention: [Corporate Trust Services] 
  

	 	Re:	PSS World Medical, Inc. (the “Company”) 2.25% Convertible Senior Notes due March 15, 2024 (the “Notes”) 

  
 Dear Sirs: 
  
 Please be advised that
                             has transferred
$                 aggregate principal amount of the above-referenced Notes or shares of the Company’s common stock, issued upon conversion, repurchase or
redemption of Notes, pursuant to an effective Registration Statement on Form S-3 (File No. 333-            ) filed by the Company. 
  
 We hereby certify that the prospectus delivery requirements, if any, of the
Securities Act of 1933, as amended, have been satisfied with respect to the transfer described above and that the above-named beneficial owner of the Notes or common stock is named as a selling securityholder in the Prospectus dated [date],
or in amendments or supplements thereto, and that the aggregate principal amount of the Notes or number of shares of common stock transferred are a portion of the Notes or shares of common stock listed in such Prospectus as amended or supplemented
opposite such owner’s name. 
  
 Dated: 
  

			
	 	 	Very truly yours,
		
	 	 	 
	 	 	

	 	 	(Name)
		
	By:	 	 
	 	 	

	 	 	 (Authorized Signature)

  

 25INDENTURE

  
 EXHIBIT 4.2 
 Execution 
 Version 

  
 PSS World Medical, Inc. 

 
 as Issuer, 
  
 and 
  
 Wachovia Bank, National Association, 
  
 as Trustee 
  

  
 INDENTURE 
  
 Dated as of March 8, 2004 
  

  
 2.25% Convertible Senior
Notes due March 15, 2024 
  

  
 CROSS-REFERENCE TABLE

  

			
	 TIA Section

	  	 Indenture
Section

	 310(a)(1)
	  	 11.10

	       (a)(2)
	  	 11.10

	       (a)(3)
	  	N.A.
	       (a)(4)
	  	N.A.
	       (a)(5)
	  	11.10
	       (b)
	  	11.3; 11.8; 11.10; 15.2
	       (c)
	  	N.A.
	 311(a)
	  	 11.11

	       (b)
	  	 11.11

	       (c)
	  	 N.A.

	 312(a)
	  	 2.5

	       (b)
	  	 15.3

	       (c)
	  	 N.A.

	 313(a)
	  	 11.6

	       (b)(1)
	  	 N.A.

	       (b)(2)
	  	 11.6

	       (c)
	  	 11.6; 15.2

	       (d)
	  	 11.6

	 314(a)
	  	 3.7; 3.8

	       (b)
	  	 N.A.

	       (c)(1)
	  	 15.4

	       (c)(2)
	  	 15.4

	       (c)(3)
	  	 15.4

	       (d)
	  	 N.A.

	       (e)
	  	 15.5

	       (f)
	  	 N.A.

	 315(a)
	  	 11.1(b); 11.1(g); 11.2

	       (b)
	  	 11.5; 15.2

	       (c)
	  	 11.1(a)

	       (d)
	  	 11.1(c)

	       (e)
	  	 10.9

	 316(a)(last sentence)
	  	 2.9; 15.6

	       (a)(1)(A)
	  	 10.7

	       (a)(1)(B)
	  	 10.7

	       (a)(2)
	  	 N.A.

	       (b)
	  	 10.4

	       (c)
	  	 14.4

	 317(a)(1)
	  	 10.2

	       (a)(2)
	  	 10.2

	       (b)
	  	 2.4

	 318(a)
	  	 15.1

  
 N.A. means not applicable 

Note: This Cross-Reference table shall not, for any purpose, be deemed to be part of this Indenture. 
  

 i 

 TABLE OF CONTENTS 
  

					
	 	  	 	  	Page

	ARTICLE I
	DEFINITIONS AND INCORPORATION BY REFERENCE
			
	 SECTION 1.1.
	  	 Definitions
	  	1
	 SECTION 1.2.
	  	 Incorporation by Reference of Trust Indenture Act
	  	11
	 SECTION 1.3.
	  	 Rules of Construction
	  	11
	
	ARTICLE II
	THE NOTES
			
	 SECTION 2.1.
	  	 Form, Dating and Terms
	  	12
	 SECTION 2.2.
	  	 Execution and Authentication
	  	18
	 SECTION 2.3.
	  	 Registrar, Conversion Agent and Paying Agent
	  	19
	 SECTION 2.4.
	  	 Paying Agent To Hold Money and Securities in Trust
	  	20
	 SECTION 2.5.
	  	 Holder Lists
	  	20
	 SECTION 2.6.
	  	 Transfer and Exchange
	  	21
	 SECTION 2.7.
	  	 Form of Certificate To Be Delivered in Connection with Transfers to Institutional Accredited Investors
	  	22
	 SECTION 2.8.
	  	 Mutilated, Destroyed, Lost or Stolen Notes
	  	24
	 SECTION 2.9.
	  	 Outstanding Notes
	  	25
	 SECTION 2.10.
	  	 Temporary Notes
	  	25
	 SECTION 2.11.
	  	 Cancellation
	  	25
	 SECTION 2.12.
	  	 Payment of Interest; Defaulted Interest
	  	26
	 SECTION 2.13.
	  	 Computation of Interest
	  	27
	 SECTION 2.14.
	  	 CUSIP Numbers
	  	27
	 SECTION 2.15.
	  	 Issuance, Transfer and Exchange of Common Stock Issuable Upon Conversion of the Notes
	  	27
	 SECTION 2.16.
	  	 Calculations in Respect of the Notes
	  	28
	
	ARTICLE III
	COVENANTS
			
	 SECTION 3.1.
	  	 Payment of Notes
	  	28
	 SECTION 3.2.
	  	 Maintenance of Office or Agency
	  	29
	 SECTION 3.3.
	  	 Money and Securities for Note Payments To Be Held in Trust
	  	29
	 SECTION 3.4.
	  	 Corporate Existence
	  	30

  

 ii 

					
	 SECTION 3.5.
	  	 Further Instruments and Acts
	  	31
	 SECTION 3.6.
	  	 Liquidated Damages Notices
	  	31
	 SECTION 3.7.
	  	 SEC Reports
	  	31
	 SECTION 3.8.
	  	 Compliance Certificates
	  	31
	 SECTION 3.9.
	  	 Rule 144A Information Requirement
	  	31
	 SECTION 3.10.
	  	 Stay, Extension and Usury Laws
	  	32
	 SECTION 3.11.
	  	 Notice of Default
	  	32
	 SECTION 3.12.
	  	 Contingent Debt Treatment
	  	32
	
	ARTICLE IV
	SUCCESSOR COMPANY
			
	 SECTION 4.1.
	  	 Merger and Consolidation
	  	33
	 SECTION 4.2.
	  	 Successor Corporation Substituted
	  	34
	
	ARTICLE V
	REDEMPTION OF NOTES
			
	 SECTION 5.1.
	  	 Optional Redemption
	  	34
	 SECTION 5.2.
	  	 Applicability of Article
	  	34
	 SECTION 5.3.
	  	 Election to Redeem; Notice to Trustee
	  	34
	 SECTION 5.4.
	  	 Selection by Trustee of Notes To Be Redeemed
	  	34
	 SECTION 5.5.
	  	 Notice of Redemption
	  	35
	 SECTION 5.6.
	  	 Deposit of Redemption Price
	  	36
	 SECTION 5.7.
	  	 Notes Payable on Redemption Date
	  	36
	 SECTION 5.8.
	  	 Notes Redeemed in Part
	  	37
	 SECTION 5.9.
	  	 Arrangement on Call for Redemption
	  	37
	
	ARTICLE VI
	REPURCHASE UPON A FUNDAMENTAL CHANGE
			
	 SECTION 6.1.
	  	 Repurchase at the Option of the Holder upon a Fundamental Change
	  	38
	 SECTION 6.2.
	  	 Notice of Fundamental Change
	  	38
	 SECTION 6.3.
	  	 Exercise of Option
	  	38
	 SECTION 6.4.
	  	 Procedures
	  	39
	
	ARTICLE VII
	OPTIONAL REPURCHASE
			
	 SECTION 7.1.
	  	 Repurchase of Notes by the Company at the Option of the Holder
	  	40

  

 iii 

					
	ARTICLE VIII
	CONDITIONS AND PROCEDURES FOR REPURCHASES AT OPTION OF HOLDERS
			
	 SECTION 8.1.
	  	 Notice of Repurchase Date or Fundamental Change
	  	42
	 SECTION 8.2.
	  	 Effect of Repurchase Notice or Fundamental Change Repurchase Notice
	  	43
	 SECTION 8.3.
	  	 Notes Repurchased in Part
	  	44
	 SECTION 8.4.
	  	 Covenant to Comply with Securities Laws upon Repurchase of Notes
	  	44
	 SECTION 8.5.
	  	 Repayment to the Company
	  	44
	 SECTION 8.6.
	  	 Exchange in Lieu of Repurchase
	  	45
	
	ARTICLE IX
	CONVERSION OF NOTES
			
	 SECTION 9.1.
	  	 Right To Convert
	  	45
	 SECTION 9.2.
	  	 Determination of Satisfaction of Certain Conversion Triggers
	  	47
	 SECTION 9.3.
	  	 Conversion Procedures
	  	48
	 SECTION 9.4.
	  	 Cash Payments in Lieu of Fractional Shares
	  	50
	 SECTION 9.5.
	  	 Taxes on Conversion
	  	50
	 SECTION 9.6.
	  	 Exchange in Lieu of Conversion
	  	50
	 SECTION 9.7.
	  	 Covenants of the Company
	  	51
	 SECTION 9.8.
	  	 Adjustments to Conversion Rate
	  	51
	 SECTION 9.9.
	  	 Calculation Methodology
	  	55
	 SECTION 9.10.
	  	 When No Adjustment Required
	  	55
	 SECTION 9.11.
	  	 Notice of Adjustment
	  	56
	 SECTION 9.12.
	  	 Voluntary Increase
	  	56
	 SECTION 9.13.
	  	 Notice to Holders Prior to Certain Actions
	  	57
	 SECTION 9.14.
	  	 Effect of Reclassification, Consolidation, Merger, Binding Share Exchange or Sale
	  	57
	 SECTION 9.15.
	  	 Responsibility of Trustee
	  	58
	 SECTION 9.16.
	  	 Successive Adjustments
	  	58
	 SECTION 9.17.
	  	 General Considerations
	  	59
	 SECTION 9.18.
	  	 Payment of Cash in Lieu of Common Stock
	  	59
	
	ARTICLE X
	DEFAULTS AND REMEDIES
			
	 SECTION 10.1.
	  	 Events of Default
	  	60

  

 iv 

					
	 SECTION 10.2.
	  	 Payment of Notes on Default; Suit Therefor
	  	62
	 SECTION 10.3.
	  	 Application of Moneys Collected by Trustee
	  	63
	 SECTION 10.4.
	  	 Proceedings by Holders
	  	64
	 SECTION 10.5.
	  	 Proceedings by Trustee
	  	64
	 SECTION 10.6.
	  	 Remedies Cumulative and Continuing
	  	65
	 SECTION 10.7.
	  	 Direction of Proceedings; Waiver of Defaults by Majority of Holders
	  	65
	 SECTION 10.8.
	  	 Notice of Defaults
	  	65
	 SECTION 10.9.
	  	 Undertaking to Pay Costs
	  	66
	
	ARTICLE XI
	TRUSTEE
			
	 SECTION 11.1.
	  	 Duties of Trustee
	  	66
	 SECTION 11.2.
	  	 Rights of Trustee
	  	67
	 SECTION 11.3.
	  	 Individual Rights of Trustee
	  	69
	 SECTION 11.4.
	  	 Trustee’s Disclaimer
	  	69
	 SECTION 11.5.
	  	 Notice of Defaults
	  	69
	 SECTION 11.6.
	  	 Reports by Trustee to Holders
	  	69
	 SECTION 11.7.
	  	 Compensation and Indemnity
	  	70
	 SECTION 11.8.
	  	 Replacement of Trustee
	  	70
	 SECTION 11.9.
	  	 Successor Trustee by Merger
	  	71
	 SECTION 11.10.
	  	 Eligibility; Disqualification
	  	72
	 SECTION 11.11.
	  	 Preferential Collection of Claims Against Company
	  	72
	
	ARTICLE XII
	CONTINGENT INTEREST
			
	 SECTION 12.1.
	  	 Contingent Interest
	  	72
	 SECTION 12.2.
	  	 Payment of Contingent Interest
	  	72
	 SECTION 12.3.
	  	 Notice of Contingent Interest
	  	72
	
	ARTICLE XIII
	SATISFACTION AND DISCHARGE OF INDENTURE; UNCLAIMED MONEYS
			
	 SECTION 13.1.
	  	 Satisfaction and Discharge of Indenture
	  	73
	 SECTION 13.2.
	  	 Application by Trustee of Funds Deposited for Payment of Notes
	  	74
	 SECTION 13.3.
	  	 Repayment of Moneys Held by Paying Agent
	  	74

  

 v 

					
	 SECTION 13.4.
	  	 Return of Moneys Held by Trustee and Paying Agent Unclaimed for Two Years
	  	74
	 SECTION 13.5.
	  	 Indemnity for U.S. Government Obligations
	  	74
	
	ARTICLE XIV
	AMENDMENTS
			
	 SECTION 14.1.
	  	 Without Consent of Holders
	  	75
	 SECTION 14.2.
	  	 With Consent of Holders
	  	75
	 SECTION 14.3.
	  	 Compliance with Trust Indenture Act
	  	76
	 SECTION 14.4.
	  	 Revocation and Effect of Consents and Waivers
	  	76
	 SECTION 14.5.
	  	 Notation on or Exchange of Notes
	  	77
	 SECTION 14.6.
	  	 Trustee To Sign Amendments
	  	77
	
	ARTICLE XV
	MISCELLANEOUS
			
	 SECTION 15.1.
	  	 Trust Indenture Act Controls
	  	77
	 SECTION 15.2.
	  	 Notices
	  	77
	 SECTION 15.3.
	  	 Communication by Holders with Other Holders
	  	78
	 SECTION 15.4.
	  	 Certificate and Opinion as to Conditions Precedent
	  	78
	 SECTION 15.5.
	  	 Statements Required in Certificate or Opinion
	  	78
	 SECTION 15.6.
	  	 When Notes Disregarded
	  	79
	 SECTION 15.7.
	  	 Rules by Trustee, Paying Agent and Registrar
	  	79
	 SECTION 15.8.
	  	 Governing Law
	  	79
	 SECTION 15.9.
	  	 No Recourse Against Others
	  	79
	 SECTION 15.10.
	  	 Successors
	  	80
	 SECTION 15.11.
	  	 Multiple Originals
	  	80
	 SECTION 15.12.
	  	 Variable Provisions
	  	80
	 SECTION 15.13.
	  	 Qualification of Indenture
	  	80

  
 EXHIBITS AND
ANNEXURES 
  

			
		
	EXHIBIT A	  	Form of Note
		
	EXHIBIT B	  	Form of Transfer Certificate for Transfer of Restricted Stock
		
	ANNEX A	  	Projected Payment Schedule

  

 vi 

  
 INDENTURE, dated as of March
8, 2004, between PSS World Medical, Inc., a Florida corporation (the “Company”), and Wachovia Bank, National Association, a national banking association, as trustee (the “Trustee”). 
  
 RECITALS OF THE COMPANY 
  
 The Company has duly authorized the execution and delivery of this Indenture
to provide for the issuance of up to $150,000,000 principal amount of the Company’s 2.25% Convertible Senior Notes due March 15, 2024, convertible into common stock, par value $0.01 per share (the “Common Stock”), of the Company (the
“Notes”). 
  
 Each party agrees as follows for the
benefit of the other parties and for the equal and ratable benefit of the Holders of the Notes: 
  
 ARTICLE I 
  
 DEFINITIONS
AND INCORPORATION BY REFERENCE 
  
 SECTION 1.1.
Definitions. 
  
 “9.8(g) Current Market
Price” means the average of the Closing Sale Prices of the Common Stock for the five consecutive Trading Days beginning on the Trading day next succeeding the date of the repurchase triggering the adjustment in Section 9.8(g). 

 
 “actual knowledge” has the meaning set forth in Section
11.2(g). 
  
 “Affiliate” of any specified Person
means any other Person, directly or indirectly, controlling or controlled by or under direct or indirect common control with such specified Person. For the purposes of this definition, “control” when used with respect to any Person means
the power to direct the management and policies of such Person, directly or indirectly, whether through the ownership of voting securities, by contract or otherwise; and the terms “controlling” and “controlled” have meanings
correlative to the foregoing. 
  
 “Agent Members”
has the meaning set forth in Section 2.1(g)(ii). 
  
 “Applicable Stock Price” means the average of the Closing Sale Prices of the Common Stock for the five consecutive Trading Day period beginning on the third Trading Day following the Conversion Date. 
  
 “Authenticating Agent” has the meaning set forth in Section
2.2. 
  
 “Bankruptcy Code” means the United
States Bankruptcy Code, 11 United States Code § 101 et seq., or any successor statute thereto. 
  
 “Beneficial Owner” has the meaning set forth in Rule 13d-3 of the Exchange Act. 
  

 1 

 “Board of Directors” means either the board of directors of the Company or other body
fulfilling the function of a board of directors of a corporation or other Person or any committee of such board. 
  
 “Board Resolution” means a copy of a resolution certified by the Secretary or an Assistant Secretary of a company to have been duly
adopted by the board of directors of such company and to be in full force and effect on the date of such certification, and delivered to the Trustee. 
  
 “Business Day” means each day that is not a Saturday, Sunday or other day on which banking institutions in New York, New York are
authorized or required by law, regulation or executive order to close. 
  
 “Capital Stock” of any Person means any and all shares (including ordinary shares or “American Depositary Shares”), interests, rights to purchase, warrants, options, participations or other equivalents of or
interests in (however designated) corporate stock or other equity participations, including partnership interests, whether general or limited, of such Person and any rights (other than debt securities convertible or exchangeable into an equity
interest), warrants or options to acquire an equity interest in such Person. 
  
 “Cash Amount Per Note” has the meaning set forth in Section 9.18(b). 
  
 A “Change in Control” shall be deemed to have occurred at such time after the original issuance of the Notes that any of the following
occurs: 
  
 (a) any person, including any
syndicate or group deemed to be a “person” under Section 13(d) (3) of the Exchange Act, files a Schedule TO or any schedule, form or report under the Exchange Act disclosing that such person, syndicate or group has become the direct or
indirect ultimate “beneficial owner,” as defined in Rule 13d-3 under the Exchange Act, of more than 50% of the Company’s Capital Stock that are entitled to vote generally in elections of directors, other than an acquisition by the
Company, any of its Subsidiaries or any of its employee benefit plans; 
  
 (b) the Company consummates any share exchange, consolidation or merger pursuant to which the Common Stock will be converted into cash, securities, or other property, or the Company conveys, sells, transfers or leases
all or substantially all of its consolidated assets to another Person, other than any transaction pursuant to which the holders of the Company’s Common Stock immediately prior to the transaction have the entitlement to exercise, directly or
indirectly, 50% or more of the total voting power of all shares of Capital Stock entitled to vote generally in the election of directors of the continuing or surviving corporation immediately after the transaction. 
  
 Notwithstanding the foregoing provisions, a Change in Control shall not be
deemed to have occurred if: (i) the Closing Sale Price of the Common Stock for any five Trading Days within the period of ten consecutive Trading Days ending immediately after the later of the Change in Control or the public announcement of the
Change in Control, in the case of a Change in Control relating to an acquisition of Capital Stock under clause (a) of this definition, or the period of ten consecutive Trading Days ending immediately before the Change in Control, 

  

 2 

 
in the case of a Change in Control relating to a merger, consolidation, asset sale or otherwise under clause (b) of this definition, equals or exceeds 105%
of the Conversion Price in effect on each of those five Trading Days; or (ii) all of the consideration paid for the Common Stock (excluding cash payments for fractional shares and cash payments made pursuant to dissenters’ appraisal rights) in
a merger or consolidation or a conveyance, sale, transfer or lease otherwise constituting a Change in Control under clause (a) and/or clause (b) of this definition consists of shares of Capital Stock traded on a national securities exchange or
quoted on Nasdaq or its successor (or will be so traded or quoted immediately following the merger or consolidation) and, as a result of the merger or consolidation, the Notes become convertible into shares of such Capital Stock. 
  
 “Closing Sale Price” of the Common Stock on any date means
the closing per share sale price per share (or, if no closing sale price is reported, the average of the bid and ask prices or, if more than one in either case, the average of the average bid and the average ask prices) on that date as reported in
composite transactions by The Nasdaq National Market or, if the Common Stock is not then quoted on The Nasdaq National Market, then on the principal U.S. national or regional securities exchange or market on which the Common Stock is then listed or
quoted. The Closing Sale Price shall be determined without reference to after-hours or extended market trading. If the Common Stock is not listed for trading on a U.S. national or regional securities exchange and not reported by The Nasdaq National
Market on the relevant date, the Closing Sale Price shall be the last quoted bid for the Common Stock in the over-the-counter market on the relevant date as reported by the National Quotation Bureau or similar organization. If the Common Stock is
not so quoted, the Closing Sale Price shall be the average of the midpoint of the last bid and asked prices for the Common Stock on the relevant date from each of at least three nationally recognized independent investment banking firm selected by
the Company for this purpose. 
  
 “Commission”
means the Securities and Exchange Commission. 
  
 “Common
Stock” has the meaning stated in the first recital of this Indenture. 
  
 “Company” means PSS World Medical, Inc., a Florida corporation, and, subject to Article IV, its successors and assigns. 
  
 “Company Notice” has the meaning set forth in Section 8.1. 
  
 “Company Notice Date” has the meaning set forth in Section
8.1. 
  
 “Company Order” has the meaning set
forth in Section 2.2. 
  
 “Contingent Interest”
means the interest amounts payable pursuant to Section 12.1. 
  
 “Conversion Agent” means the office or agency designated by the Company where Notes may be presented for conversion. 
  
 “Conversion Date” has the meaning set forth in Section 9.3. 
  

 3 

 “Conversion Obligation” has the meaning set forth in Section 9.18. 
  
 “Conversion Price” means $1,000 divided by the Conversion
Rate. 
  
 “Conversion Rate” has the meaning set
forth in Section 9.1. 
  
 “Corporate Trust
Office” means the designated corporate trust office of the Trustee at which at any time its corporate trust business shall be administered, which office at the date hereof is located at 40 Broad Street, 5th floor, New York, New York 10004, or such other address as the Trustee may designate from time to time by notice to the Holders and the Company, or
the designated corporate trust office of any successor Trustee (or such other address as such successor Trustee may designate from time to time by notice to the Holders and the Company). 
  
 “Current Market Price” means the average of the Closing Sale Prices of the Common Stock for the five
consecutive Trading Days ending on or at the Time of Determination. 
  
 “Default” means any event or condition that is, or after notice or passage of time or both would be, an Event of Default. 
  
 “Defaulted Interest” has the meaning set forth in Section 2.12. 
  
 “Definitive Notes” means the Notes that are in registered definitive form. 
  
 “Depositary” means The Depository Trust Company, its
nominees and their respective successors and assigns, or such other depositary institution hereinafter appointed by the Company. 
  
 “Distributed Assets” has the meaning set forth in Section 9.8(c). 
  
 “Equity Interests” means any Capital Stock, partnership, joint venture, member or limited liability or
unlimited liability company interest, beneficial interest in a trust or similar entity or other equity interest or equity investment of whatever nature. 
  
 “Event of Default” means any event or condition specified as such in Section 10.1. 
  
 “Exchange Act” means the Securities Exchange Act of 1934, as
amended. 
  
 “ex-date” or “ex-dividend
date” has the meaning set forth in Section 9.1(g). 
  
 “Expiration Time” has the meaning set forth in Section 9.8(f). 
  
 “Fair Market Value” means, with respect to any asset or property, the price which could be negotiated in an arm’s-length, free market transaction, for cash, between a willing seller and a willing
and able buyer, neither of whom is under undue pressure or compulsion to 

  

 4 

 
complete the transaction. Fair Market Value shall be determined by the Board of Directors acting reasonably and in good faith. 
  
 “Fundamental Change” means the occurrence of a Change in
Control or a Termination of Trading. 
  
 “Fundamental
Change Repurchase Date” has the meaning set forth in Section 6.1. 
  
 “Fundamental Change Repurchase Notice” has the meaning set forth in Section 6.3. 
  
 “Fundamental Change Repurchase Price” has the meaning set forth in Section 6.1. 
  
 “GAAP” means generally accepted accounting principles set
forth in the opinions and pronouncements of the Accounting Principles Board of the American Institute of Certified Public Accountants and statements and pronouncements of the Financial Accounting Standards Board or in such other statements by such
other entity as may be approved by a significant segment of the accounting profession of the United States, as in effect on the date hereof. 
  
 “Global Notes” means Notes that are in the form of the Note attached hereto as Exhibit A and that are issued to a Depositary.

  
 “Holder” means, in the case of any Note, the
Person in whose name such Note is registered in the Note Register kept by the Registrar for that purpose in accordance with the terms hereof. 
  
 “IAI” means institutional accredited investors (as defined in Rules 501(a)(1), (2), (3) and (7) under the Securities Act) who are not
QIBs. 
  
 “Indebtedness” as applied to any
Person, means (i) all indebtedness, obligations and other liabilities, contingent or otherwise, (A) for borrowed money, including overdrafts, foreign exchange contracts, currency exchange agreements, interest rate protection agreements, any
liability for the deferred purchase price of property or services, and any loans or advances from banks, whether or not evidenced by notes or similar instruments, or (B) evidenced by credit or loan agreements, bonds, debentures, notes or similar
instruments, whether or not the recourse of the lender is to the whole of such Person’s assets or to only a portion thereof, other than any account payable or other accrued current liability or obligation incurred in the ordinary course of
business in connection with the obtaining of materials or services; (ii) all reimbursement obligations and other liabilities, contingent or otherwise, with respect to letters of credit, bank guarantees, bankers’ acceptances or other similar
credit transactions; (iii) all obligations and liabilities, contingent or otherwise, in respect of leases required, in conformity with GAAP, to be accounted for as capitalized lease obligations on such Person’s balance sheet; (iv) all
obligations and other liabilities, contingent or otherwise, under any lease or related document, including a purchase agreement, conditional sale or other title retention agreement, in connection with the lease of real property or improvements
thereon (or any personal property included as part of any such lease) which provides that such Person is contractually obligated to purchase or cause a third party to 

  

 5 

 
purchase the leased property or pay an agreed upon residual value of the leased property, including such Person’s obligations under such lease or
related document to purchase or cause a third party to purchase such leased property or pay an agreed upon residual value of the leased property to the lessor; (v) all such Person’s obligations, contingent or otherwise, with respect to an
interest rate or other swap, cap, floor or collar agreement or hedge agreement, forward contract or other similar instrument or agreement or foreign currency hedge, exchange, purchase or similar instrument or agreement; (vi) all such Person’s
direct or indirect guarantees or similar agreements by such Person in respect of, and all of its obligations or liabilities to purchase or otherwise acquire or otherwise assure a creditor against loss in respect of, indebtedness, obligations or
liabilities of another Person of the kinds described in clauses (i) through (v); and (vii) any and all deferrals, renewals, extensions, refinancings and refundings of, or amendments, modifications or supplements to, any indebtedness, obligation or
liability of the kinds described in clauses (i) through (vi). 
  
 “Indenture” means this Indenture as amended or supplemented from time to time, including, for all purposes of this instrument and any supplemental indenture or amendment hereto, the provisions of the TIA that are deemed to
be a part of and govern this instrument and any such supplemental indenture or amendment, respectively. 
  
 “Initial Public Offering” means, in the event of a Spin-Off, the first time securities of the same class or type as the securities being
distributed in the Spin-Off are bona fide offered to the public for cash. 
  
 “Initial Purchasers” means the initial purchasers of the Notes. 
  
 “Interest Payment Date” has the meaning set forth in the form of Note attached hereto as Exhibit A. 
  
 “Interest Period” has the meaning set forth in Section 12.1.

  
 “Liquidated Damages” has the meaning set
forth in Section 3.6. For all purposes under this Indenture, the term “interest” shall include Liquidated Damages, if any, with respect to the Notes. 
  

“Liquidated Damages Notice” has the meaning set forth in Section 3.6. 
  
 “Market Capitalization” means the product of (i) 9.8(g) Current Market Price multiplied by (ii) number of
Common Stocks outstanding on the date of the repurchase triggering the adjustment set forth under Section 9.8(g). 
  
 “Measurement Period” has the meaning set forth in Section 12.1. 
  
 “Moody’s” means Moody’s Investor Services, Inc. (or its successors). 
  
 “non-electing share” has the meaning set forth in Section
9.14. 
  

 6 

 “Note” or “Notes” has the meaning stated in the first recital of this
Indenture or, as the case may be, means Notes that have been authenticated and delivered pursuant to this Indenture, including the Global Note(s). 
  
 “Notes Custodian” means the Trustee or any Person appointed by the Trustee to act as custodian of Global Notes for the Depositary.

  
 “Note Register” has the meaning set forth in
Section 2.3. 
  
 “Notes Custodian” means the
custodian with respect to the Global Note (as appointed by the Depositary or any successor Person thereto) and shall initially be the Trustee. 
  
 “Officer” means the Chief Executive Officer, the President, the Chief Financial Officer, any Vice President, the Treasurer, any Assistant
Treasurer, the Secretary or any Assistant Secretary of the Company. 
  
 “Officers’ Certificate” means a certificate signed by any two Officers of the Company. Each such certificate shall include the statements provided for in Section 15.5, if and to the extent required by the provisions of
Section 15.4. 
  
 “Opinion of Counsel” means a
written opinion from legal counsel. The counsel may be an employee of or counsel to the Company. Each such opinion shall include the statements provided for in Section 15.5, if and to the extent required by the provisions of Section 15.4.

  
 “Outstanding Notes” has the meaning set forth
in Section 2.9. 
  
 “Paying Agent” means the
office or agency designated by the Company where Notes may be presented for payment, initially the Trustee. 
  
 “Person” means any individual, corporation, partnership, limited liability company, joint venture, association, joint-stock company,
trust, unincorporated organization, government or any agency or political subdivision thereof or any other entity. 
  
 “Principal Value Conversion” has the meaning set forth in Section 9.1(c). 
  
 “protected purchaser” has the meaning set forth in Section 2.8. 
  
 “Purchased Shares” has the meaning set forth in Section
9.8(f)(i). 
  
 “QIB” means any “qualified
institutional buyer” (as defined in Rule 144A under the Securities Act). 
  
 “Redemption Date” means the date fixed for redemption of the Notes. 
  
 “Redemption Price” has the meaning set forth in paragraph 6 of the Notes. 
  
 “Registrar” means the office or agency maintained by the Company where Notes may be presented for
registration of transfer or exchange, initially the Trustee. 
  

 7 

 “Registration Rights Agreement” means that certain registration rights agreement dated
as of the date of this Indenture by and between the Company and the Initial Purchasers. 
  
 “Regular Record Date” has the meaning set forth in the form of Note attached hereto as Exhibit A. 
  
 “Repurchase Date” has the meaning set forth in Section 7.1(a). 
  
 “Repurchase Notice” has the meaning set forth in Section 7.1(a)(1). 
  
 “Repurchase Premium” has the meaning set forth in Section
9.8(g). 
  
 “Repurchase Price” has the meaning
provided in paragraph 8 of the Notes. 
  
 “Resale
Restriction Termination Date” has the meaning set forth on Section 2.6(a). 
  
 “Responsible Officer,” when used with respect to the Trustee, means any officer assigned by the Trustee to administer its corporate trust matters and who is located at the Corporate Trust Office and
who shall have the direct responsibility for the administration of this Indenture. 
  
 “Restricted Note Legend” means the legend set forth in Section 2.1(d). 
  
 “Restricted Stock Legend” means the legend required by Section 2.1(e). 
  
 “Securities Act” means the Securities Act of 1933, as amended. 
  
 “Shelf Registration Statement” shall have the meaning set
forth in the Registration Rights Agreement. 
  
 “Significant Subsidiary” means any Subsidiary that is a “Significant Subsidiary” of the Company within the meaning of Rule 1-02(w) under Regulation S-X promulgated by the Commission. 
  
 “Special Interest Payment Date” has the meaning set forth in
Section 2.12(a). 
  
 “Special Record Date” has
the meaning set forth in Section 2.12(a). 
  
 “Spin-Off” means a dividend or other distribution of shares of Capital Stock of any class or series, or similar Equity Interests, of or relating to a Subsidiary or other business unit of the Company. 
  
 “Spin-Off Market Price” (a) per share of Common Stock means
(i) in the event a Spin-Off is not effected simultaneously with an Initial Public Offering, the average of the Closing Sale Prices of the Common Stock for the ten Trading Days after the effective date of such Spin-Off or (ii) in the event an Initial
Public Offering is effected simultaneously with the Spin-Off, the Closing Sale Price of the Common Stock on the Trading Day on which the initial public offering price of securities being distributed in the Initial Public Offering is determined and

  

 8 

 
(b) per Equity Interest of a Subsidiary or other business unit of the Company means (i) in the event a Spin-Off is not effected simultaneously with an
Initial Public Offering, the average of the closing sale prices of such Equity Interest to be distributed with respect to one share of Common Stock for the ten Trading Days after the “ex date” with respect to such Spin-Off or (ii) in the
event an Initial Public Offering is effected simultaneously with the Spin-Off, the initial public offering price in the Initial Public Offering of such Equity Interest to be distributed with respect to one share of Common Stock. 
  
 “Standard & Poor’s” means Standard &
Poor’s Rating Services (or its successors). 
  
 “Stated Maturity,” when used with respect to the Notes, means March 15, 2024. 
  
 “Subsidiary” of any Person means (a) any corporation, association or other business entity (other than a partnership, joint venture,
limited liability company or similar entity) of which more than 50% of the total ordinary voting power of shares of Capital Stock entitled (without regard to the occurrence of any contingency) to vote in the election of directors, managers or
trustees thereof (or Persons performing similar functions) or (b) any partnership, joint venture, limited liability company or similar entity of which more than 50% of the capital accounts, distribution rights, total equity and voting interests or
general or limited partnership interests, as applicable, are, in the case of clauses (a) and (b), at the time owned or controlled, directly or indirectly, by (1) such Person, (2) such Person and one or more Subsidiaries of such Person or (3) one or
more Subsidiaries of such Person. Unless otherwise specified herein, each reference to a Subsidiary will refer to a Subsidiary of the Company. 
  
 “Successor Company” shall have the meaning assigned thereto in clause (i) of Section 4.1(a). 
  
 “Tax Original Issue Discount” means the amount of ordinary
interest income on a Note that must be accrued as original issue discount for United States federal income tax purposes pursuant to United States Treasury Regulation Section 1.1275-4 or any successor provision. 
  
 “Termination of Trading” will be deemed to have occurred if
the Common Stock (or other Common Stock into which the Notes are then convertible) is neither approved for trading on The Nasdaq National Market or another established automated over-the-counter trading market in the United States nor listed for
trading on a U.S. national securities exchange. 
  
 “TIA” or “Trust Indenture Act” means the Trust Indenture Act of 1939 (15 U.S.C. §§ 77aaa-77bbbb), as in effect from time to time. 
  
 “Time of Determination” means the time and date of the determination of stockholders entitled to receive
rights, warrants or options or a distribution, in each case, to which Section 9.1(g), 9.8(a) or (b) applies (or, if such date is not a Trading Day, then on the last Trading Day prior to such date). 
  
 “Trading Day” means a day during which trading in securities
generally occurs on The Nasdaq National Market or, if the Common Stock is not then quoted on The Nasdaq 

  

 9 

 
National Market, then on another national or regional securities exchange on which the Common Stock is then listed or, if the Common Stock is not listed on
The Nasdaq National Market or a national or regional securities exchange, on the principal other market on which the Common Stock is then traded or quoted. 
  
 “Trading Price,” with respect to the Notes, on any date of determination means the average of the secondary market bid quotations per
Note obtained by the Trustee, at any time the Company instructs the Trustee to determine the Trading Price, for $5.0 million principal amount of the Notes at approximately 3:30 p.m., New York City time, on such determination date from two
independent nationally recognized securities dealers selected by the Company, which may include the Initial Purchasers, provided that if at least two such bids cannot reasonably be obtained by the Trustee, but one such bid can reasonably be
obtained by the Trustee, this one bid shall be used. If the Trustee cannot reasonably obtain at least one bid for $5.0 million principal amount of the Notes from a nationally recognized securities dealer, or in the reasonable judgment of the
Company, the bid quotations are not indicative of the secondary market value of the Notes, then the Trading Price of the Notes will equal (a) the applicable Conversion Rate of the Notes multiplied by (b) the Closing Sale Price of the Common Stock on
such determination date; provided that, for purposes of Section 12.1, if the Trustee cannot reasonably obtain at least one bid for $5.0 million principal amount of the Notes from a nationally recognized securities dealer, or in the reasonable
judgment of the Company, the bid quotations are not indicative of the secondary market value of the Notes, then the Trading Price of the Notes will equal (x) the applicable Conversion Rate of the Notes multiplied by (y) the average of the Closing
Sales Prices of the Common Stock during the Measurement Period. 
  
 “Transfer Restricted Notes” has the meaning set forth in Section 2.1(d). 
  
 “Trustee” means the Person identified as “Trustee” in the first paragraph hereof and, subject to the provisions of Article XI,
shall also include any successor trustee. 
  
 “Trust
Officer” means, with respect to the Trustee, any officer assigned to the Corporate Trust Office, and also, with respect to a particular matter, any other officer to whom such matter is referred because of such officer’s knowledge of
and familiarity with the particular subject. 
  
 “Uniform
Commercial Code” means the New York Uniform Commercial Code as in effect from time to time in the State of New York. 
  
 “U.S. Government Obligations” means securities that are (a) direct obligations of the United States of America for the timely payment of
which its full faith and credit is pledged or (b) obligations of a Person controlled or supervised by and acting as an agency or instrumentality of the United States of America the timely payment of which is unconditionally guaranteed as a full
faith and credit obligation of the United States of America, which, in either case, are not callable or redeemable at the option of the issuer thereof, and shall also include a depositary receipt issued by a bank (as defined in Section 3(a)(2) of
the Securities Act), as custodian with respect to any such U.S. Government Obligations or a specific payment of principal of or interest on any such U.S. Government Obligations held by such custodian for the account of the holder of such depositary
receipt; provided that (except as required by law) such 

  

 10 

 
custodian is not authorized to make any deduction from the amount payable to the holder of such depositary receipt from any amount received by the custodian
in respect of the U.S. Government Obligations or the specific payment of principal of or interest on the U.S. Government Obligations evidenced by such depositary receipt. 
  
 SECTION 1.2. Incorporation by Reference of Trust Indenture Act . This Indenture is subject to the mandatory
provisions of the TIA which are incorporated by reference in and made a part of this Indenture. The following TIA terms have the following meanings: 
  
 “indenture securities” means the Notes. 
  
 “indenture security holder” means a Holder. 
  
 “indenture to be qualified” means this Indenture. 
  
 “indenture trustee” or “institutional trustee” means the Trustee. 
  
 “obligor” on the indenture securities means the Company and any other obligor on the indenture securities.

  
 All other TIA terms used in this Indenture that are defined by
the TIA, defined by the TIA by reference to another statute or defined by Commission rule have the meanings assigned to them by such definitions. 
  
 SECTION 1.3. Rules of Construction . Unless the context otherwise requires: 
  
 (1) a term has the meaning assigned to it; 
  
 (2) an accounting term not otherwise defined has the meaning
assigned to it in accordance with GAAP; 
  
 (3)
“or” is not exclusive; 
  
 (4) words in
the singular include the plural and words in the plural include the singular; 
  
 (5) unsecured Indebtedness shall not be deemed to be subordinate or junior to secured Indebtedness merely by virtue of its nature as unsecured Indebtedness; 
  
 (6) the principal amount of any non-interest bearing or
other discount security at any date shall be the principal amount thereof that would be shown on a balance sheet of the issuer dated such date prepared in accordance with GAAP; 
  
 (7) the table of contents and headings of the Articles and Sections of this Indenture have been inserted for
convenience of reference only, are not intended to be considered a part hereof and shall not modify or restrict any of the terms or provisions hereof; 
  

 11 

 (8) the words “herein,” “hereof” and “hereunder” and other
words of similar import refer to this Indenture as a whole and not to any particular Article, Section or other subdivision; 
  
 (9) all references to “$” or “dollars” shall refer to the lawful currency of the United States of America; 

 
 (10) the words “include,” “included”
and “including” as used herein shall be deemed in each case to be followed by the phrase “without limitation,” if not expressly followed by such phrase or the phrase “but not limited to”; 
  
 (11) references to sections of or rules under the Securities
Act, the Exchange Act or the TIA shall be deemed to include substitute, replacement or successor sections or rules adopted by the Commission from time to time thereunder; and 
  
 (12) any reference to a Section or Article refers to such Section or Article of this Indenture unless
otherwise indicated. 
  
 ARTICLE II 
  
 THE NOTES 
  
 SECTION 2.1. Form, Dating and Terms. 
  
 (a) The maximum aggregate principal amount of Notes that may be authenticated and delivered under this Indenture is
$150,000,000. Furthermore, Notes may be authenticated and delivered upon registration or transfer, or in lieu of, other Notes pursuant to Section 2.6, 2.8 or 14.5. 
  
 The Notes shall be known and designated as 2.25% Convertible Senior Notes due March 15, 2024. Pursuant to the provisions of
Article IX, the Notes shall be convertible into Common Stock. 
  
 Each Note shall bear the applicable legends, if any, set forth in Section 2.1(d) and transfers of the Notes shall be made only in accordance with the restrictions described in the applicable legend. The Notes may have notations, legends or
endorsements required by law, stock exchange rule or usage, in addition to those set forth on Exhibit A and in Section 2.1(d). The Company and the Trustee shall approve the forms of the Notes and any notation, endorsement or legend on them. Each
Note shall be dated the date of its authentication. The terms of the Note set forth in Exhibit A are part of the terms of this Indenture and, to the extent applicable, the Company and the Trustee, by their execution and delivery of this Indenture,
expressly agree to be bound by such terms. 
  
 The principal of
and interest on the Notes shall be payable at the office or agency of the Company maintained for such purpose in the City of New York, or at such other office or agency of the Company as may be maintained for such purpose pursuant to Section 2.3.
Payments 

  

 12 

 
in respect of a Definitive Note (including principal, interest and Liquidated Damages, if any) shall be made in U.S. dollars at the office of the Trustee. At
the Company’s option, however, the Company may make such payments by mailing a check to the registered address of each Holder thereof as such address as shall appear on the Note Register or with respect to Notes represented by a Global Note, by
wire transfer of immediately available funds to the accounts specified by the Depositary. If a payment date is a date other than a Business Day, payment may be made at that place on the next succeeding day that is a Business Day and no interest
shall accrue for the intervening period. 
  
 (b) Notes offered and
sold to QIBs in reliance on Rule 144A and resold to IAIs in the United States of America shall be issued in the form of one or more permanent Global Notes, without interest coupons, substantially in the form of Exhibit A. Such Global Notes shall be
deposited on behalf of the purchasers of the Notes represented thereby with the Notes Custodian for the Depositary for the accounts of participants in the Depositary, duly executed by the Company and authenticated by the Trustee as hereinafter
provided. The aggregate principal amount of a Global Note may from time to time be increased or decreased by adjustments made on the records of the Notes Custodian, as hereinafter provided. 
  
 (c) The Notes shall be issuable only in fully registered form, without
coupons, and only in denominations of $1,000 and any integral multiple thereof. 
  
 (d) Every Note that bears or is required under this Section 2.1(d) to bear the legend set forth in this Section 2.1(d) (the “Transfer Restricted Notes”) shall be subject to the restrictions on transfer set
forth in this Section 2.1(d) (including those set forth in the legend set forth below), and the Holder of each such Transfer Restricted Note, by such Holder’s acceptance thereof, agrees to be bound by all such restrictions on transfer. As used
in Sections 2.1(d) and 2.1(e), the term “transfer” includes any sale, pledge, transfer or other disposition whatsoever of any Transfer Restricted Note. The Registrar shall not register any transfer of a Transfer Restricted Note not made in
accordance with the restrictions on transfer set forth in this Section 2.1. 
  
 Subject to the last paragraph of this Section 2.1(d) and Section 2.15 with respect to Common Stock, until the expiration of the holding period applicable to sales thereof under Rule 144(k) under the Securities Act (or
any successor provision), any certificate evidencing any Note (and all securities issued in exchange therefor or substitution thereof, including Common Stock, if any, issued upon conversion thereof, which shall bear the legend set forth in Section
2.1(e), if applicable), shall bear a legend in substantially the following form: 
  
 “THIS NOTE AND ANY COMMON STOCK ISSUABLE UPON THE CONVERSION OF THIS NOTE HAVE NOT BEEN REGISTERED UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED (THE ‘SECURITIES ACT’), AND MAY NOT BE SOLD OR
OTHERWISE TRANSFERRED IN THE ABSENCE OF SUCH REGISTRATION OR AN APPLICABLE EXEMPTION THEREFROM. EACH PURCHASER OF THIS NOTE IS HEREBY NOTIFIED THAT THE SELLER OF THIS NOTE MAY BE RELYING ON THE EXEMPTION FROM THE PROVISIONS OF SECTION 5 OF THE
SECURITIES ACT PROVIDED BY RULE 144A THEREUNDER. 
  

 13 

 THIS NOTE AND ANY COMMON STOCK ISSUABLE UPON THE CONVERSION OF THIS NOTE MAY NOT BE OFFERED, SOLD,
PLEDGED OR OTHERWISE TRANSFERRED EXCEPT (A) (1) TO A PERSON WHO THE TRANSFEROR REASONABLY BELIEVES IS A QUALIFIED INSTITUTIONAL BUYER WITHIN THE MEANING OF RULE 144A UNDER THE SECURITIES ACT ACQUIRING FOR ITS OWN ACCOUNT OR FOR THE ACCOUNT OF A
QUALIFIED INSTITUTIONAL BUYER IN A TRANSACTION MEETING THE REQUIREMENTS OF RULE 144A, (2) PURSUANT TO AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT PROVIDED BY RULE 144 THEREUNDER (IF AVAILABLE), (3) TO AN INSTITUTIONAL INVESTOR THAT IS AN
ACCREDITED INVESTOR WITHIN THE MEANING OF RULE 501(a)(1), (2), (3) OR (7) OF REGULATION D UNDER THE SECURITIES ACT PURSUANT TO AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT (IF AVAILABLE) OR (4) PURSUANT TO AN EFFECTIVE REGISTRATION
STATEMENT UNDER THE SECURITIES ACT, AND (B) IN ACCORDANCE WITH ALL APPLICABLE SECURITIES LAWS OF THE STATES OF THE UNITED STATES AND OTHER JURISDICTIONS. 
  
 “THIS NOTE, ANY SHARES OF COMMON STOCK ISSUABLE UPON ITS CONVERSION AND ANY RELATED DOCUMENTATION MAY BE AMENDED OR SUPPLEMENTED FROM TIME TO TIME TO
MODIFY THE RESTRICTIONS ON RESALES AND OTHER TRANSFERS OF THIS NOTE AND ANY SUCH SHARES TO REFLECT ANY CHANGE IN APPLICABLE LAW OR REGULATION (OR THE INTERPRETATION THEREOF) OR IN PRACTICES RELATING TO THE RESALE OR TRANSFER OF RESTRICTED SECURITIES
GENERALLY. THE HOLDER OF THIS NOTE AND SUCH SHARES OF COMMON STOCK SHALL BE DEEMED BY THE ACCEPTANCE OF THIS NOTE AND ANY SUCH SHARES TO HAVE AGREED TO ANY SUCH AMENDMENT OR SUPPLEMENT.” 
  
 Any Note (or security issued in exchange or substitution therefor) as to
which such restrictions on transfer shall have expired in accordance with their terms or that has been transferred pursuant to a registration statement that has been declared effective under the Securities Act may, upon surrender of such Note to the
Registrar for exchange in accordance with the provisions of this Section 2.1, be exchanged for a new Note or Notes, of like tenor and aggregate principal amount, which shall not bear the Restricted Note Legend required by this Section 2.1(d).

  
 (e) Every stock certificate representing Common Stock issued
upon conversion of a Transfer Restricted Note that bears or is required under this Section 2.1(e) to bear the legend set forth in this Section 2.1(e) shall be subject to the restrictions on transfer set forth in this Section 2.1(e) (including those
set forth in the legend set forth below), and the Holder of such Common Stock issued upon conversion of a Transfer Restricted Note, by such Holder’s 

  

 14 

 
acceptance thereof, agrees to be bound by all such restrictions on transfer and the further restrictions set forth in Section 2.15. The Company shall not
register any transfer of Common Stock issued upon conversion of such a Transfer Restricted Note not made in accordance with the restrictions on transfer set forth in this Section 2.1. 
  
 Until the expiration of the holding period applicable to sales thereof under Rule 144(k) under the Securities Act (or any
successor provision), any stock certificate representing Common Stock issued upon conversion of a Transfer Restricted Note shall bear a legend in substantially the following form, unless such Common Stock has been sold pursuant to a registration
statement that has been declared effective under the Securities Act (and which continues to be effective at the time of such transfer) or such Common Stock has been issued upon conversion of Notes that have been transferred pursuant to a
registration statement that has been declared effective under the Securities Act: 
  
 “THIS SECURITY (OR ITS PREDECESSOR) WAS ORIGINALLY ISSUED IN A TRANSACTION EXEMPT FROM REGISTRATION UNDER THE UNITED STATES SECURITIES ACT OF 1933 (THE ‘SECURITIES ACT’), AND THIS SECURITY MAY NOT BE
OFFERED, SOLD OR OTHERWISE TRANSFERRED IN THE ABSENCE OF SUCH REGISTRATION OR AN APPLICABLE EXEMPTION THEREFROM. EACH PURCHASER OF THIS SECURITY IS HEREBY NOTIFIED THAT THE SELLER OF THIS SECURITY MAY BE RELYING ON THE EXEMPTION FROM THE PROVISIONS
OF SECTION 5 OF THE SECURITIES ACT PROVIDED BY RULE 144A THEREUNDER. 
  
 “THE HOLDER OF THIS SECURITY AGREES FOR THE BENEFIT OF THE COMPANY THAT (A) THIS SECURITY MAY NOT BE OFFERED, SOLD, PLEDGED OR OTHERWISE TRANSFERRED, EXCEPT (X) (I) TO A PERSON WHOM THE SELLER REASONABLY BELIEVES IS A QUALIFIED
INSTITUTIONAL BUYER WITHIN THE MEANING OF RULE 144A UNDER THE SECURITIES ACT ACQUIRING FOR ITS OWN ACCOUNT OR FOR THE ACCOUNT OF ANOTHER QUALIFIED INSTITUTIONAL BUYER IN A TRANSACTION MEETING THE REQUIREMENTS OF RULE 144A, (II) PURSUANT TO AN
EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT PROVIDED BY RULE 144 THEREUNDER (IF AVAILABLE), (III) TO AN INSTITUTIONAL INVESTOR THAT IS AN ACCREDITED INVESTOR WITHIN THE MEANING OF RULE 501(a)(1), (2), (3) OR (7) OF REGULATION D UNDER THE
SECURITIES ACT PURSUANT TO AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT (IF AVAILABLE) OR (IV) PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT, AND (Y) IN ACCORDANCE WITH ALL APPLICABLE SECURITIES LAWS OF THE
STATES OF THE UNITED STATES AND OTHER JURISDICTIONS, AND (B) THE HOLDER WILL, AND EACH SUBSEQUENT HOLDER IS REQUIRED TO, 

  

 15 

 
NOTIFY ANY PURCHASER OF THE SECURITY FROM IT OF THE RESALE RESTRICTIONS REFERRED TO IN (A) ABOVE.” 
  
 “THIS SECURITY AND ANY RELATED DOCUMENTATION MAY BE AMENDED OR
SUPPLEMENTED FROM TIME TO TIME TO MODIFY THE RESTRICTIONS ON RESALES AND OTHER TRANSFERS OF THIS SECURITY TO REFLECT ANY CHANGE IN APPLICABLE LAW OR REGULATION (OR THE INTERPRETATION THEREOF) OR IN PRACTICES RELATING TO THE RESALE OR TRANSFER OF
RESTRICTED SECURITIES GENERALLY. THE HOLDER OF THIS SECURITY SHALL BE DEEMED BY THE ACCEPTANCE OF THIS SECURITY TO HAVE AGREED TO ANY SUCH AMENDMENT OR SUPPLEMENT.” 
  
 Any stock certificate (or security issued in exchange or substitution therefor) as to which such restrictions on transfer
shall have expired in accordance with their terms or that has been transferred pursuant to a registration statement that has been declared effective under the Securities Act may, upon surrender of such stock certificate to the Registrar for exchange
in accordance with the provisions of this Section 2.1 and Section 2.15, be exchanged for a new stock certificate, of like tenor and aggregate number of shares, which shall not bear the Restricted Stock Legend required by this Section 2.1(e).

  
 (f) Each Global Note, whether or not a Transfer Restricted
Note, shall bear the following legend: 
  
 “THIS SECURITY IS
A GLOBAL SECURITY WITHIN THE MEANING OF THE INDENTURE HEREINAFTER REFERRED TO AND IS REGISTERED IN THE NAME OF THE DEPOSITORY TRUST COMPANY, A NEW YORK CORPORATION (“DEPOSITARY”), OR A NOMINEE OF THE DEPOSITARY, WHICH MAY BE TREATED BY THE
COMPANY, THE TRUSTEE AND ANY AGENT THEREOF AS THE OWNER AND HOLDER OF THIS SECURITY FOR ALL PURPOSES. UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITARY TO THE COMPANY OR ITS AGENT FOR REGISTRATION OF TRANSFER,
EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE & CO. OR IN SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITARY (AND ANY PAYMENT IS MADE TO CEDE & CO. OR TO SUCH OTHER ENTITY AS
IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITARY), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL INASMUCH AS THE REGISTERED OWNER HEREOF, CEDE & CO., HAS AN INTEREST HEREIN.

  

 16 

 “TRANSFERS OF THIS GLOBAL SECURITY SHALL BE LIMITED TO TRANSFERS IN WHOLE, BUT NOT IN PART, BY THE
DEPOSITARY TO A NOMINEE OF THE DEPOSITARY OR BY A NOMINEE OF THE DEPOSITARY TO THE DEPOSITARY OR ANOTHER NOMINEE OF THE DEPOSITARY OR BY THE DEPOSITARY OR ANY SUCH NOMINEE TO A SUCCESSOR DEPOSITARY OR A NOMINEE OF SUCH SUCCESSOR DEPOSITARY, AND
TRANSFERS OF PORTIONS OF THIS GLOBAL SECURITY SHALL BE LIMITED TO TRANSFERS MADE IN ACCORDANCE WITH THE RESTRICTIONS SET FORTH IN THE INDENTURE REFERRED TO ON THE REVERSE HEREOF.” 
  
 (g) The following book-entry provisions shall apply only to Global Notes deposited with the Notes Custodian: 
  
 (i) Each Global Note initially shall (x) be registered in
the name of the Depositary for such Global Note or the nominee of such Depositary, (y) be delivered to the Notes Custodian and (z) bear legends as set forth in Section 2.1(d). 
  
 (ii) Except as provided herein, members of, or participants in, the Depositary (“Agent Members”)
shall have no rights under this Indenture with respect to any Global Note held on their behalf by the Depositary or by the Notes Custodian or under such Global Note, and the Depositary may be treated by the Company, the Trustee, the Notes Custodian
and any agent of the Company or the Trustee as the absolute owner of such Global Note for all purposes whatsoever. Notwithstanding the foregoing, nothing herein shall prevent the Company, the Trustee or any agent of the Company or the Trustee from
giving effect to any written certification, proxy or other authorization furnished by the Depositary or impair, as between the Depositary and its Agent Members, the operation of customary practices of the Depositary governing the exercise of the
rights of a Beneficial Owner of an interest in any Global Note. 
  
 (iii) The registered Holder of a Global Note may grant proxies and otherwise authorize any Person, including Agent Members and Persons that may hold interests through Agent Members, to take any action which a Holder
is entitled to take under this Indenture or the Notes. 
  
 (iv) In connection with any transfer of a portion of the beneficial interest in a Global Note pursuant to Section 2.1(h) to Beneficial Owners who are required to hold Definitive Notes, the Trustee shall reflect on its books and records the
date and a decrease in the principal amount of such Global Note in an amount equal to the principal amount of the beneficial interest in the Global Note to be transferred, and the Company shall execute, and the Trustee shall authenticate and
deliver, one or more Definitive Notes of like tenor and amount. 
  
 (v) In connection with the transfer of an entire Global Note to Beneficial Owners pursuant to Section 2.1(h), such Global Note shall be deemed to be surrendered to the Trustee for cancellation, and the Company shall
execute, and the Trustee shall 

  

 17 

 
authenticate and deliver, to each Beneficial Owner identified by the Depositary in exchange for its beneficial interest in such Global Note, an equal
aggregate principal amount of Definitive Notes of authorized denominations. 
  
 (vi) Any Holder of a Global Note shall, by acceptance of such Global Note, agree that transfers of beneficial interests in such Global Note may be effected only through a book-entry system maintained by (a) the Holder
of such Global Note (or its agent) or (b) any Holder of a beneficial interest in such Global Note, and that ownership of a beneficial interest in such Global Note shall be required to be reflected in a book entry. 
  
 (h) Except as provided below, owners of beneficial interests
in Global Notes will not be entitled to receive Definitive Notes. If required to do so pursuant to any applicable law or regulation, Beneficial Owners may obtain Definitive Notes in exchange for their beneficial interests in a Global Note upon
written request in accordance with the Depositary’s and the Registrar’s procedures. In addition, Definitive Notes shall be transferred to all Beneficial Owners in exchange for their beneficial interests in a Global Note if (i) the
Depositary notifies the Company that it is unwilling or unable to continue as depositary for such Global Note or the Depositary ceases to be a clearing agency registered under the Exchange Act, at a time when the Depositary is required to be so
registered in order to act as Depositary, and in each case a successor depositary is not appointed by the Company within 90 days of such notice or (ii) the Company, in its sole discretion, executes and delivers to the Trustee and Registrar an
Officers’ Certificate stating that such Global Note shall be so exchangeable or (iii) an Event of Default has occurred and is continuing and the Registrar has received a request from the Depositary. 
  
 In the event that the Definitive Notes are not issued to each such Beneficial
Owner promptly after the Registrar has received a request from the Holder of a Global Note to issue such Definitive Notes, the Company expressly acknowledges, with respect to the right of any Holder to pursue a remedy pursuant to Section 10.4 or
10.6 hereof, the right of any Beneficial Owner of Notes to pursue such remedy with respect to the portion of the Global Note that represents such Beneficial Owner’s Notes as if such Definitive Notes had been issued. 
  
 (i) Any Definitive Note delivered in exchange for an
interest in a Global Note pursuant to Section 2.1(g)(iv) or (v) shall, except as otherwise provided by Section 2.6, bear the Restricted Note Legend applicable to the Definitive Note set forth in Section 2.1(d). 
  
 (j) In connection with the exchange of a portion of a
Definitive Note for a beneficial interest in a Global Note, the Trustee shall cancel such Definitive Note, and the Company shall execute, and the Trustee shall authenticate and deliver, to the transferring Holder a new Definitive Note representing
the principal amount not so transferred. 
  
 SECTION 2.2.
Execution and Authentication. An Officer shall sign the Notes for the Company by manual or facsimile signature. If an Officer whose signature is on a Note no longer holds that office at the time the Trustee authenticates the Note, the Note
shall be valid nevertheless. 
  

 18 

 A Note shall not be valid until an authorized signatory of the Trustee manually authenticates the Note.
The signature of the Trustee on a Note shall be conclusive evidence that such Note has been duly and validly authenticated and issued under this Indenture. 
  
 At any time and from time to time after the execution and delivery of this Indenture, the Trustee shall, upon the written direction or order of the
Company, authenticate and make available for delivery: Notes for original issue in an aggregate principal amount of up to $150,000,000 upon a written order of the Company signed by two Officers of the Company (the “Company Order”). Such
Company Order shall specify the amount of the Notes to be authenticated. 
  
 The Trustee may appoint an agent (the “Authenticating Agent”) reasonably acceptable to the Company to authenticate the Notes. Unless limited by the terms of such appointment, any such Authenticating Agent
may authenticate Notes whenever the Trustee may do so. Each reference in this Indenture to authentication by the Trustee includes authentication by such agent. 
  

In case the Company pursuant to Article IV shall be consolidated or merged with or into any other Person or shall convey, transfer, lease or otherwise
dispose of its properties and assets substantially as an entirety to any Person, and the successor Person resulting from such consolidation, or surviving such merger, or into which the Company shall have been merged, or the Person which shall have
received a conveyance, transfer, lease or other disposition as aforesaid, shall have executed an indenture supplemental hereto with the Trustee pursuant to Article IV, any of the Notes authenticated or delivered prior to such consolidation, merger,
conveyance, transfer, lease or other disposition may, from time to time, at the request of the successor Person, be exchanged for other Notes executed in the name of the successor Person with such changes in phraseology and form as may be
appropriate, but otherwise in substance of like tenor as the Notes surrendered for such exchange and of like principal amount; and the Trustee, upon Company Order of the successor Person, shall authenticate and deliver Notes as specified in such
order for the purpose of such exchange. If Notes shall at any time be authenticated and delivered in any new name of a successor Person pursuant to this Section 2.2 in exchange or substitution for or upon registration of transfer of any Notes, such
successor Person, at the option of the Holders but without expense to them, shall provide for the exchange of all Notes at the time outstanding for Notes authenticated and delivered in such new name. 
  
 SECTION 2.3. Registrar, Conversion Agent and Paying Agent. The Trustee
shall initially serve as the Registrar, Conversion Agent and Paying Agent for the Notes. The Registrar, the Conversion Agent and the Paying Agent shall each maintain an office or agency in the Borough of Manhattan, The City of New York. The
Registrar shall keep a register of the Notes and of their transfer and exchange (the “Note Register”). The Company may have one or more co-registrars and one or more additional conversions agents and paying agents. The term Paying Agent
includes any additional paying agents, the term Conversion Agent includes any additional conversion agents and the term Registrar includes any co-registrar. The Company may appoint and change any Paying Agent, Conversion Agent or Registrar without
prior notice to any Holder. 
  

 19 

 The Company shall enter into an appropriate agency agreement with any Registrar, Conversion Agent or
Paying Agent not a party to this Indenture, which shall incorporate the terms of the TIA. The agreement shall implement the provisions of this Indenture that relate to such agent. The Company shall notify the Trustee in writing of the name and
address of each such agent. If the Company fails to maintain a Registrar, Conversion Agent or Paying Agent, the Trustee shall act as such and shall be entitled to appropriate compensation therefor pursuant to Section 11.7. The Company or any of its
domestically incorporated Subsidiaries may act as Paying Agent, Conversion Agent or Registrar. 
  
 The Company may remove any Registrar, Conversion Agent or Paying Agent upon written notice to such Registrar, Conversion Agent or Paying Agent and to the Trustee; provided, however, that no such removal
shall become effective until (i) acceptance of any appointment by a successor as evidenced by an appropriate agreement entered into by the Company and such successor Registrar, Conversion Agent or Paying Agent, as the case may be, and delivered to
the Trustee or (ii) notification to the Trustee that the Trustee shall serve as Registrar, Conversion Agent or Paying Agent until the appointment of a successor in accordance with clause (i) above. The Registrar, Conversion Agent or Paying Agent may
resign at any time upon written notice to the Company and the Trustee. 
  
 SECTION 2.4. Paying Agent To Hold Money and Securities in Trust. Except as otherwise provided herein, on or prior to 10:00 a.m. (New York City time) on each due date of payment in respect of any Note, the Company shall deposit with
the Paying Agent a sum of money (in immediately available funds) sufficient to make such payments when due. The Company shall require each Paying Agent (other than the Trustee) to agree in writing that such Paying Agent shall hold in trust for the
benefit of Holders or the Trustee all money held by such Paying Agent for the payment of principal of, interest on, and other payments in respect of the Notes, and shall notify the Trustee in writing of any default by the Company in making any such
payment. If the Company or a Subsidiary acts as Paying Agent, it shall segregate the money held by it as Paying Agent and hold it as a separate trust fund for the benefit of the Holders of the Notes. The Company at any time may require a Paying
Agent (other than the Trustee) to pay all money held by it to the Trustee and to account for any funds disbursed by such Paying Agent. Upon complying with this Section 2.4, the Paying Agent (if other than the Company or a Subsidiary) shall have no
further liability for the money delivered to the Trustee. Upon any bankruptcy, reorganization or similar proceeding with respect to the Company, the Trustee shall serve as Paying Agent for the Notes. 
  
 SECTION 2.5. Holder Lists. The Trustee shall preserve in as current a
form as is reasonably practicable the most recent list available to it of the names and addresses of Holders and shall otherwise comply with TIA § 312(a). If the Trustee is not the Registrar or to the extent otherwise required under the TIA,
the Company, on its own behalf, shall furnish to the Trustee, in writing at least seven Business Days before each Interest Payment Date and at such other times as the Trustee may reasonably request in writing within 15 days, a list in such form and
as of such date as the Trustee may reasonably require of the names and addresses of Holders and the Company shall otherwise comply with TIA § 312(a). 
  

 20 

 SECTION 2.6. Transfer and Exchange. 
  
 (a) The following provisions shall apply with respect to any proposed transfer of a Note prior to the date which is two
years after the later of the date of its original issue and the last date on which the Company or any Affiliate of the Company was the owner of such Notes (or any predecessor thereto) (the “Resale Restriction Termination Date”):

  
 (i) a transfer of a Note or a beneficial
interest therein to a QIB shall be made upon receipt by the Trustee or its agent of a certificate substantially in the form of the Form of Certificate to be Delivered Upon Exchange or Registration of Transfer of Securities set forth on the reverse
of the Note that the transferee is purchasing the Note for its own account or an account with respect to which it exercises sole investment discretion and that it and any such account is a “qualified institutional buyer” within the meaning
of Rule 144A, and is aware that the sale to it is being made in reliance on Rule 144A and acknowledges that it has received such information regarding the Company as it has requested pursuant to Rule 144A or has determined not to request such
information and that it is aware that the transferor is relying upon its foregoing representations in order to claim the exemption from registration provided by Rule 144A; and 
  
 (ii) a transfer of a Note or a beneficial interest therein to an IAI shall be made upon receipt by the
Trustee or its agent of a certificate substantially in the form set forth in Section 2.7 from the proposed transferee and the delivery of an Opinion of Counsel, certification and/or other information satisfactory to each of them. 
  
 (b) Upon the transfer, exchange or replacement of Notes not bearing a
Restricted Note Legend, the Registrar shall deliver Notes that do not bear a Restricted Note Legend. Upon the transfer, exchange or replacement of Notes bearing a Restricted Note Legend, the Registrar shall deliver only Notes that bear such
Restricted Note Legend unless (i) a Note is being transferred pursuant to an effective registration statement or (ii) there is delivered to the Registrar an Opinion of Counsel to the effect that neither such legend nor the related restrictions on
transfer are required in order to maintain compliance with the provisions of the Securities Act. 
  
 (c) The Registrar shall retain copies of all letters, notices and other written communications received pursuant to Section 2.1 or this Section 2.6 until
the Notes have matured and been paid in full. The Company shall have the right to inspect and make copies of all such letters, notices or other written communications at any reasonable time upon the giving of reasonable written notice to the
Registrar. 
  
 (d) The following obligations with respect to
transfers and exchanges of Notes shall apply: 
  
 (i) To permit registrations of transfers and exchanges, the Company shall, subject to the other terms and conditions of this Article II, execute and the Trustee shall upon receipt of a Company Order, authenticate Definitive Notes and Global
Notes at the Registrar’s request. 
  
 (ii)
No service charge shall be made to a Holder for any registration of transfer or exchange, but the Company may require payment of a sum sufficient to cover any transfer tax, assessments or similar governmental charge payable in connection therewith

  

 21 

 
(other than any such transfer taxes, assessments or similar governmental charges payable upon exchange or transfer pursuant to Section 6.4, 7.1 or 9.5).

  
 (iii) The Registrar shall not be required to
register the transfer of or exchange of any Note (A) for a period beginning at the opening of business 15 days before any selection of Notes for redemption or repurchase and ending at the close of business on the day notice of such redemption or
repurchase is deemed to have been given to all Holders of Notes to be so redeemed or repurchased or (B) selected for redemption or repurchase in whole or in part, except for the transfer of the unredeemed portion of any Note being redeemed in part.

  
 (iv) Prior to the due presentation for
registration of transfer of any Note, the Company, the Trustee, Paying Agent, the Conversion Agent or the Registrar may deem and treat the Person in whose name a Note is registered as the absolute owner of such Note for the purpose of receiving
payment of principal of and interest (including Liquidated Damages, if any) on such Note and for all other purposes whatsoever, whether or not such Note is overdue, and none of the Company, the Trustee, the Paying Agent, the Conversion Agent or the
Registrar shall be affected by notice to the contrary. 
  
 (v) All Notes issued upon any transfer or exchange pursuant to the terms of this Indenture shall evidence the same debt and shall be entitled to the same benefits under this Indenture as the Notes surrendered upon such transfer or exchange.

  
 SECTION 2.7. Form of Certificate To Be Delivered in
Connection with Transfers to Institutional Accredited Investors. 
  
 [Date] 
  
 PSS World Medical, Inc. 
 c/o Wachovia Bank, National Association 
 225 Water Street 
 Jacksonville, FL 32202 
  
 Attention: John Speichert 
  
 Ladies and
Gentlemen: 
  
 This certificate is delivered to request a transfer
of $                     principal amount of the 2.25% Convertible Senior Notes due March 15, 2024 (the “Notes”) of PSS World
Medical, Inc. (the “Company”). 
  
 Upon transfer, the
Notes would be registered in the name of the new beneficial owner as follows: 
  
 Name: ___________________________________________________ 
  
 Address: _________________________________________________ 
  
 Taxpayer ID Number: _______________________________________ 
  

 22 

 The undersigned represents and warrants to you that: 
  
 1. We are an institutional accredited investor (as defined
in Rule 501(a)(1), (2), (3) or (7) under the Securities Act of 1933, as amended (the “Securities Act”)) purchasing for our own account or for the account of such an institutional accredited investor at least $250,000 principal amount of
the Notes, and we are acquiring the Notes not with a view to, or for offer or sale in connection with, any distribution in violation of the Securities Act. We have such knowledge and experience in financial and business matters as to be capable of
evaluating the merits and risk of our investment in the Notes and we invest in or purchase securities similar to the Notes in the normal course of our business. We and any accounts for which we are acting are each able to bear the economic risk of
the complete loss of our or its investment. 
  
 2. We understand that the Notes have not been registered under the Securities Act and, unless so registered, may not be sold except as permitted in the following sentence. We agree on our own behalf and on behalf of any investor account for
which we are purchasing Notes to offer, sell or otherwise transfer such Notes prior to the date that is two years after the later of the date of original issue and the last date on which the Company or any affiliate of the Company was the owner of
such Notes (or any predecessor thereto) (the “Resale Restriction Termination Date”) only (a) to the Company, (b) pursuant to a registration statement which has been declared effective under the Securities Act, (c) in a transaction
complying with the requirements of Rule 144A under the Securities Act (“Rule 144A”), to a person we reasonably believe is a qualified institutional buyer under Rule 144A (a “QIB”) that purchases for its own account or for the
account of a QIB and to whom notice is given that the transfer is being made in reliance on Rule 144A, (d) to an institutional accredited investor within the meaning of Rule 501(a)(1), (2), (3) or (7) under the Securities Act that is purchasing for
its own account or for the account of such an institutional accredited investor, in each case in a minimum principal amount of Notes of $250,000 or (e) pursuant to any other available exemption from the registration requirements of the Securities
Act, subject in each of the foregoing cases to any requirement of law that the disposition of our property or the property of such investor account or accounts be at all times within our or their control and in compliance with any applicable state
securities laws. The foregoing restrictions on resale will not apply subsequent to the Resale Restriction Termination Date. If any resale or other transfer of the Notes is proposed to be made pursuant to clause (e) above prior to the Resale
Restriction Termination Date, the transferor shall deliver a letter from the transferee substantially in the form of this letter to the Company and the Trustee, which shall provide, among other things, that the transferee is an institutional
accredited investor (within the meaning of Rule 501(a)(1), (2), (3) or (7) under the Securities Act) and that it is acquiring such Notes for investment purposes and not for distribution in violation of the Securities Act. Each purchaser acknowledges
that the Company and the Trustee reserve the right prior to any offer, sale or other transfer prior to the Resale Termination Date of the Notes pursuant to clauses (d), (e) or (f) above to require the delivery of an opinion of counsel,
certifications and/or other information satisfactory to the Company and the Trustee. 
  

 23 

			
		
	 TRANSFEREE:
	 	 
	 	 	

		
	 BY:
	 	 
	 	 	

  
 SECTION 2.8.
Mutilated, Destroyed, Lost or Stolen Notes. If a mutilated Note is surrendered to the Registrar or if the Holder of a Note claims that the Note has been lost, destroyed or wrongfully taken, subject to compliance with the provisions of the
next sentence of this Section 2.8, the Company shall issue and the Trustee, upon Company Order, shall authenticate a replacement Note if the requirements of Section 8-405 of the Uniform Commercial Code are met such that the Holder (a) notifies the
Company and the Trustee within a reasonable time after such Holder has notice of such loss, destruction or wrongful taking and the Registrar has not registered a transfer prior to receiving such notification, (b) makes such request to the Company
prior to the Company having notice that the Note has been acquired by a protected purchaser as defined in Section 8-303 of the Uniform Commercial Code (a “protected purchaser”) and (c) satisfies any other reasonable requirements of the
Company and the Trustee. Such Holder shall furnish an indemnity bond sufficient in the judgment of the Company and the Trustee to protect the Company, the Trustee, the Paying Agent, the Conversion Agent and the Registrar from any loss which any of
them may suffer if a Note is replaced, then, in the absence of notice to the Company, or the Trustee, Paying Agent, Conversion Agent or Registrar, that such Note has been acquired by a protected purchaser, the Company shall execute and upon Company
Order the Trustee shall authenticate and deliver, in exchange for any such mutilated Note or in lieu of any such destroyed, lost or stolen Note, a new Note of like tenor and principal amount, bearing a number not contemporaneously outstanding.

  
 In case any such mutilated, destroyed, lost or stolen Note has
become or is about to become due and payable, the Company in its discretion, but subject to any conversion rights, may, instead of issuing a new Note, pay such Note upon satisfaction of the conditions set forth in the preceding paragraph.

  
 Upon the issuance of any new Note under this Section, the
Company may require the payment of a sum sufficient to cover any tax or other governmental charge that may be imposed in relation thereto and any other expenses (including attorneys’ fees and expenses and the fees and expenses of the Trustee)
in connection therewith. 
  
 Every new Note issued pursuant to
this Section in lieu of any mutilated, destroyed, lost or stolen Note shall constitute an original additional contractual obligation of the Company and any other obligor upon the Notes, whether or not the mutilated, destroyed, lost or stolen Note
shall be at any time enforceable by anyone, and shall be entitled to all benefits of this Indenture equally and proportionately with any and all other Notes duly issued hereunder. 
  
 The provisions of this Section are exclusive and shall preclude (to the extent lawful) all other rights and remedies with
respect to the replacement or payment of mutilated, destroyed, lost or stolen Notes. 
  

 24 

 SECTION 2.9. Outstanding Notes . Notes outstanding at any time (“Outstanding Notes”) are
all Notes authenticated by the Trustee except for: 
  
 (a) Notes
theretofore canceled by the Trustee or delivered to the Trustee for cancellation: 
  
 (b) Notes for the payment or redemption of which money in the necessary amount has been theretofore deposited with the Trustee or any Paying Agent (other than the Company) in trust or set aside and segregated in trust
by the Company (if the Company shall act as its own Paying Agent) for the Holders of such Notes, provided that if such Notes are to be redeemed, notice of such redemption has been duly given pursuant to this Indenture or provision therefor
reasonably satisfactory to the Trustee has been made; 
  
 (c)
Notes which have been paid pursuant to Section 2.8 or in exchange for or in lieu of which other Notes have been authenticated and delivered pursuant to this Indenture, other than any such Notes in respect of which there shall have been presented to
the Trustee proof satisfactory to it that such Notes are held by a bona fide purchaser in whose hands such Notes are valid obligations of the Company; and 
  
 (d) Notes converted into Common Stock pursuant to Article IX; 
  
 provided, however that in determining whether the Holders of the requisite principal amount of Outstanding Notes are present at a meeting of Holders of
Notes for quorum purposes or have given, made or taken any request, demand, authorization, direction, notice, consent or waiver or other action hereunder, Notes owned by the Company or any Affiliate of the Company shall be disregarded and deemed not
to be Outstanding Notes, except that, in determining whether the Trustee shall be protected in relying upon any such determination as to the presence of a quorum or upon any such request, demand, authorization, direction, notice, consent or waiver
or other action, only Notes which a Responsible Officer of the Trustee has been notified in writing to be so owned shall be so disregarded. Notes so owned which have been pledged in good faith may be regarded as Outstanding Notes if the pledgee is
not the Company or any Affiliate of the Company, and the Trustee shall be protected in relying upon an Officer’s Certificate to such effect. 
  
 SECTION 2.10. Temporary Notes. In the event that Definitive Notes are to be issued under the terms of this Indenture, until such Definitive Notes
are ready for delivery, the Company may prepare and, upon receipt of a Company Order, the Trustee shall authenticate temporary Notes. Temporary Notes shall be substantially in the form of Definitive Notes but may have variations that the Company
considers appropriate for temporary Notes. Without unreasonable delay, the Company shall prepare and the Trustee shall authenticate Definitive Notes. After the preparation of Definitive Notes, the temporary Notes shall be exchangeable for Definitive
Notes upon surrender of the temporary Notes at any office or agency maintained by the Company for that purpose and such exchange shall be without charge to the Holder. Upon surrender for cancellation of any one or more temporary Notes, the Company
shall execute, and the Trustee shall authenticate and make available for delivery in exchange therefor, one or more Definitive Notes representing an equal principal amount of Notes. Until so exchanged, the Holder of temporary Notes shall in all
respects be entitled to the same benefits under this Indenture as a Holder of Definitive Notes. 
  
 SECTION 2.11. Cancellation. The Company at any time may deliver Notes to the Trustee for cancellation. The Registrar and the Paying Agent shall
forward to the Trustee 

  

 25 

 
any Notes surrendered to them for registration of transfer, exchange or payment. The Trustee and no one else shall cancel and return to the Company all Notes
surrendered for registration of transfer, exchange, payment, redemption, purchase, conversion or cancellation. All Notes so delivered to the Trustee shall be cancelled promptly by the Trustee. The Company may not issue new Notes to replace Notes it
has paid or delivered to the Trustee for cancellation. 
  
 At such
time as all beneficial interests in a Global Note have either been exchanged for Definitive Notes, transferred, paid, redeemed, repurchased, converted or canceled, such Global Note shall be returned by the Depositary or the Notes Custodian to the
Trustee for cancellation or retained and canceled by the Trustee. At any time prior to such cancellation, if any beneficial interest in a Global Note is exchanged for Definitive Notes, transferred in exchange for an interest in another Global Note,
paid, redeemed, repurchased, converted or canceled, the principal amount of Notes represented by such Global Note shall be reduced and an adjustment shall be made on the Global Note and on the books and records of the Trustee (if it is then the
Notes Custodian for such Global Note) with respect to such Global Note, by the Trustee or the Notes Custodian, to reflect such reduction. 
  
 SECTION 2.12. Payment of Interest; Defaulted Interest. Interest (and Contingent Interest, if any) on any Note which is payable, and is punctually
paid or duly provided for, on any Interest Payment Date shall be paid to the Person in whose name such Note (or one or more predecessor Notes) is registered at the close of business on the Regular Record Date for such interest (and Contingent
Interest, if any) at the office or agency of the Company maintained for such purpose pursuant to Section 2.3. 
  
 Any interest (and Contingent Interest, if any) on any Note which is payable, but is not paid when the same becomes due and payable and such nonpayment
continues for a period of 30 days shall forthwith cease to be payable to the Holder on the Regular Record Date, and such defaulted interest and (to the extent lawful) interest on such defaulted interest at the rate borne by the Notes (such defaulted
interest and interest thereon herein collectively called “Defaulted Interest”) shall be paid by the Company, at its election in each case, as provided in clause (a) or (b) below: 
  
 (a) The Company may elect to make payment of any Defaulted Interest to the
Persons in whose names the Notes (or their respective predecessor Notes) are registered at the close of business on a Special Record Date (as defined below) for the payment of such Defaulted Interest, which shall be fixed in the following manner.
The Company shall notify the Trustee in writing of the amount of Defaulted Interest proposed to be paid on each Note and the date (not less than 30 days after such notice) of the proposed payment (the “Special Interest Payment Date”), and
the Company shall make arrangements reasonably satisfactory to the Trustee to deposit with the Trustee an amount of money equal to the aggregate amount proposed to be paid in respect of such Defaulted Interest on or prior to the date of the proposed
payment, such money when deposited to be held in trust for the benefit of the Persons entitled to such Defaulted Interest as in this clause provided. Thereupon the Trustee shall fix a record date (the “Special Record Date”) for the payment
of such Defaulted Interest which shall be not more than 15 days and not less than 10 days prior to the Special Interest Payment Date and not less than 10 days after the receipt by the Trustee of the notice of the proposed payment. The Trustee shall
promptly notify the Company of such Special Record Date, and in the name and at the expense of the Company, 

  

 26 

 
shall cause notice of the proposed payment of such Defaulted Interest and the Special Record Date and Special Interest Payment Date therefor to be given in
the manner provided for in Section 15.2, not less than 10 days prior to such Special Record Date. Notice of the proposed payment of such Defaulted Interest and the Special Record Date and Special Interest Payment Date therefor having been so given,
such Defaulted Interest shall be paid on the Special Interest Payment Date to the Persons in whose names the Notes (or their respective Predecessor Notes) are registered at the close of business on such Special Record Date and shall no longer be
payable pursuant to the following clause (b). 
  
 (b) The Company
may make payment of any Defaulted Interest in any other lawful manner not inconsistent with the requirements of any securities exchange on which the Notes may be listed, and upon such notice as may be required by such exchange, if, after notice
given by the Company to the Trustee of the proposed payment pursuant to this clause, such manner of payment shall be deemed practicable by the Trustee. 
  
 Subject to the foregoing provisions of this Section, each Note delivered under this Indenture upon registration of transfer of, or in exchange for, or in
lieu of any other Note shall carry the rights to interest accrued and unpaid which were carried by such other Note. 
  
 SECTION 2.13. Computation of Interest. Interest (and Contingent Interest, if any) on the Notes shall be computed on the basis of a 360-day year
comprised of twelve 30-day months. 
  
 SECTION 2.14. CUSIP
Numbers. The Company in issuing the Notes and Common Stock upon conversion of the Notes may use CUSIP numbers (if then generally in use). The Trustee shall not be responsible for the use of CUSIP numbers, and the Trustee makes no representation
as to their correctness as printed on any Note, certificate of Common Stock or notice to Holders and that reliance may be placed only on the other identification numbers printed on the Notes, and any redemption shall not be affected by any defect in
or omission of such CUSIP numbers. The Company shall promptly notify the Trustee in writing of any change in the CUSIP numbers. 
  
 SECTION 2.15. Issuance, Transfer and Exchange of Common Stock Issuable Upon Conversion of the Notes. 
  
 (a) Shares of Common Stock to be issued upon conversion of Notes prior to the
effectiveness of a Shelf Registration Statement shall be physically delivered in certificated form to the Holders converting such Notes and the certificate representing such shares of Common Stock shall bear the Restricted Stock Legend unless
removed in accordance with Section 2.1(e). 
  
 (b) If (i) shares
of Common Stock to be issued upon conversion of Notes prior to the effectiveness of a Shelf Registration Statement are to be registered in a name other than that of the Holder of such Notes or (ii) shares of Common Stock represented by a certificate
bearing the Restricted Stock Legend are transferred subsequently by such Holder, then, unless the Shelf Registration Statement has become effective and such shares are being transferred pursuant to the Shelf Registration Statement, the Holder must
deliver to the transfer agent for the 

  

 27 

 
Common Stock and to the Company a certificate in substantially the form of Exhibit B as to compliance with the restrictions on transfer applicable to such
shares of Common Stock and neither the transfer agent nor the registrar for the Common Stock shall be required to register any transfer of such Common Stock not so accompanied by a properly completed certificate. 
  
 (c) Except in connection with a Shelf Registration Statement, if certificates
representing shares of Common Stock are issued upon the registration of transfer, exchange or replacement of any other certificate representing shares of Common Stock bearing the Restricted Stock Legend, or if a request is made to remove such
Restricted Stock Legend from certificates representing shares of Common Stock, the certificates so issued shall bear the Restricted Stock Legend, or the Restricted Stock Legend shall not be removed, as the case may be, unless there is delivered to
the Company such reasonably satisfactory evidence, which, in the case of a transfer made pursuant to Rule 144 under the Securities Act, may include an Opinion of Counsel, as may be reasonably required by the Company, that neither the legend nor the
restrictions on transfer set forth therein are required to ensure that transfers thereof comply with the provisions of Rule 144A or Rule 144 under the Securities Act and that such shares of Common Stock are securities that are not
“restricted” within the meaning of Rule 144 under the Securities Act. Upon provision to the Company of such reasonably satisfactory evidence, the Company shall cause the transfer agent for the Common Stock to countersign and deliver
certificates representing shares of Common Stock that do not bear the Restricted Stock Legend. 
  
 SECTION 2.16. Calculations in Respect of the Notes. The Company shall be responsible for making all calculations called for under the Notes. These calculations include, but are not limited to, determinations of
the Trading Prices of the Notes and the Closing Sale Price of the Common Stock, any accrued interest, Contingent Interest and Liquidated Damages, if any, payable on the Notes and the Conversion Rate of the Notes, and the projected payment schedule.
The Company shall make these calculations in good faith and, absent manifest error, such calculations will be final and binding on Holders of the Note. The Company shall provide to the Trustee a schedule of its calculations, and the Trustee, subject
to Sections 11.1 and 11.2, shall be entitled to rely upon the accuracy of such calculations without independent verification. The Trustee shall forward the Company’s calculations to any Holder of the Notes upon the request of such Holder.

  
 ARTICLE III 
  
 COVENANTS 
  
 SECTION 3.1. Payment of Notes. The Company shall promptly pay the principal of and interest, Contingent Interest and
Liquidated Damages, if any, on the Notes on the dates and in the manner provided in the Notes and in this Indenture. Principal, interest, Contingent Interest and Liquidated Damages, if any, shall be considered paid on the date due if on such date
the Trustee or the Paying Agent holds in accordance with this Indenture money sufficient to pay all principal, interest, Contingent Interest and Liquidated Damages, if any, then due and the Trustee or the Paying Agent, as the case may be, is not
prohibited from paying such money to the Holders on that date pursuant to the terms of this Indenture. 
  

 28 

 The Company shall pay interest on overdue principal at the rate specified therefor in the Notes, and it
shall pay interest on overdue installments of interest at the same rate to the extent lawful. 
  
 Notwithstanding anything to the contrary contained in this Indenture, the Company may, to the extent it is required to do so by law, deduct or withhold income or other taxes imposed by the United States of America or
any state or local government from principal or interest (including, Contingent Interest and Liquidated Damages, if any) payments hereunder. 
  
 SECTION 3.2. Maintenance of Office or Agency. The Company will maintain in the City of New York, as required by Section 2.3, an office or agency
where the Notes may be presented or surrendered for payment, where, if applicable, the Notes may be surrendered for registration of transfer or exchange or conversion and where notices and demands to or upon the Company in respect of the Notes and
this Indenture may be served. The office of the Trustee, at 40 Broad Street, 5th floor, New York, New York 10004,
Attention: Corporate Trust Office, shall be such office or agency of the Company for payment, unless the Company shall designate and maintain some other office or agency for one or more of such purposes. The Company will give prompt written notice
to the Trustee of any change in the location of any such office or agency. If at any time the Company shall fail to maintain any such required office or agency or shall fail to furnish the Trustee with the address thereof, such presentations,
surrenders, notices and demands may be made or served at the Corporate Trust Office of the Trustee, and the Company hereby appoints the Trustee as its agent to receive all such presentations, surrenders, notices and demands. 
  
 The Company may also from time to time designate one or more other offices or
agencies (in or outside of the City of New York) where the Notes may be presented or surrendered for any or all such purposes and may from time to time rescind any such designation; provided, however, that no such designation or
rescission shall in any manner relieve the Company of its obligation to maintain an office or agency in the City of New York for such purposes. The Company will give prompt written notice to the Trustee of any such designation or rescission and any
change in the location of any such other office or agency. 
  
 SECTION 3.3. Money and Securities for Note Payments To Be Held in Trust. If the Company shall at any time act as its own Paying Agent, it will, on or before each due date of any payment in respect of the Notes, segregate and hold in
trust for the benefit of the Persons entitled thereto a sum of money in same day funds (or New York Clearing House funds if such deposit is made prior to the date that such deposit is required to be made), sufficient to make such payments when so
becoming due until such sums shall be paid to such Persons or otherwise disposed of as herein provided and will promptly notify the Trustee in writing of its action or failure to so act. 
  
 Whenever the Company shall have one or more Paying Agents for the Notes, it will, on or before each due date of any payment
in respect of the Notes, deposit with any Paying Agent a sum of money in same day funds (or New York Clearing House funds if such deposit is made prior to the date on which such deposit is required to be made, that shall be available to the Trustee
by 11:00 a.m. New York City time on such due date, sufficient to pay the amount so becoming due, such sum to be held in trust for the benefit of the Persons entitled to such payment, 

  

 29 

 
and (unless such Paying Agent is the Trustee) the Company will promptly notify the Trustee in writing of such action or any failure to so act. 
  
 The Company will cause each Paying Agent (other than the Trustee) to execute
and deliver to the Trustee an instrument in which such Paying Agent shall agree with the Trustee, subject to the provisions of this Section 3.3, that such Paying Agent will: 
  
 (a) hold all money held by it for the making of any payments in respect of the Notes in trust for the benefit of the Persons
entitled thereto until such money shall be paid to such Persons or otherwise disposed of as herein provided; 
  
 (b) give the Trustee prompt written notice of any Default by the Company (or any other obligor upon the Notes) in the making of any payment in respect of
the Notes; and 
  
 (c) at any time during the continuance of any
such Default, upon the written request of the Trustee, forthwith pay to the Trustee all money so held in trust by such Paying Agent. 
  
 The Company may at any time, for the purpose of obtaining the satisfaction and discharge of this Indenture or for any other purpose, pay, or by Company
Order direct any Paying Agent to pay, to the Trustee all money held in trust by the Company or such Paying Agent, such money to be held by the Trustee upon the same trusts as those upon which such money were held by the Company or such Paying Agent;
and, upon such payment by any Paying Agent to the Trustee, such Paying Agent shall be released from all further liability with respect to such money and/or shares of Common Stock. 
  
 Any money deposited with the Trustee or any Paying Agent, or then held by the Company, in trust for the payment of any
amounts due in respect of the Notes and remaining unclaimed for two years after such payment has become due and payable shall be paid to the Company on Company Order, or (if then held by the Company) shall be discharged from such trust; and the
Holder of such Note shall thereafter, as an unsecured general creditor, look only to the Company for payment thereof, and all liability of the Trustee or such Paying Agent with respect to such trust money, and all liability of the Company as trustee
thereof, shall thereupon cease; provided, however, that the Trustee or such Paying Agent, before being required to make any such repayment to the Company, shall at the expense of the Company cause to be published once, in a leading
daily newspaper (if practicable, The Wall Street Journal (Eastern Edition)) printed in the English language and of general circulation in New York City, notice that such money and/or shares of Common Stock remains unclaimed and that, after a
date specified therein, which shall not be less than 30 days from the date of such publication nor shall it be later than two years after such payment shall have become due and payable, any unclaimed balance of such money then remaining will be
repaid to the Company. 
  
 SECTION 3.4. Corporate
Existence. Subject to Article IV, the Company will do or cause to be done all things necessary to preserve and keep in full force and effect its corporate existence and the corporate rights (charter and statutory) licenses and franchises of the
Company; provided, however, that the Company shall not be required to preserve any such existence, right, license or franchise if the Board of Directors shall determine that the preservation thereof is no 

  

 30 

 
longer desirable in the conduct of the business of the Company, and that the loss thereof is not, and will not be, disadvantageous in any material respect to
the Holders. 
  
 SECTION 3.5. Further Instruments and Acts.
Upon request of the Trustee, the Company will execute and deliver such further instruments and do such further acts as may be reasonably necessary or proper to carry out more effectively the purpose of this Indenture. 
  
 SECTION 3.6. Liquidated Damages Notices. In the event that the Company
is required to pay liquidated damages to Holders of Notes pursuant to the Registration Rights Agreement (“Liquidated Damages”), the Company will provide a direction or order in the form of a written notice (“Liquidated Damages
Notice”) to the Trustee of its obligation to pay Liquidated Damages no later than five Business Days prior to the proposed payment date set for the amount of Liquidated Damages, and the Liquidated Damages Notice shall set forth the amount of
Liquidated Damages to be paid by the Company on such Payment Date and direct the Trustee to make payment. 
  
 SECTION 3.7. SEC Reports. The Company shall file all reports and other information and documents which it is required to file with the Commission
pursuant to Section 13 or 15(d) of the Exchange Act, and within 15 days after it files them with the Commission, the Company shall send copies of all such reports, information and other documents to the Trustee. The Company shall file such reports,
information and documents as may be required by TIA § 314(a) with the Trustee and the Commission. The Company shall transmit to the Holders, in the manner required by TIA § 313(c), such reports, information or documents as shall be
required by TIA § 314(a)(3). 
  
 SECTION 3.8. Compliance
Certificates. The Company shall deliver to the Trustee, within 90 days after the end of each fiscal year of the Company (beginning with the fiscal year ending April 2, 2004), an Officers’ Certificate as to the signer’s knowledge of the
Company’s compliance with all conditions and covenants on their part contained in this Indenture and stating whether or not the signer knows of any Default or Event of Default. If such signer knows of such a Default or Event of Default, the
Officers’ Certificate shall describe the Default or Event of Default and the efforts to remedy the same. For the purposes of this Section 3.8, compliance shall be determined without regard to any grace period or requirement of notice provided
pursuant to the terms of this Indenture. 
  
 SECTION 3.9. Rule
144A Information Requirement. Within the period prior to the expiration of the holding period applicable to sales of the Notes under Rule 144(k) under the Securities Act (or any successor provision), the Company covenants and agrees that it
shall, during any period in which it is not subject to Section 13 or 15(d) under the Exchange Act, upon the request of any Holder or beneficial holder of the Notes or any Common Stock issued upon conversion thereof make available to such Holder or
beneficial holder of Notes or any Common Stock issued upon conversion thereof in connection with any sale thereof and any prospective purchaser of Notes or such Common Stock designated by such Holder or beneficial holder, the information required
pursuant to Rule 144A(d)(4) under the Securities Act and they will take such further action as any Holder or beneficial holder of such Notes or such Common Stock may reasonably request, all to the extent required from time to time to enable such
Holder or 

  

 31 

 
beneficial holder to sell its Notes or Common Stock without registration under the Securities Act within the limitation of the exemption provided by Rule
144A, as such Rule may be amended from time to time. Upon the request of any Holder or any beneficial holder of the Notes or such Common Stock, the Company will deliver to such Holder a written statement as to whether such Holder and prospective
purchaser have complied with such requirements 
  
 SECTION 3.10.
Stay, Extension and Usury Laws. The Company covenants (to the extent that it may lawfully do so) that it shall not at any time insist upon, plead, or in any manner whatsoever claim or take the benefit or advantage of, any stay, extension or
usury law or other law which would prohibit or forgive the Company from paying all or any portion of the principal of, interest, Contingent Interest or Liquidated Damages, if any, on the Notes as contemplated herein, wherever enacted, now or at any
time hereafter in force, or which may affect the covenants or the performance of this Indenture, and the Company (to the extent it may lawfully do so) hereby expressly waives all benefit or advantage of any such law and covenant that it will not, by
resort to any such law, hinder, delay or impede the execution of any power herein granted to the Trustee, but will suffer and permit the execution of every such power as though no such law had been enacted. 
  
 SECTION 3.11. Notice of Default. In the event that any Default that
could mature into an Event of Default under Section 10.1(c) hereof shall occur, the Company shall give written notice of such Default to the Trustee within 30 days of such Default. 
  
 SECTION 3.12. Contingent Debt Treatment. The Company agrees, and by acceptance of a beneficial interest in a Note,
each Holder and any Beneficial Owner of a Note shall be deemed to agree, to treat, for United States tax purposes, the Notes as debt instruments that are subject to Treasury Regulation Section 1.1275-4(b) or any successor provision (the
“contingent debt regulations”). For United States tax purposes, the Company shall accrue, and each Holder or Beneficial Owner of a Note shall accrue, interest with respect to outstanding Notes as Tax Original Issue Discount according to
the “noncontingent bond method,” set forth in Treasury Regulation Section 1.1275-4(b), using the comparable yield set forth in Annex A to this Indenture compounded semiannually and the projected payment schedule attached as Annex A to this
Indenture. 
  
 The Company acknowledges and agrees, and by
acceptance of a beneficial interest in a Note each Holder and any Beneficial Owners of a Note shall be deemed to acknowledge, and agree, that (i) the comparable yield means the annual yield the Company would pay, as of the issue date, on a
noncontingent, nonconvertible, fixed-rate debt instrument with terms and conditions otherwise similar to those of the Notes and (ii) the comparable yield and projected payment schedule that Holder or Beneficial Owner may obtain as described above do
not constitute a representation by the Company regarding the actual amounts that will be paid on the Notes or the value of the Common Stock into which the Notes may be converted. 
  

 32 

 ARTICLE IV 
  

SUCCESSOR COMPANY 
  
 SECTION 4.1. Merger and Consolidation. The Company shall not (1) consolidate with or merge with or into, or convey, sell, transfer, lease or
otherwise dispose of all or substantially all its properties and assets to, any other Person in any one transaction or series of related transactions, or (2) permit any Person to consolidate with or merge into the Company, unless: 
  
 (a) in the case of a merger or consolidation, either the Company is the
surviving Person, or if the Company is not the surviving Person, the surviving Person formed by such consoldation or into which the Company is merged or to which the properties and assets of the Company are transferred (such surviving Person in any
such case, the “Successor Company”) shall be a corporation organized and existing under the laws of the United States of America, any State of the United States or the District of Columbia and the Successor Company (if not the Company)
shall expressly assume, by supplemental indenture, executed and delivered to the Trustee, in form reasonably satisfactory to the Trustee, the payment when due of the principal of and interest (including Contingent Interest and Liquidated Damages, if
any) on the Notes and the performance of each of the Company’s other obligations under the Notes and this Indenture; 
  
 (b) immediately after giving effect to such transaction, no Default or Event of Default shall have occurred and be continuing; and 
  
 (c) the Company shall have delivered to the Trustee on or prior to the
proposed transaction an Officers’ Certificate and an Opinion of Counsel, each stating that (i) such consolidation, merger or transfer and such supplemental indenture (if any) comply with this Indenture, (ii) the Successor Company agrees to be
bound by this Indenture and (iii) that all conditions precedent herein provided for relating to such transaction have been complied with. 
  
 For purposes of this Article IV, the sale, lease, conveyance, assignment, transfer, or other disposition of all or substantially all of the properties and
assets of one or more Subsidiaries of the Company, which properties and assets, if held by the Company instead of such Subsidiaries, would constitute all or substantially all of the properties and assets of the Company on a consolidated basis, shall
be deemed to be the transfer of all or substantially all of the properties and assets of the Company. 
  

 33 

 SECTION 4.2. Successor Corporation Substituted. Upon any consolidation of the Company with, or
merger of the Company into, any other Person or any conveyance, transfer or lease of all or substantially all the properties and assets of the Company in accordance with Section 4.1, the Successor Company shall succeed to, and be substituted for,
and may exercise every right and power of, the Company under this Indenture with the same effect as if the Successor Company had been named as the Company herein, and thereafter, except in the case of a lease of all or substantially all of its
assets, the predecessor Person shall be relieved of all obligations and covenants under this Indenture and the Notes. 
  
 ARTICLE V 
  
 REDEMPTION OF NOTES 
  
 SECTION 5.1. Optional Redemption. On or after March 15, 2009, the Notes may be redeemed for cash, as a whole or from time to time in part, subject to the conditions specified in the form of Note set forth in
Exhibit A hereto, which is hereby incorporated by reference and made a part of this Indenture, in an amount equal to the Redemption Price. 
  
 SECTION 5.2. Applicability of Article. Redemption of Notes at the election of the Company or otherwise, as permitted or required by any provision
of this Indenture or the Notes, shall be made in accordance with such provision and this Article. 
  
 SECTION 5.3. Election to Redeem; Notice to Trustee. The election of the Company to redeem any Notes pursuant to Section 5.1 shall be evidenced by a
Board Resolution. In case of any redemption at the election of the Company, the Company shall, not later than the earlier of the date that is 35 days prior to the Redemption Date fixed by the Company and the date on which notice is given to the
Holders (except as provided in Section 5.5 or unless a shorter notice shall be satisfactory to the Trustee), notify the Trustee of such Redemption Date and of the principal amount of Notes to be redeemed, deliver to the Trustee such documentation
and records as shall enable the Trustee to select the Notes to be redeemed pursuant to Section 5.4 and direct the Trustee to redeem the Notes in accordance with the Board Resolution. Any such notice may be canceled at any time prior to notice of
such redemption being mailed to any Holder and shall thereby be void and of no effect. 
  
 SECTION 5.4. Selection by Trustee of Notes To Be Redeemed. If less than all the Notes are to be redeemed at any time pursuant to an optional redemption, the particular Notes to be redeemed shall be selected not
more than 60 days prior to the Redemption Date by the Trustee, from the outstanding Notes not previously called for redemption, in compliance with the requirements of the principal securities exchange, if any, on which such Notes are listed, or, if
such Notes are not so listed, on a pro rata basis, by lot or by such other method as the Trustee shall deem fair and appropriate (and in such manner as complies with applicable legal requirements) and which may provide for the
selection for redemption of portions of the principal of the Notes; provided, however, that Notes selected for partial redemption shall be in denominations of $1,000 and integral multiples thereof. 
  

 34 

 The Trustee shall promptly notify the Company in writing of the Notes selected for redemption and, in the
case of any Notes selected for partial redemption, the method it has chosen for the selection of Notes and the principal amount thereof to be redeemed and upon the Company’s written approval of such selection, the Trustee shall redeem the
selected Notes. 
  
 For all purposes of this Indenture, unless the
context otherwise requires, all provisions relating to redemption of Notes shall relate, in the case of any Note redeemed or to be redeemed only in part, to the portion of the principal amount of such Note which has been or is to be redeemed.

  
 SECTION 5.5. Notice of Redemption. Notice of redemption
shall be given by first class mail not less than 30 nor more than 60 days prior to the Redemption Date, to each Holder of Notes to be redeemed. At the Company’s written request, the Trustee shall give notice of redemption in the Company’s
name and at the Company’s expense; provided, however, that the Company shall deliver to the Trustee, at least 35 days prior to the Redemption Date (unless a shorter notice period shall be satisfactory to the Trustee) a Company
Order requesting that the Trustee give such notice at the Company’s expense and setting forth the information to be stated in such notice as provided in the following items: 
  
 (a) the Redemption Date, 
  
 (b) the Redemption Price and the amount of accrued interest (including Contingent Interest, if any) to but excluding the Redemption Date payable as
provided in Section 5.7, if any, 
  
 (c) the then existing
Conversion Rate, 
  
 (d) if less than all outstanding Notes are to
be redeemed, the aggregate principal amount of Notes to be redeemed and the aggregate principal amount of Notes to be outstanding after such partial redemption, 
  

(e) in case any Note is to be redeemed in part only, the notice that relates to such Note shall state that on and after the Redemption Date, upon
surrender of such Note, the Holder will receive, without charge, a new Note or Notes of authorized denominations for the principal amount thereof remaining unredeemed, 
  
 (f) that on the Redemption Date, 100% of the principal amount of the Notes to be redeemed (and accrued interest, if any, and
Contingent Interest, if any, to but excluding the Redemption Date payable as provided in Section 5.7) will become due and payable upon each such Note, or the portion thereof, to be redeemed, and, unless the Company defaults in making the redemption
payment, that interest (and Contingent Interest and Liquidated Damages, if any) on Notes called for redemption (or the portion thereof) will cease to accrue on and after said date, 
  
 (g) the place or places where such Notes are to be surrendered for payment of the Redemption Price and accrued interest and
Contingent Interest, if any, 
  
 (h) the name and address of the
Paying Agent and the Conversion Agent, 
  

 35 

 (i) that Notes called for redemption must be surrendered to the Paying Agent to collect the Redemption
Price, 
  
 (j) the CUSIP number of the Notes to be redeemed,
provided that no representation is made as to the accuracy or correctness of the CUSIP number, if any, listed in such notice or printed on the Notes, and any redemption shall not be affected by any defect in such CUSIP numbers, 
  
 (k) the paragraph of the Notes pursuant to which the Notes are to be
redeemed, 
  
 (l) that the Notes called for redemption may be
converted at any time before the close of business one Business Day prior to the Redemption Date, 
  
 (m) whether the Company intends to satisfy its obligation by delivering Common Stock, cash or a combination of cash and Common Stock (and in such case,
the dollar amount per Note to be satisfied in cash) in the event that Holders elect to convert their Notes in connection with the redemption, and 
  
 (n) the Holders who wish to convert Notes must comply with the procedures in Article IX and paragraph 10 of the Notes. 
  
 If the Company exercises its right to redeem the Notes, in whole or in part,
the Company shall disseminate a press release containing information regarding the redemption, through a public medium that is customary for such press releases or publish the information on its website or through such other public medium as the
Company may use at that time. 
  
 SECTION 5.6. Deposit of
Redemption Price. On or before 10:00 a.m. on any Redemption Date, the Company shall deposit with the Trustee or with a Paying Agent (or, if the Company is acting as its own Paying Agent, segregate and hold in trust as provided in Section 2.4) an
amount of money sufficient to pay the Redemption Price of the Notes which are to be redeemed on that date, other than Notes or portions of Notes called for redemption that are beneficially owned by the Company and have been delivered by the Company
to the Trustee for cancellation or Notes that have been converted. 
  
 SECTION 5.7. Notes Payable on Redemption Date. Notice of redemption having been given as aforesaid, the Notes or portions of Notes so to be redeemed shall, on the Redemption Date, become due and payable at a price equal to the
Redemption Price, except for Notes which are converted in accordance with the terms of this Indenture, and from and after such date (unless the Company shall default in the payment of the Redemption Price) such Notes shall cease to bear interest
(and Contingent Interest and Liquidated Damages, if any). Upon surrender of any such Note for redemption in accordance with said notice, such Note shall be paid by the Company at the Redemption Price on the Redemption Date (subject to the rights of
Holders of record on the relevant Regular Record Date to receive interest and Contingent Interest, if any, due on the relevant Interest Payment Date). 
  

 36 

 If any Note called for redemption shall not be so paid upon surrender thereof for redemption, the
principal shall, until paid, bear interest (and Contingent Interest and Liquidated Damages, if any) from the Redemption Date at the rate borne by the Notes. 
  
 SECTION 5.8. Notes Redeemed in Part. Any Note which is to be redeemed only in part (pursuant to the provisions of this Article) shall be
surrendered at the office or agency of the Company maintained for such purpose pursuant to Section 2.3 (with due endorsement by, or a written instrument of transfer in form satisfactory to the Company and the Trustee duly executed by, the Holder
thereof or such Holder’s attorney duly authorized in writing), and the Company shall execute, and the Trustee shall authenticate and make available for delivery to the Holder of such Note at the expense of the Company, a new Note or Notes, of
any authorized denomination as requested by such Holder, in an aggregate principal amount equal to and in exchange for the unredeemed portion of the principal amount of the Note so surrendered, provided, that each such new Note will be in a
principal amount of $1,000 or integral multiple thereof. 
  
 If a
Holder converts a portion of its Note prior to receipt of the redemption notice for a Note to be redeemed only in part, the converted portion will be deemed to be from the portion selected for redemption. In the event of any redemption in part, the
Company will not be required to (i) issue, register the transfer of or exchange any Note during a period beginning at the opening of business 15 days before any selection of Notes for redemption and ending at the close of business on the earliest
date on which the relevant notice of redemption is deemed to have been given to all Holders of Notes to be so redeemed; or (ii) register the transfer of or exchange any Note so selected for redemption, in whole or in part, except the unredeemed
portion of any Note being redeemed in part. 
  
 SECTION 5.9.
Arrangement on Call for Redemption. 
  
 (a) In connection
with any redemption of Notes, the Company may arrange at or shortly before the time of the redemption for the purchase and conversion of any Notes called for redemption by an agreement with one or more investment banks or other purchasers to
purchase such Notes by paying to the Trustee in trust for the Holders, on or prior to 11:00 a.m. (New York City time) on the Redemption Date, an amount that, together with any amounts deposited with the Trustee by the Company for the redemption of
such Notes, is not less than the Redemption Price of such Notes. Notwithstanding anything to the contrary contained in this Article V, the obligation of the Company to pay the Redemption Prices of such Notes shall be deemed to be satisfied and
discharged to the extent such amount is so paid by such purchasers; provided, however, that nothing in this Section 5.9 shall relieve the Company of its obligation to pay the Redemption Price (plus accrued interest, Contingent Interest and
Liquidated Damages, if any to, but excluding, the relevant Redemption Date) on Notes called for redemption. 
  
 (b) If such an agreement is entered into, any Notes called for redemption that are not duly surrendered for conversion by the Holders thereof may, at the
option of the Company, be deemed, to the fullest extent permitted by law, acquired by such purchasers from such Holders as of the close of business on the Redemption Date, subject to payment of the above amount as aforesaid. 
  

 37 

 (c) At the written direction of the Company, the Trustee shall hold and pay to the Holders whose Notes
are selected for redemption any such amount paid to it for purchase in the same manner as it would moneys deposited with it by the Company for the redemption of Notes. Without the Trustee’s prior written consent, no arrangement between the
Company and such purchasers for the purchase and conversion of any Notes shall increase or otherwise affect any of the powers, duties, responsibilities or obligations of the Trustee as set forth in this Indenture, and the Company agrees to indemnify
the Trustee from, and hold it harmless against, any loss, liability or expense arising out of or in connection with any such arrangement for the purchase of any Notes between the Company and such purchasers, including the reasonable costs and
out-of-pocket expenses incurred by the Trustee in the defense of any claim or liability arising out of or in connection with the exercise or performance of any of its powers, duties, responsibilities or obligations under this Section 5.9.

  
 ARTICLE VI 
  
 REPURCHASE UPON A FUNDAMENTAL CHANGE 
  
 SECTION 6.1. Repurchase at the Option of the Holder upon a Fundamental
Change. If a Fundamental Change shall occur, each Holder shall have the right, at such Holder’s option, to require the Company to purchase any or all of such Holder’s Notes not previously called for redemption for cash on the date that
is no less than 20 Business Days and no more than 35 Business Days after the date of the Company Notice of the occurrence of such Fundamental Change (subject to extension to comply with applicable law, as provided in Section 8.4) (the
“Fundamental Change Repurchase Date”). The Notes shall be repurchased in integral multiples of $1,000 of the principal amount. The Company shall purchase such Notes at a price (the “Fundamental Change Repurchase Price”) equal to
100% of the principal amount of the Notes to be purchased plus accrued and unpaid interest, if any, Contingent Interest, if any, and Liquidated Damages, if any, to, but not including, the Fundamental Change Repurchase Date. 
  
 SECTION 6.2. Notice of Fundamental Change. The Company, or at its
request (which must be received by the Paying Agent at least three Business Days (or such lesser period as agreed to by the Paying Agent) prior to the date the Paying Agent is requested to give such notice as described below), the Paying Agent in
the name of and at the expense of the Company, shall mail to all Holders and the Trustee a Company Notice of the occurrence of a Fundamental Change and of the purchase right arising as a result thereof, including the information required by Section
8.1, on or before the 30th day after the occurrence of such Fundamental Change. In addition, simultaneous with
mailing the Company Notice, the Company will disseminate a press release containing information about the Fundamental Change and the repurchase right arising as a result of the Fundamental Change through a public medium that is customary for such
press releases or publish the information on the Company’s website or through such other public medium as the Company may use at that time. 
  
 SECTION 6.3. Exercise of Option. For a Note to be so purchased at the option of the Holder, the Trustee must receive such Note duly endorsed for
transfer, together with a written notice of repurchase (the “Fundamental Change Repurchase Notice”) in the form 

  

 38 

 
attached to the Note, before the close of business on the Business Day immediately preceding the Fundamental Change Repurchase Date, subject to extension to
comply with applicable law, as provided in Section 8.4. The Fundamental Change Repurchase Notice shall state: 
  
 (a) if the Notes are certificated, the certificate numbers of the Notes which the Holder shall deliver to be purchased, or, if the Notes are not
certificated, the Fundamental Change Repurchase Notice must comply with appropriate Depositary procedures; 
  
 (b) the portion of the principal amount of the Notes which the Holder shall deliver to be purchased, which portion must be $1,000 in principal amount or
an integral multiple thereof; and 
  
 (c) that such Notes shall be
purchased as of the Fundamental Change Repurchase Date pursuant to the terms and conditions specified in paragraph 9 of the Notes and in this Indenture. 
  
 SECTION 6.4. Procedures. The Company shall purchase from a Holder, pursuant to this Article VI, Notes if the principal amount of such Notes is
$1,000 or a multiple of $1,000 if so requested by such Holder. 
  
 Any purchase by the Company contemplated pursuant to the provisions of this Article VI shall be consummated by the delivery of the Fundamental Change Repurchase Price to be received by the Holder promptly following the later of the
Fundamental Change Repurchase Date or the time of book-entry transfer or delivery of the Notes. 
  
 The Paying Agent shall promptly notify the Company of the receipt by it of any Fundamental Change Repurchase Notice. 
  
 On or before 11:00 a.m., New York City time, on the Fundamental Change
Repurchase Date, the Company shall deposit with the Paying Agent (or if the Company or an Affiliate of the Company is acting as the Paying Agent, shall segregate and hold in trust) cash, sufficient to pay the aggregate Fundamental Change Repurchase
Price of the Notes to be purchased pursuant to this Article VI. Payment by the Paying Agent of the Fundamental Change Repurchase Price for such Notes shall be made promptly following the later of the Fundamental Change Repurchase Date or the time of
book-entry transfer or delivery of such Notes. If the Paying Agent holds, in accordance with the terms of this Indenture, cash sufficient to pay the Fundamental Change Repurchase Price of such Notes on the Business Day immediately following the
Fundamental Change Repurchase Date, then, on and after such date, such Notes shall cease to be outstanding and interest (including Contingent Interest and Liquidated Damages, if any) on such Notes shall cease to accrue, whether or not book-entry
transfer of such Notes is made or such Notes are delivered to the Paying Agent, and all other rights of the Holder shall terminate (other than the right to receive the Fundamental Change Repurchase Price upon delivery or transfer of the Notes).
Nothing herein shall preclude the withholding of any tax required by law or regulations. 
  
 The Company shall require each Paying Agent (other than the Trustee) to agree in writing that the Paying Agent shall hold in trust for the benefit of Holders or the Trustee all cash held by the Paying Agent for the
payment of the Fundamental Change Repurchase Price and 

  

 39 

 
shall notify the Trustee of any Default by the Company in making any such payment. The Company at any time may require a Paying Agent to deliver all cash
held by it to the Trustee and to account for any funds disbursed by the Paying Agent. Upon doing so, the Paying Agent shall have no further liability for the cash delivered to the Trustee. 
  
 All questions as to the validity, eligibility (including time of receipt) and
acceptance of any Notes for repurchase shall be determined by the Company, whose determination shall be final and binding. 
  
 ARTICLE VII 
  
 OPTIONAL REPURCHASE 
  
 SECTION 7.1. Repurchase of Notes by the Company at the Option of the Holder. 
  
 (a) On each of March 15, 2009, March 15, 2014 and March 15, 2019 (each, a “Repurchase Date”), Holders shall have the option to require the
Company to purchase any Notes at 100% of the principal amount of the Notes to be repurchased plus accrued and unpaid interest and Contingent Interest and Liquidated Damages, if any, to but not including such Repurchase Date, subject to the
satisfaction by or on behalf of the Holder of the requirements set forth below: 
  
 (1) Repurchases of Notes under this Section 7.1 shall be made, at the option of the Holder thereof, upon delivery to the Paying Agent by
the Holder of a written notice of repurchase (a “Repurchase Notice”) in the form attached to the Note at any time from the opening of business on the date that is 20 Business Days prior to a Repurchase Date until the close of business on
the last Business Day immediately prior to such Repurchase Date, stating: 
  
 (i) if the Notes are certificated, the certificate numbers of the Notes which the Holder will deliver to be purchased, or, if the Notes are not certificated, the Repurchase Notice must comply with appropriate
Depositary procedures; 
  
 (ii) the portion of
the principal amount of the Notes which the Holder will deliver to be purchased, which portion must be $1,000 in principal amount or an integral multiple thereof; and 
  
 (iii) that such Notes shall be purchased as of the Repurchase Date pursuant to the terms and conditions
specified in paragraph 8 of the Notes and in this Indenture; and 
  
 (2) delivery or book-entry transfer of such Notes to the Paying Agent prior to, on or after the Repurchase Date (together with all necessary endorsements) at the offices of the Paying Agent, such delivery or transfer
being a condition to receipt by the Holder 

  

 40 

 
of the Repurchase Price therefor; provided, however, that such Repurchase Price shall be so paid pursuant to this Section 7.1 only if the Notes
so delivered or transferred to the Paying Agent shall conform in all respects to the description thereof in the related Repurchase Notice. 
  
 The Repurchase Price with respect to Notes purchased on a Repurchase Date shall be paid solely in cash. 
  
 (b) The Company shall purchase from a Holder, pursuant to the terms of this
Section 7.1, Notes if the principal amount of such Notes is $1,000 or a multiple of $1,000 if so requested by such Holder. 
  
 (c) Any purchase by the Company contemplated pursuant to the provisions of this Section 7.1 shall be consummated by the delivery of the Repurchase Price
to be received by the Holder promptly following the later of the Repurchase Date and the time of book-entry transfer or delivery of the Notes. 
  
 (d) Notwithstanding anything herein to the contrary, any Holder delivering to the Paying Agent the Repurchase Notice contemplated by this Section 7.1
shall have the right at any time prior to the close of business on the Business Day prior to the Repurchase Date to withdraw such Repurchase Notice (in whole or in part) by delivery of a written notice of withdrawal to the Paying Agent in accordance
with Section 8.2. 
  
 (e) The Paying Agent shall promptly notify
the Company of the receipt by it of any Repurchase Notice or written notice of withdrawal thereof. 
  
 (f) On or before 11:00 a.m. on the Repurchase Date, the Company shall deposit with the Paying Agent (or if the Company or an Affiliate of the Company is
acting as the Paying Agent, shall segregate and hold in trust) cash sufficient to pay the aggregate Repurchase Price of the Notes to be purchased pursuant to this Section 7.1. Payment by the Paying Agent of the Repurchase Price for such Notes shall
be made promptly following the later of the Repurchase Date and the time of book-entry transfer or delivery of such Notes. If the Paying Agent holds, in accordance with the terms of this Indenture, cash sufficient to pay the Repurchase Price of such
Notes on the Business Day immediately following the Repurchase Date, then, on and after such date, such Notes shall cease to be outstanding and interest, Contingent Interest, if any, and Liquidated Damages, if any, on such Notes shall cease to
accrue, whether or not book-entry transfer of such Notes is made or such Notes are delivered to the Paying Agent, and all other rights of the Holder shall terminate (other than the right to receive the Repurchase Price upon delivery or transfer of
the Notes). 
  
 (g) The Company shall require each Paying Agent
(other than the Trustee) to agree in writing that the Paying Agent shall hold in trust for the benefit of Holders or the Trustee all cash held by the Paying Agent for the payment of the Repurchase Price and shall notify the Trustee of any Default by
the Company in making any such payment. The Company at any time may require a Paying Agent to deliver all cash held by it to the Trustee and to account for any funds disbursed by the Paying Agent. Upon doing so, the Paying Agent shall have no
further liability for the cash and/or Common Stock, as the case may be, delivered to the Trustee. 
  

 41 

 ARTICLE VIII 
  
 CONDITIONS AND PROCEDURES FOR REPURCHASES AT OPTION OF HOLDERS 
  
 SECTION 8.1. Notice of Repurchase Date or Fundamental Change. The
Company shall send notices (each, a “Company Notice”) to the Holders (and to Beneficial Owners as required by applicable law) at their addresses shown in the Note Register not less than 20 Business Days prior to each Repurchase Date, in
accordance with Section 7.1 hereof, or on or before the 30th day after the occurrence of a Fundamental Change, in
accordance with Section 6.2 hereof, as the case may be (each such date of delivery, a “Company Notice Date”). The Company shall also deliver a copy of such Company Notice to the Trustee and any Paying Agent. Each Company Notice shall
include a form of Repurchase Notice or Fundamental Change Repurchase Notice to be completed by a Holder and shall state: 
  
 (a) the applicable Repurchase Price or Fundamental Change Repurchase Price, excluding accrued and unpaid interest, Conversion Rate at the time of such
notice (and any adjustments to the Conversion Rate) and, to the extent known at the time of such notice, the amount of accrued and unpaid interest, Contingent Interest, if any, and Liquidated Damages, if any, that will be payable with respect to the
Notes on the applicable Repurchase Date or Fundamental Change Repurchase Date; 
  
 (b) if the notice relates to a Fundamental Change, the events causing the Fundamental Change and the date of the Fundamental Change; 
  
 (c) the Repurchase Date or Fundamental Change Repurchase Date; 
  
 (d) the last date on which a Holder may exercise its purchase right; 
  
 (e) the name and address of the Paying Agent and the Conversion Agent;

  
 (f) that Notes must be surrendered to the Paying Agent to
collect payment of the Repurchase Price or Fundamental Change Repurchase Price; 
  
 (g) that Notes as to which a Repurchase Notice or Fundamental Change Repurchase Notice has been given may be converted only if the applicable Repurchase Notice or Fundamental Change Repurchase Notice has been
withdrawn in accordance with the terms of this Indenture; 
  
 (h)
that the Repurchase Price or Fundamental Change Repurchase Price for any Notes as to which a Repurchase Notice or a Fundamental Change Repurchase Notice, as applicable, has been given and not withdrawn shall be paid by the Paying Agent promptly
following the later of the Repurchase Date or Fundamental Change Repurchase Date, as applicable, and the time of book-entry transfer or delivery of such Notes; 
  

(i) the procedures the Holder must follow under Article VI or VII hereof, as applicable, and this Article VIII; 
  

 42 

 (j) briefly, the conversion rights of the Notes; 
  
 (k) that, unless the Company defaults in making payment of such Repurchase
Price or Fundamental Change Repurchase Price on Notes covered by any Repurchase Notice or Fundamental Change Repurchase Notice, as applicable, interest, Contingent Interest, if any, and Liquidated Damages, if any, will cease to accrue on and after
the Repurchase Date or Fundamental Change Repurchase Date, as applicable; 
  
 (l) the CUSIP or ISIN number of the Notes; and 
  
 (m) the procedures for withdrawing a Repurchase Notice or Fundamental Change Repurchase Notice. 
  
 In connection with providing such Company Notice, the Company will issue a press release and publish a notice containing the information in such Company
Notice in a newspaper of general circulation in the City of New York or publish such information on the Company’s then existing website or through such other public medium as the Company may use at the time. 
  
 If any of the Notes is in the form of a Global Note, then the Company shall
modify such Company Notice to the extent necessary to accord with the procedures of the Depositary applicable to the repurchase of Global Notes. 
  
 At the Company’s request, made at least one Business Day prior to the date upon which such notice is to be mailed, and at the Company’s expense,
the Paying Agent shall give the Company Notice in the Company’s name to the Holders; provided, however, that, in all cases, the text of the Company Notice shall be prepared by the Company. 
  
 SECTION 8.2. Effect of Repurchase Notice or Fundamental Change Repurchase
Notice. Upon receipt by the Company of a properly completed and executed Repurchase Notice or Fundamental Change Repurchase Notice specified in Section 7.1 or Section 6.3, as applicable, the Holder of the Notes in respect of which such
Repurchase Notice or Fundamental Change Repurchase Notice, as the case may be, was given shall (unless such Repurchase Notice or Fundamental Change Repurchase Notice is withdrawn as specified in the following two paragraphs) thereafter be entitled
to receive solely the Repurchase Price or Fundamental Change Repurchase Price with respect to such Notes. Such Repurchase Price or Fundamental Change Repurchase Price shall be paid by the Paying Agent to such Holder promptly following the later of
(i) the Repurchase Date or the Fundamental Change Repurchase Date, as the case may be, with respect to such Notes (provided the conditions in Section 7.1 or Section 6.2, as applicable, have been satisfied) and (ii) the time of delivery or
book-entry transfer of such Notes to the Paying Agent by the Holder thereof in the manner required by Section 7.1 or Section 6.4, as applicable. Notes in respect of which a Repurchase Notice or Fundamental Change Repurchase Notice, as the case may
be, has been given by the Holder thereof may not be converted for shares of Common Stock on or after the date of the delivery of such Repurchase Notice or Fundamental Change Repurchase Notice, as the case may be, unless such Repurchase Notice or
Fundamental Change Repurchase Notice, as the case may be, has first been validly withdrawn as specified in the following two paragraphs. 
  

 43 

 A Repurchase Notice or Fundamental Change Repurchase Notice, as the case may be, may be withdrawn by
means of a written notice of withdrawal delivered to the office of the Paying Agent (with a copy to the Company) at any time prior to the close of business on the Business Day prior to the Repurchase Date or the Fundamental Change Repurchase Date,
as the case may be, to which it relates specifying: 
  
 (a) if the
Notes are certificated, the certificate number of the Notes in respect of which such notice of withdrawal is being submitted, or, if not certificated, the written notice of withdrawal must comply with appropriate Depositary procedures; 

 
 (b) the principal amount of the Notes with respect to which such notice of
withdrawal is being submitted; and 
  
 (c) the principal amount,
if any, of such Notes which remains subject to the original Repurchase Notice or Fundamental Change Repurchase Notice, as the case may be, and which has been or shall be delivered for purchase by the Company. 
  
 The Paying Agent shall promptly return to the respective Holders thereof any
Notes with respect to which a Repurchase Notice or Fundamental Change Repurchase Notice, as the case may be, has been withdrawn in compliance with this Indenture. 
  
 SECTION 8.3. Notes Repurchased in Part. Any Notes that are to be repurchased only in part shall be surrendered at the
office of the Paying Agent (with, if the Company or the Trustee so requires, due endorsement by, or a written instrument of transfer in form satisfactory to the Company and the Trustee duly executed by, the Holder thereof or such Holder’s
attorney duly authorized in writing) and the Company shall execute and the Trustee or the Authenticating Agent shall authenticate and deliver to the Holder of such Notes, without service charge, a new Note or Notes, of any authorized denomination as
requested by such Holder in aggregate principal amount equal to, and in exchange for, the portion of the principal amount of the Notes so surrendered which is not purchased. 
  
 SECTION 8.4. Covenant to Comply with Securities Laws upon Repurchase of Notes. In connection with any offer to
repurchase Notes under Article VI or Article VII hereof, the Company shall, to the extent required by applicable law, (a) comply with Rules 13e-4 and 14e-1 (and any successor provisions thereto) and any other rules relating to tender offers under
the Exchange Act, if applicable; (b) file the related Schedule TO (or any successor schedule, form or report) under the Exchange Act, if applicable; and (c) otherwise comply in all material respects with all applicable federal and state securities
laws so as to permit the rights and obligations under Article VI or Article VII to be exercised in the time and in the manner specified in Article VI or Article VII. 
  
 SECTION 8.5. Repayment to the Company. The Trustee and the Paying Agent shall return to the Company any cash or
property that remains unclaimed as provided in paragraph 13 of the Notes and Section 3.3 hereof, together with interest (including Contingent Interest, if any) that the Trustee or Paying Agent, as the case may be, has agreed to pay, if any, held by
them for the payment of a Repurchase Price or Fundamental Change Repurchase Price, as the case may be; provided, however, that to the extent that the aggregate amount of cash or property 

  

 44 

 
deposited by the Company pursuant to Section 7.1(f) or 6.4, as applicable, exceeds the aggregate Repurchase Price or Fundamental Change Repurchase Price, as
the case may be, of the Notes or portions thereof which the Company is obligated to purchase as of the Repurchase Date or Fundamental Change Repurchase Date, as the case may be, then promptly on and after the Business Day immediately following the
Repurchase Date or Fundamental Change Repurchase Date, as the case may be, the Trustee and the Paying Agent shall return any such excess to the Company together with interest (including Contingent Interest, if any) that the Trustee or Paying Agent,
as the case may be, has agreed to pay, if any. 
  
 SECTION 8.6.
Exchange in Lieu of Repurchase. The Company shall have the option, exercisable at any time or from time to time, by an instrument in writing signed by the Company and provided to the Paying Agent, to designate a, or change the existing
designation of the, financial institution (a “Repurchase Party”) to which Notes surrendered by a Holder for repurchase in accordance with Article VI or Article VII, as applicable, will be initially offered by the Paying Agent on behalf of
a Holder for exchange in lieu of repurchase. In order to accept any Notes surrendered for repurchase, the Repurchase Party must agree to deliver, in exchange for such Notes, the Repurchase Price or the Fundamental Change Repurchase Price, as the
case may be, for such Notes in the amount that would be payable if the Notes were repurchased by the Company in accordance with Article VI or Article VII, as applicable. If the Repurchase Party accepts any Notes for repurchase, it will deliver to
the Paying Agent, and the Paying Agent will deliver to Holders that surrendered such Notes for repurchase, the Repurchase Price or the Fundamental Change Repurchase Price, as applicable, payable with respect to such Notes. In the event that the
Repurchase Party agrees to accept any Notes for repurchase but fails to deliver the Repurchase Price or the Fundamental Change Repurchase Price to the Paying Agent by the Repurchase Date, the Notes will be repurchased by the Company in accordance
with Article VI or Article VII, as applicable, and the Company will, as promptly as practical thereafter, but not later than one Business Day following the Repurchase Date or the Fundamental Change Repurchase Date, as the case may be, cause the
Repurchase Price or the Fundamental Change Repurchase Price, as the case may be, for the Notes to be paid (provided, however, that interest, Contingent Interest and Liquidated Damages, if any, shall continue to accrue on the Notes to
be repurchased until the Repurchase Price or the Fundamental Change Repurchase Price, as the case may be, has been paid). Any Notes purchased by the Repurchase Party shall remain outstanding. The designation by the Company of a Repurchase Party does
not require such Repurchase Party to accept any Notes. If the Repurchase Party declines to accept any Notes surrendered for repurchase, the Company will repurchase the Notes on the terms provided in this Indenture. The Company will not pay any
consideration to, or otherwise enter into any arrangement with, the Repurchase Party for or with respect to such designation. 
  
 ARTICLE IX 
  
 CONVERSION OF NOTES 
  
 SECTION 9.1. Right To Convert. Subject to and upon compliance with the provisions of this Article IX, a Holder may convert its Notes into shares of Common Stock at the 

  

 45 

 
applicable Conversion Rate (defined below) at any time during which the following conditions are met: 
  
 (a) on any Business Day during a calendar quarter (and only during that
calendar quarter) prior to March 15, 2019, if the Closing Sale Price of the Common Stock for at least 20 Trading Days in a period of 30 consecutive Trading Days ending on the last Trading Day of the previous calendar quarter, is greater than 120% of
the applicable Conversion Price; 
  
 (b) at any time after March
15, 2019, if the Closing Sale Price of the Common Stock is greater than 120% of the applicable Conversion Price; 
  
 (c) during the five consecutive Business Day period following any five consecutive Trading Day period in which the Trading Price for a Note for each day
of that trading period was less than 98% of the Closing Sale Price of the Common Stock on such corresponding Trading Day multiplied by the applicable Conversion Rate; provided, however, that if, on the Trading Day immediately prior to
the Conversion Date, the Closing Sale Price of the Common Stock is greater than 100% of the applicable Conversion Price but less than or equal to 120% of the applicable Conversion Price, a Note is surrendered for conversion and the Notes are not
otherwise convertible, then Holders will receive, in lieu of Common Stock based on the Conversion Rate, cash, Common Stock or a combination of cash and Common Stock, at the Company’s option, with a value equal to 100% of the principal amount of
the Note to be converted plus accrued and unpaid interest and Contingent Interest, if any, to but not including the Conversion Date (a “Principal Value Conversion”). If a Holder surrenders its Notes for a Principal Value Conversion
pursuant to this Section 9.1(c), the Company will notify such Holder through the Conversion Agent whether the Company will pay such Holder all or a portion of the principal amount plus accrued and unpaid interest, if any, of such Notes in cash,
Common Stock or a combination of cash and Common Stock and in what percentage or amount at any time on or before the date that is two Trading Days following the Conversion Date. Settlement (in cash and/or Common Stock) will occur on the third
Business Day following the final day of the five consecutive Trading Day period beginning on the third Trading Day following the Conversion Date. Any Common Stock delivered upon a Principal Value Conversion in accordance with this Section 9.1(c)
shall be valued at 100% of the average of the Closing Sale Prices of the Common Stock for the five consecutive Trading Days commencing on the third Trading Day following the Conversion Date; 
  
 (d) during such period, if any, in which (i) the Company’s long-term
issuer rating assigned by Moody’s is at or below Caa1 and the corporate credit rating by Standard & Poor’s is at or below B-, or (ii) if the Company is no longer rated by at least one of Moody’s or Standard & Poor’s;

  
 (e) in the event that the Company calls the Notes for
redemption pursuant to Article V hereof, prior to the close of business on the Business Day prior to the Redemption Date, even if the Notes are not otherwise convertible at such time, provided that if the Company elects to redeem less than all the
Notes, only those Notes called for redemption may be redeemed pursuant to this Section 9.1(e); 
  

 46 

 (f) the Company becomes a party to a consolidation, merger or binding share exchange pursuant to which
all or substantially all of the Common Stock would be converted into cash, securities or other property, in which case a Holder may surrender Notes for conversion at any time from and after the date that is 15 days prior to the anticipated effective
date for the transaction until 15 days after the actual effective date of such transaction; or 
  
 (g) the Company elects to (i) distribute to all holders of Common Stock assets, debt securities or rights to purchase securities, other than rights referred to in clause (ii) below of the Company, which distribution
has a per share value as determined by the Board of Directors exceeding 10% of the Closing Sale Price of the Common Stock on the Trading Day immediately preceding the declaration date for such distribution, or (ii) distribute to all holders of
Common Stock rights, options or warrants entitling them to purchase shares of Common Stock at less than the Current Market Price. In the case of the foregoing clauses (i) and (ii), the Company must notify the Holders at least 20 days immediately
prior to the ex-dividend date for such distribution. Once the Company has given such notice, Holders may surrender their Notes for conversion at any time thereafter until the earlier of the close of business on the Business Day immediately prior to
the ex-dividend date and the Company’s announcement that such distribution will not take place, even if the Notes are not otherwise convertible at such time; provided, however, that a Holder may not exercise this right to convert
if the Holder is otherwise entitled to participate in the distribution without conversion. As used herein, the term “ex-dividend date” or “ex-date” when used with respect to any issuance or distribution, shall mean the first date
upon which a sale of shares of Common Stock does not automatically transfer the right to receive the relevant dividend or distribution from the seller of such Common Stock to its buyer. 
  
 Upon the Company’s determination that Holders are or will be entitled to convert Notes into shares of Common Stock in
accordance with the provisions of this Section 9.1, the Company will issue a press release through a public medium that is customary for such press releases or publish the information on the Company’s website or through such other public medium
as the Company may use at that time. 
  
 The number of shares of
Common Stock issuable upon conversion of a Note per $1,000 principal amount (the “Conversion Rate”) shall be that set forth in paragraph 10 in the Notes, subject to adjustment as herein set forth. The initial Conversion Rate is 58.4949
shares of Common Stock issuable upon conversion of a Note per $1,000 principal amount. 
  
 A Holder may convert a portion of the principal amount of Notes if the portion is $1,000 or a multiple of $1,000. 
  
 SECTION 9.2. Determination of Satisfaction of Certain Conversion Triggers. 
  
 (a) The Conversion Agent shall, on the Company’s behalf, determine if the Notes are convertible in accordance with
Sections 9.1(a) or 9.1(b) and shall notify the Company and the Trustee if the Notes become convertible; provided that the Company shall provide to the Conversion Agent, upon written request, the Closing Sale Price of the Common Stock. Prior
to March 15, 2019, the Conversion Agent shall make such determination during the last 30 consecutive Trading Days ending on the last Trading Day of each calendar quarter. Beginning after March 15, 2019, the Conversion Agent shall make such
determination on a daily basis. 
  

 47 

 (b) The Conversion Agent will, on behalf of the Company, determine if the Notes are convertible in
accordance with Section 9.1(c) and notify the Company and the Trustee if the Notes become convertible; provided, however, that the Conversion Agent shall have no obligation to determine the Trading Price of the Notes unless the Company
has requested such determination in writing and the Company shall have no obligation to make such request unless requested in writing to do so by a Holder. Upon request by the Company to the Conversion Agent to determine the Trading Price, the
Company shall instruct the Conversion Agent to determine the Trading Price of the Notes beginning on the next succeeding Trading Day and on each successive Trading Day until the Trading Price of the Notes is greater than or equal to 98% of the
product of the Closing Sale Price of the Common Stock and the applicable Conversion Rate. 
  
 SECTION 9.3. Conversion Procedures. To convert Notes, a Holder must satisfy the requirements in this Section 9.3 and in paragraph 10 of the Notes. The date on which the Holder satisfies all those requirements
and delivers an irrevocable conversion notice, together, if the Notes are in certificated form, with the certificated Note, to the Conversion Agent, along with appropriate endorsements and transfer documents, and pays any transfer or similar tax, is
the conversion date (the “Conversion Date”). As soon as practicable, but in no event later than the third Business Day following the determination of the Applicable Stock Price, the Company shall deliver to the Holder, through the
Conversion Agent, a certificate for the number of full shares of Common Stock issuable upon the conversion which shall be equal to (1) the aggregate original principal amount of the Notes to be converted divided by 1,000, multiplied by (2) the
Conversion Rate rounded down to the nearest whole share, and cash in lieu of any fractional share determined pursuant to Section 9.4. Upon conversion, the Company may choose to deliver, in lieu of Common Stock, cash or a combination of cash and
Common Stock as set forth in Section 9.18. The Person in whose name the certificate is registered shall only be treated as a stockholder of record on and after the Conversion Date; provided, however, that no surrender of Notes on any
date when the stock transfer books of the Company shall be closed shall be effective to constitute the Person or Persons entitled to receive the shares of Common Stock upon such conversion as the record holder or holders of such shares of Common
Stock on such date, but such surrender shall be effective to constitute the Person or Persons entitled to receive such shares of Common Stock as the record holder or holders thereof for all purposes at the close of business on the next succeeding
Business Day on which such stock transfer books are open; such conversion shall be at the Conversion Rate in effect on the date that such Notes were surrendered for conversion, as if the stock transfer books of the Company had not been closed. Upon
conversion of Notes, such Person shall no longer be a Holder of such Notes. 
  
 No payment or adjustment shall be made for dividends on or other distributions with respect to any Common Stock except as provided in Section 9.8 or as otherwise provided in this Indenture. 
  
 Except as provided in this paragraph, a converting Holder of Notes shall not
be entitled to received any accrued and unpaid cash interest (including Contingent Interest) on any such Notes being converted. By delivery to the Holder of the number of shares of Common Stock or other consideration issuable or payable upon
conversion in accordance with this Section 9.3, any accrued and unpaid cash interest (including Contingent Interest) on such Notes will be deemed to have been paid in full. If any Conversion Date occurs subsequent to the Regular Record Date
preceding an Interest Payment Date but prior to such Interest Payment Date, the Holder of such Notes at the close of business New York City time on any Regular Record Date shall receive the cash interest (including Contingent Interest) payable on
such Note on such Interest Payment Date notwithstanding the conversion thereof. Notes surrendered for conversion during the period from the close of business New York City time on any Regular Record 

  

 48 

 
Date (except in the case of Notes which have been called for redemption on a Redemption Date within such period) shall be accompanied by payment from
converting Holders, for the account of the Company, in New York Clearing House funds, of an amount equal to the interest (including Contingent Interest) payable on such Interest Payment Date on the Notes being surrendered for conversion;
provided, however, if the Company elects to redeem Notes on a date that is after the Regular Record Date but on or prior to the corresponding Interest Payment Date, and such Holder elects to convert those Notes, the Holder will not be
required to pay the Company, at the time that Holder surrenders those Notes for conversion, the amount of cash interest (including Contingent Interest) such Holder will receive on the Interest Payment Date. Upon conversion of Notes, that portion of
accrued but unpaid cash interest, if any, (including Contingent Interest, if any) with respect to the converted Notes shall not be canceled, extinguished or forfeited, but rather shall be deemed to be paid in full to the Holder thereof through
delivery of the Common Stock (together with the cash payment, if any, in lieu of fractional shares) or cash or a combination of cash and Common Stock in exchange for the Notes being converted pursuant to the provisions hereof, and the cash or the
Fair Market Value of such shares of Common Stock (together with any such cash payment in lieu of fractional shares) shall be treated as issued, to the extent thereof, first in exchange for cash interest (including Contingent Interest) accrued and
unpaid through the Conversion Date and the balance, if any, of such cash or the Fair Market Value of such Common Stock (and any such cash payment) shall be treated as issued in exchange for the principal amount of the Notes being converted pursuant
to the provisions hereof. The Company will not adjust the Conversion Rate to account for accrued cash interest (including Contingent Interest) on any Note. 
  
 If a Holder converts more than one Note at the same time, the number of shares of Common Stock issuable upon the conversion shall be based on the total
principal amount of the Notes converted. 
  
 Upon surrender of a
Note that is converted in part, the Company shall execute, and the Trustee or the Authenticating Agent shall authenticate and deliver to the Holder, a new Note in an authorized denomination equal in principal amount to the unconverted portion of the
Note surrendered. 
  
 If the last day on which Notes may be
converted is not a Business Day in a place where a Conversion Agent is located, the Notes may be surrendered to that Conversion Agent on the next succeeding Business Day. 
  
 Holders that have already delivered a Repurchase Notice or a Fundamental Change Repurchase Notice with respect to a Note,
may not surrender such Note for conversion until the Repurchase Notice or Fundamental Change Repurchase Notice, as the case may be, has been withdrawn in accordance with the procedures set forth in Section 8.2. 
  

 49 

 SECTION 9.4. Cash Payments in Lieu of Fractional Shares. The Company shall not issue a fractional
share of Common Stock upon conversion of Notes. Instead the Company shall deliver cash for the Fair Market Value of the fractional share. The Fair Market Value of a fractional share shall be determined to the nearest 1/10,000th of a share by
multiplying the Applicable Stock Price of a full share of Common Stock by the fractional amount and rounding the product to the nearest whole cent. Whether fractional shares are issuable upon a conversion will be determined on the basis of the total
number of Notes that the Holder is then converting into Common Stock and the aggregate number of shares of Common Stock issuable upon such conversion. 
  
 SECTION 9.5. Taxes on Conversion. If a Holder converts Notes, the Company shall pay any documentary, stamp or similar issue or transfer tax due on
the issue of shares of Common Stock upon the conversion. However, the Holder shall pay any such tax which is due because the Holder requests the shares to be issued in a name other than the Holder’s name. The Conversion Agent may refuse to
deliver the certificates representing the Common Stock being issued in a name other than the Holder’s name until the Conversion Agent receives a sum sufficient to pay any tax which shall be due because the shares are to be issued in a name
other than the Holder’s name. Nothing herein shall preclude the withholding of any tax required by law or regulations. 
  
 SECTION 9.6. Exchange in Lieu of Conversion. The Company shall have the option, exercisable at any time or from time to time, by an instrument in
writing signed by the Company and provided to the Conversion Agent, to designate a financial institution, or change the existing designation of the financial institution, to which Notes surrendered by a Holder for conversion will be initially
offered by the Conversion Agent on behalf of a Holder for exchange in lieu of conversion (the “Exchange Party”). In order to accept any Notes surrendered for conversion, the Exchange Party must agree to deliver in exchange for such Notes,
a number of full shares of Common Stock issuable on conversion thereof based on the applicable Conversion Rate, plus cash for any fractional shares, or cash or a combination of cash and Common Stock in lieu thereof in the form that would otherwise
have been deliverable by the Company under this Article IX. If the Exchange Party accepts any Notes for conversion, it will deliver to the Conversion Agent, and the Conversion Agent will deliver to converting Holders, the shares of Common Stock or
other consideration payable with respect to such Notes. In the event that the Exchange Party agrees to accept any Notes for conversion but fails to deliver the consideration for the converted Notes by the second Business Day following the
determination of the Applicable Stock Price, the Notes will be converted by the Company in accordance with this Article IX and the Company will, as promptly as practical thereafter, but not later than three Business Days following the determination
of the Applicable Stock Price, deliver to the Holder shares of Common Stock (together with any cash payment in lieu of fractional shares) or cash or a combination of cash and shares of Common Stock in accordance with Section 9.3. Any Notes exchanged
by the Exchange Party shall remain outstanding. The designation by the Company of an Exchange Party does not require such Exchange Party to accept any Notes for conversion. If the Exchange Party declines to accept any Notes surrendered for
conversion, the Company will convert the Notes on the terms provided in this Indenture. The Company will not pay any consideration to, or otherwise enter into any arrangement with, the Exchange Party for or with respect to such designation.

  

 50 

 SECTION 9.7. Covenants of the Company. The Company shall, prior to issuance of any Notes
hereunder, and from time to time as may be necessary, reserve out of its authorized but unissued Common Stock a sufficient number of shares of Common Stock to permit the conversion of the Notes. 
  
 All shares of Common Stock delivered upon conversion of the Notes shall be
newly issued shares or treasury shares, shall be duly and validly issued and fully paid and nonassessable and shall be free from preemptive rights and free of any lien or adverse claim placed thereon by the Company. 
  
 The Company shall endeavor promptly to comply with all federal and state
securities laws regulating the order and delivery of shares of Common Stock upon the conversion of Notes, if any, and shall cause to have listed or quoted all such shares of Common Stock on each United States national securities exchange or
over-the-counter or other domestic market on which the Common Stock is then listed or quoted. 
  
 SECTION 9.8. Adjustments to Conversion Rate. The Conversion Rate shall be subject to adjustment from time to time, without duplication, as follows: 
  
 (a) In case the Company shall (i) pay a dividend, or make a distribution on its Common Stock, payable exclusively in shares
of Common Stock or other Capital Stock of the Company; (ii) subdivide or split its outstanding Common Stock into a greater number of shares; (iii) combine or reclassify its outstanding Common Stock into a smaller number of shares; or (iv) issue by
reclassification of the shares of Common Stock any shares of the Company’s Capital Stock, the Conversion Rate in effect immediately prior to the record date or effective date, as the case may be, for the adjustment pursuant to this Section
9.8(a) as described below, shall be adjusted so that the Holder of any Notes thereafter surrendered for conversion shall be entitled to receive the number of shares of Common Stock and/or Capital Stock which such Holder would have owned or have been
entitled to receive after the happening of any of the events described above had such Notes been converted immediately prior to such record date or effective date, as the case may be. An adjustment made pursuant to this Section 9.8(a) shall become
effective immediately after the applicable record date in the case of a dividend or distribution and shall become effective immediately after the applicable effective date in the case of subdivision, combination or reclassification of the Common
Stock. If any dividend or distribution of the type described in clause (i) above is not so paid or made, the Conversion Rate shall again be immediately readjusted, effective as of the date the Board of Directors determines not to pursue such action,
to the Conversion Rate that would then be in effect if such dividend or distribution had not been declared. If any subdivision or split, combination or reclassification or issuance of the type described in clauses (ii) through (iv) of this Section
9.8(a) is not so made, the Conversion Rate shall again be immediately readjusted, effective as of the date the Board of Directors determines not to pursue such action, to the Conversion Rate that would then be in effect if such subdivision or split,
combination or reclassification or issuance had not been declared. 
  
 (b) In case the Company at any time or from time to time after the issuance of the Notes shall issue rights or warrants to all or substantially all holders of the Common Stock entitling them to purchase Common Stock for a period of 60 days
from the date of issuance of such rights or warrants at a price per share less (or having a conversion price per share less) than 

  

 51 

 
the Current Market Price per share of Common Stock, the Conversion Rate shall be adjusted so that the same shall equal the Conversion Rate determined by
multiplying the Conversion Rate in effect immediately prior to the close of business on the record date fixed for determination of stockholders entitled to receive such rights or warrants (prior to any adjustment in accordance with this Section
9.8(b)) by a fraction of which (i) the numerator shall be the number of shares of Common Stock outstanding on such record date plus the number of additional shares of Common Stock offered for subscription or purchase, and (ii) the denominator shall
be the number of shares of Common Stock outstanding on such record date plus the number of shares which the aggregate offering price of the total number of shares so offered would purchase at the Current Market Price per share of Common Stock on the
earlier of such record date and the Trading Day immediately preceding the ex date for such issuance of rights or warrants. Such adjustment shall be made successively whenever any such rights or warrants are issued, and shall become effective
immediately after the opening of business on the day following the record date for the determination of stockholders entitled to receive such rights or warrants. To the extent that shares of Common Stock are not delivered after the expiration of
such rights or warrants, the Conversion Rate shall immediately be readjusted to the Conversion Rate which would then be in effect had the adjustments made upon the issuance of such rights or warrants been made on the basis of delivery of only the
number of shares of Common Stock actually delivered. If such rights or warrants are not so issued, the Conversion Rate shall again be immediately readjusted to be the Conversion Rate which would then be in effect if such record date for the
determination of shareholders entitled to receive such rights or warrants had not been fixed. In determining whether any rights or warrants entitle the holders to purchase shares of Common Stock at less than such Current Market Price, and in
determining the aggregate offering price of such shares of Common Stock, there shall be taken into account any consideration received by the Company for such rights or warrants, the value of such consideration, if other than cash, to be determined
by the Board of Directors. 
  
 (c) In case the Company shall, by
dividend or in a merger, amalgamation or consolidation or otherwise, distribute to all or substantially all holders of Common Stock any evidences of Indebtedness, shares of Capital Stock of any class or series, other securities, cash or assets
(excluding (i) any dividend, distribution or issuance covered by those referred to in Section 9.8(a) or 9.8(b) hereof, (ii) any dividend or distribution paid exclusively in cash referred to in Section 9.8(d), 9.8(f) or 9.8(g) hereof or (iii) any
dividend or distribution that constitutes a Spin-Off which is covered by Section 9.8(e) hereof), or rights or warrants to purchase any of its securities (including the distribution of rights to all holders of Common Stock pursuant to a stockholders
rights plan or the detachment of such rights under the terms of such stockholder rights plan but excluding those rights or warrants referred to in Section 9.8(b)) (any of the foregoing hereinafter in this Section 9.8(c) called the “Distributed
Assets”), then in each such case the Conversion Rate shall be adjusted so that the same shall equal the Conversion Rate determined by multiplying the Conversion Rate in effect immediately prior to the close of business on the record date fixed
for determination of stockholders entitled to receive such distribution by a fraction of which (A) the numerator shall be the Current Market Price per share of the Common Stock and (B) the denominator shall be (1) the Current Market Price per share
of the Common Stock less (2) the Fair Market Value on such record date (as determined in good faith by the Board of Directors, whose determination shall be conclusive evidence of such Fair Market Value, and described in a certificate filed with the
Trustee and the Paying Agent) of the portion of the Distributed Assets so distributed applicable to one share of Common Stock. Such adjustment 

  

 52 

 
shall become effective immediately after the record date for the determination of stockholders entitled to receive such distribution; provided,
however, that, if (i) the Fair Market Value of the portion of the Distributed Assets so distributed applicable to one share of Common Stock is equal to or greater than the Current Market Price of the Common Stock or (ii) the Current Market
Price of the Common Stock is greater than the Fair Market Value per share of such Distributed Assets by less than $1.00, then, in lieu of the adjustment provided in this Section 9.8(c), adequate provision shall be made so that each Holder shall have
the right to receive upon conversion, in addition to the shares of Common Stock, the kind and amount of assets, debt securities, or rights or warrants comprising the Distributed Assets the Holder would have received had such Holder converted such
Notes immediately prior to the record date for the determination of stockholders entitled to receive such distribution. In the event that such distribution is not so paid or made, the Conversion Rate shall again be adjusted to the Conversion Rate
which would then be in effect if such distribution had not been declared. 
  
 (d) In case the Company shall make any distributions, by dividend or otherwise, consisting exclusively of cash to all or substantially all holders of outstanding shares of Common Stock, then, and in each such case,
the Conversion Rate shall be adjusted so that the same shall equal the Conversion Rate determined by multiplying the Conversion Rate in effect immediately prior to the close of business on the record date fixed for the determination of holders of
Common Stock entitled to receive such distribution by a fraction of which (A) the numerator shall be the Current Market Price per share of the Common Stock and (B) the denominator shall be (1) the Current Market Price per share of Common Stock minus
(2) the amount per share of such distributions (appropriately adjusted from time to time for any stock dividends on or subdivisions or combination of Common Stock); provided, however, that if (i) the per share amount of such distribution
equals or exceeds the Current Market Price of the Common Stock or (ii) the Current Market Price of the Common Stock exceeds the per share amount of such distribution by less than $1.00, in lieu of the foregoing adjustment, adequate provision shall
be made so that each Holder of a Note shall have the right to receive upon conversion, such dividend or distribution such Holder would have received had such Holder converted each Note immediately prior to the record date for the determination of
stockholders entitled to receive the distribution. 
  
 (e) In the
event that the Company makes any distribution to all holders of Common Stock that constitutes a Spin-Off, the Conversion Rate shall be adjusted so that the same shall equal the Conversion Rate determined by multiplying the Conversion Rate in effect
immediately prior to the close of business on the record date fixed for the determination of holders of Common Stock entitled to receive such distribution by a fraction of which (i) the numerator shall be the Spin-Off Market Price per share of the
Common Stock on such record date plus the Spin-Off Market Price per Equity Interest of the Subsidiary or other business unit of the Company on such record date applicable to each share of Common Stock and (ii) the denominator shall be the Spin-Off
Market Price per share of the Common Stock. The adjustment to the Conversion Rate set forth in this Section 9.8(e) will occur at the earlier of (1) the 10th Trading Day from, and including, the effective date of the Spin-Off and (2) the date of the Initial Public Offering of the securities being distributed in the Spin-Off, if that Initial Public Offering
is effected simultaneously with the Spin-Off; provided, however, that, if (i) the Spin-Off Market Price per Equity Interest of the Subsidiary so distributed applicable to one share of Common Stock is equal to or greater than the
Current Market Price of the Common Stock or (ii) the Current Market Price of the Common Stock is greater than the Spin-Off Market price per Equity Interest 

  

 53 

 
of the Subsidiary by less than $1.00, in lieu of the foregoing adjustment, adequate provision shall be made so that each Holder of a Note shall have the
right to receive upon conversion, such distribution such Holder would have received had such Holder converted each Note immediately prior to the record date for the determination of stockholders entitled to receive the distribution. 
  
 (f) In case a tender or exchange offer made by the Company or any Subsidiary
shall expire and such tender or exchange offer (as amended upon the expiration thereof) shall require the payment to stockholders of consideration per share of Common Stock having a Fair Market Value (as determined in good faith by the
Company’s Board of Directors, whose determination shall be conclusive and described in a resolution of the Board of Directors) that as of the last time (the “Expiration Time”) tenders or exchanges may be made pursuant to such tender
or exchange offer (as it may be amended) exceeds the Closing Sale Price of a share of Common Stock on the Trading Day next succeeding the Expiration Time, the Conversion Rate shall be adjusted so that the same shall equal the rate determined by
multiplying the Conversion Rate by a fraction, 
  
 (i) the numerator of which shall be the sum of (x) the Fair Market Value (determined as aforesaid) of the aggregate consideration payable to stockholders based on the acceptance (up to any maximum specified in the terms of the tender or
exchange offer) of all shares validly tendered or exchanged and not withdrawn as of the Expiration Time (the shares deemed so accepted up to any such maximum, being referred to as the “Purchased Shares”) and (y) the product of (a) the
number of shares of Common Stock outstanding (less any Purchased Shares) at the Expiration Time and (b) the Closing Sale Price of a share of Common Stock on the Trading Day next succeeding the Expiration Time, and 
  
 (ii) the denominator of which shall be the number of shares
of Common Stock outstanding (including any Purchased Shares) at the Expiration Time multiplied by the Closing Sale Price of a share of Common Stock on the Trading Day next succeeding the Expiration Time, such adjustment to become effective
immediately prior to the opening of business on the day following the Expiration Time. If the Company is obligated to purchase shares pursuant to any such tender or exchange offer, but the Company is permanently prevented by applicable law from
effecting any such purchases or all such purchases are rescinded, the Conversion Rate shall again immediately be readjusted to be the Conversion Rate that would then be in effect if such tender or exchange offer had not been made. 
  
 (g) In the event that the Company or any Subsidiary makes any payment in cash
to repurchase Common Stocks, the consideration for which exceeded the average Closing Sale Prices of the Common Stock for the five consecutive Trading Days ending on the last date of such repurchase (the excess amount, the “Repurchase
Premium”), and such repurchase (together with any other repurchases of Common Stock by the Company or any Subsidiary concluded within 12 months of such repurchase, the consideration for which involved a Repurchase Premium) resulted in the
payment by the Company or any Subsidiary of an aggregate consideration exceeding an amount equal to 10% of the Company’s Market Capitalization, the Conversion 

  

 54 

 
Rate shall be adjusted so that the same shall equal the rate determined by multiplying the Conversion Rate by a fraction, 
  
 (i) the numerator of which shall be the 9.8(g) Current
Market Price, and 
  
 (ii) the denominator of
which shall be (A) the 9.8(g) Current Market Price, minus (B) the quotient of (x) aggregate amount of all of the Repurchase Premium paid in connection with all such repurchases and (u) the number of share of Common Stock outstanding on the next
succeeding the date of the repurchase triggering the adjustment in this Section 9.8(g), as determined by the Board of Directors. 
  
 (h) Upon conversion of the Notes, the Holders shall receive, if they receive shares of Common Stock, in addition to the Common Stock issuable upon such
conversion, the rights issued under any shareholder rights plan the Company implements (notwithstanding the occurrence of an event causing such rights to separate from the Common Stock at or prior to the time of conversion) unless, prior to
conversion, the rights have expired, terminated or been redeemed or exchanged in accordance with the rights plan. If, and only if, the Holders of Notes receive rights under such shareholder rights plans as described in the preceding sentence upon
conversion of their Notes, then no other adjustment pursuant to this Section 9.8 shall be made in connection with such shareholder rights plans. 
  
 (i) For purposes of this Section 9.8, the number of shares of Common Stock at any time outstanding shall not include shares held in the treasury of the
Company but shall include shares issuable in respect of scrip certificates issued in lieu of fractions of shares of Common Stock. The Company shall not pay any dividend or make any distribution on shares of Common Stock held in the treasury of the
Company. 
  
 SECTION 9.9. Calculation Methodology. Except
as stated in this Article IX, the Conversion Rate will not be adjusted for the issuance of Common Stock or any securities convertible into or exchangeable for Common Stock or carrying the right to purchase any of the foregoing. If after an
adjustment a Holder of a Note upon conversion of such Note may receive shares of two or more classes of Capital Stock of the Company, the Conversion Rate shall thereafter be subject to adjustment upon the occurrence of an action with respect to any
such class of Capital Stock as is contemplated by this Article IX with respect to the Common Stock, on terms comparable to those applicable to Common Stock in this Article IX. All calculations under Article VIII, Section 9.8 and this Section 9.9
shall be made to the nearest cent or to the nearest 1/10,000th of a share, as the case may be. 
  
 SECTION 9.10. When No Adjustment Required. No adjustment to the Conversion Rate need be made: 
  
 (a) upon the issuance of any shares of Common Stock pursuant to any present or future plan providing for the reinvestment of dividends or interest payable
on securities of the Company and the investment of additional optional amounts in shares of Common Stock under any such plan; 
  

 55 

 (b) upon the issuance of any shares of Common Stock or options or rights to purchase those shares
pursuant to any present or future employee, director or consultant benefit plan or program of or assumed by the Company or any of its Subsidiaries; 
  
 (c) upon the issuance of any shares of Common Stock pursuant to any option, warrant, right, or exercisable, exchangeable or convertible security not
described in paragraph (ii) above and outstanding as of the date of this Indenture; 
  
 (d) for a change in the par value of the Common Stock; or 
  
 (e) for accrued and unpaid interest (including Contingent Interest and Liquidated Damages owed, if any). 
  
 To the extent the Notes become convertible into cash, assets, or property (other than Capital Stock of the Company or securities to which Section 9.14
applies), no adjustment shall be made thereafter as to the cash, assets or property. Interest shall not accrue on such cash. 
  
 No adjustment need be made for a transaction referred to in Sections 9.8(b), (c) or (e) if Holders of the Notes may participate in the transaction on a
basis and with notice that the Board of Directors determines to be fair and appropriate in light of the basis and notice on which holders of Common Stock participate in the transaction. 
  
 SECTION 9.11. Notice of Adjustment. Whenever the Conversion Rate is adjusted, the Company shall promptly mail, or
cause to be mailed, by first class mail to Holders in accordance with Section 15.2 a notice of the adjustment. The Company shall file with the Trustee and the Conversion Agent a certificate signed by the Chief Financial Officer of the Company
setting forth the adjusted Conversion Rate. The certificate shall, absent manifest error, be conclusive evidence that the adjustment is correct. Neither the Trustee nor any Conversion Agent shall be under any duty or responsibility with respect to
any such certificate except to exhibit the same to any Holder desiring inspection thereof. 
  
 SECTION 9.12. Voluntary Increase. The Company may make such increases in the Conversion Rate, in addition to those required by Section 9.8, as the Board of Directors considers to be advisable to avoid or
diminish any income tax to holders of Common Stock or rights to purchase Common Stock resulting from any dividend or distribution of stock (or rights to acquire stock) or from any event treated as such for income tax purposes. To the extent
permitted by applicable law, the Company may from time to time increase the Conversion Rate by any amount for any period of time if the period is at least 20 days, the increase is irrevocable during the period and the Board of Directors shall have
made a determination that such increase would be in the best interests of the Company, which determination shall be conclusive. Whenever the Conversion Rate is so increased, the Company shall mail to Holders and file with the Trustee and the
Conversion Agent a notice of such increase. Neither the Trustee nor any Conversion Agent shall be under any duty or responsibility with respect to any such notice except to exhibit the same to any Holder desiring inspection thereof. The Company
shall mail the notice at least 15 days before the date the increased Conversion Rate takes effect. The notice shall state the increased Conversion Rate and the period it shall be in effect. 
  

 56 

 SECTION 9.13. Notice to Holders Prior to Certain Actions. In case: 
  
 (a) The Company shall declare a dividend (or any other distribution) on its
Common Stock that would require an adjustment in the Conversion Rate pursuant to Section 9.8; 
  
 (b) The Company shall authorize the granting to all or substantially all the holders of its Common Stock of rights or warrants to subscribe for or purchase any share of any class or any other rights or warrants;

  
 (c) Of any reclassification or reorganization of the Common
Stock of the Company (other than a subdivision or combination of its outstanding Common Stock, or a change in par value, or from par value to no par value, or from no par value to par value), or of any consolidation or merger to which the Company is
a party and for which approval of any shareholders of the Company is required, or of the sale or transfer of all or substantially all of the assets of the Company; or 
  
 (d) Of the voluntary or involuntary dissolution, liquidation or winding-up of the Company, the Company shall cause to be
filed with the Conversion Agent and shall cause to be mailed to each Holder at its address appearing on the Note Register, as promptly as possible but in any event at least 15 days (10 days in the case of (a) or (b) above) prior to the applicable
date hereinafter specified, a notice stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution or rights or warrants, or, if a record is not to be taken, the date as of which the holders of Common Stock of
record to be entitled to such dividend, distribution, or rights or warrants are to be determined or (y) the date on which such reclassification, reorganization, consolidation, merger, sale, transfer, dissolution, liquidation or winding-up is
expected to become effective or occur, and the date as of which it is expected that holders of Common Stock of record shall be entitled to exchange their Common Stock for securities, cash or other property deliverable upon such reclassification,
reorganization, consolidation, merger, sale, transfer, dissolution, liquidation or winding-up. Failure to give such notice, or any defect therein, shall not affect the legality or validity of such dividend, distribution, reclassification,
reorganization, consolidation, merger, sale, transfer, dissolution, liquidation or winding-up. 
  
 SECTION 9.14. Effect of Reclassification, Consolidation, Merger, Binding Share Exchange or Sale. If any of the following events occur, namely (a) any reclassification or change of outstanding shares of Common
Stock (other than a change in par value, or from par value to no par value, or from no par value to par value, or as a result of a subdivision or combination); (b) any consolidation, merger, combination or binding share exchange of the Company with
another corporation as a result of which holders of Common Stock shall be entitled to receive stock, securities or other property or assets (including cash) with respect to or in exchange for such Common Stock; or (c) any sale or conveyance of the
properties and assets of the Company as, or substantially as, an entirety to any other corporation as a result of which holders of Common Stock shall be entitled to receive stock, securities or other property or assets (including cash) with respect
to or in exchange for such Common Stock, then the Company or the successor or purchasing corporation, as the case may be, shall execute with the Trustee a supplemental indenture, providing that each Note shall be convertible into the kind and amount
of shares of stock and other securities or property or assets (including cash) receivable upon such reclassification, change, consolidation, merger, combination, binding share exchange, sale or conveyance by a holder of a number of shares of Common
Stock issuable upon conversion of such Note immediately prior to such reclassification, change, consolidation, merger, combination, binding 

  

 57 

 
share exchange, sale or conveyance assuming such holder of Common stock did not exercise his rights of election, if any, as to the kind or amount of stock,
other securities or other property or assets (including cash) receivable upon such reclassification, change, consolidation, merger, combination, binding share exchange, sale or conveyance (provided that, if the kind or amount of stock, other
securities or other property or assets (including cash) receivable upon such reclassification, change, consolidation, merger, combination, sale or conveyance is not the same for each share of Common Stock in respect of which such rights of election
shall not have been exercised (“non-electing share”), then for the purposes of this Section 9.14 the kind and amount of stock, other securities or other property or assets (including cash) receivable upon such reclassification, change,
consolidation, merger, combination, binding share exchange, sale or conveyance for each non-electing share shall be deemed to be the kind and amount so receivable per share by a plurality of the non-electing shares). Such supplemental indenture
shall provide for adjustments which shall be as nearly equivalent as may be practicable to the adjustments provided for in this Article IX. 
  
 The Company shall cause notice of the execution of such supplemental indenture to be mailed to each Holder, at its address appearing on the Note Register,
within 20 days after execution thereof. Failure to deliver such notice shall not affect the legality or validity of such supplemental indenture. 
  
 The above provisions of this Section 9.14 shall similarly apply to successive reclassifications, changes, consolidations, mergers, combinations, binding
share exchanges, sales and conveyances. 
  
 If this Section 9.14
applies to any event or occurrence, Section 9.8 shall not apply. 
  
 SECTION 9.15. Responsibility of Trustee. Except as specifically required in Section 9.2 herein, the Trustee and any Conversion Agent shall not at any time be under any duty or responsibility to any Holder to either calculate the
Conversion Rate or determine whether any facts exist which may require any adjustment of the Conversion Rate, or with respect to the nature or extent or calculation of any such adjustment when made, or with respect to the method employed, or herein
or in any supplemental indenture provided to be employed, in making the same and, subject to Sections 11.1 and 11.2 hereof and the provisions of this Article IX, shall be protected in relying upon an Officers’ Certificate with respect to the
same. The Trustee and any Conversion Agent shall not be accountable with respect to the validity or value (or the kind or amount) of any shares of Common Stock, or of any securities or property, which may at any time be issued or delivered upon the
conversion of any Notes and the Trustee and any Conversion Agent make no representations with respect thereto. Neither the Trustee nor any Conversion Agent shall be responsible for any failure of the Company to issue, transfer or deliver any shares
of Common Stock or stock certificates or other securities or property or cash upon the surrender of any Notes for the purpose of conversion or to comply with any of the duties, responsibilities or covenants of the Company contained herein.

  
 SECTION 9.16. Successive Adjustments. After an
adjustment to the Conversion Rate under Section 9.8, any subsequent event requiring an adjustment under Section 9.8 shall cause an adjustment to the Conversion Rate as so adjusted. 
  

 58 

 SECTION 9.17. General Considerations. Whenever successive adjustments to the Conversion Rate are
called for pursuant to this Article IX, such adjustments shall be made to the Current Market Price as may be necessary or appropriate to effectuate the intent of this Article IX and to avoid unjust or inequitable results as determined in good faith
by the Board of Directors of the Company. 
  
 SECTION 9.18.
Payment of Cash in Lieu of Common Stock. If a Holder elects to convert all or any portion of a Note into shares of Common Stock as set forth in Section 9.1 and delivers an irrevocable conversion notice, together, if the Notes are in
certificated form, with the certificated Note as set forth in Section 9.3, the Company may choose to satisfy all or any portion of its conversion obligation with respect to a Note (the “Conversion Obligation”) in cash or a combination of
cash and Common Stock. Upon such election, the Company will notify such Holder through the Conversion Agent of the Company’s election to pay cash in lieu of delivery of some or all of the shares of Common Stock and the dollar amount per Note to
be satisfied in cash (which must be expressed either as 100% of the Conversion Obligation or as a fixed dollar amount) at any time on or before the date that is two Business Days following the Conversion Date unless the Company has previously
informed Holders of its election in connection with a redemption of the Notes in accordance with Section 5.1 of this Indenture. Settlement (in cash and/or Common Stock) will occur on the third Business Day following the final day of the five
consecutive Trading Day period beginning on the third Trading Day after the Conversion Date. Settlement amounts will be computed as follows: 
  
 (a) if the Company elects to satisfy the entire Conversion Obligation in cash, the Company will deliver to such Holder cash in an amount equal to the
product of: (1) a number equal to (x) the aggregate original principal amount of Notes to be converted divided by 1,000, multiplied by (y) the Conversion Rate, and (2) the Applicable Stock Price; and 
  
 (b) if the Company elects to satisfy a fixed portion (other than 100%) of the
Conversion Obligation in cash, the Company will deliver to such Holder (1) cash in an amount equal to (x) the aggregate principal amount of Notes to be converted divided by 1,000, multiplied by (y) such cash amount per $1,000 aggregate original
principal amount Notes to be converted (“Cash Amount Per Note”) and (2) a number of shares of Common Stock equal to (x) the aggregate original principal amount of Notes to be converted by such Holder divided by 1,000, multiplied by (y) a
fraction, the numerator of which is (A) the Applicable Stock Price multiplied by the Conversion Rate, less (B) the Cash Amount Per Note, and the denominator of which is the Applicable Stock Price; provided, however, that the Company
will pay cash in lieu of fractional shares of Common Stock in accordance with Section 9.4. 
  
 The Company has adopted a stated policy that it will settle in cash the principal amount of any Notes that are converted. At any time prior to maturity, the Company may, at its option, elect, by notice to the Trustee
and the Holders, that upon conversion of the Notes at any time following the date of such notice, the Company shall be required to deliver cash in an amount at least equal to the principal amount of the Notes converted. If the Company makes such
election, it shall also be required to deliver cash only in connection with any Principal Value Conversion pursuant to Section 9.1(c). 
  

 59 

 ARTICLE X 
  

DEFAULTS AND REMEDIES 
  
 SECTION 10.1. Events of Default. “Event of Default,” wherever used herein with respect to the Notes, means any one or more of the
following events: 
  
 (a) default in the payment of any
installment of interest, Contingent Interest or Liquidated Damages, if any, upon any of the Notes as and when the same shall become due and payable, and continuance of such Default for a period of 30 days; or 
  
 (b) default in the payment of the principal of any of the Notes as and when
the same shall become due and payable either at maturity, upon redemption, required repurchase, by declaration or otherwise (including the failure to purchase Notes in accordance with Articles VI, VII and VIII); or 
  
 (c) failure on the part of the Company to perform any other of the covenants
or agreements on the part of the Company in the Notes or in this Indenture for a period of 60 days after the date on which written notice of such failure, requiring the same to be remedied, shall have been given to the Company by the Trustee, or to
the Company and the Trustee by the Holders of at least 25% in aggregate principal amount of the Notes then outstanding; or 
  
 (d) default by the Company or any of its Significant Subsidiaries in the payment of principal, interest or premium at final maturity under any instrument
or instruments evidencing Indebtedness (other than the Notes), which Default is in an aggregate amount exceeding $10.0 million or its equivalent in any other currency or currencies and continues in effect for more than 30 days after the expiration
of any grace period or extension of time for payment applicable thereto; or 
  
 (e) default by the Company or any of its Significant Subsidiaries under any instrument or instruments evidencing Indebtedness (other than the Notes) having an outstanding principal amount of $10.0 million (or its
equivalent in any other currency or currencies) or more, which results in acceleration of the maturity of such Indebtedness, unless such acceleration has been rescinded or annulled within 30 days after the date on which written notice of such
acceleration has been received by the Company or such defaulting Significant Subsidiary; or 
  
 (f) default on the part of the Company in its obligation to convert the Notes upon exercise of a Holder’s conversion right in accordance with the terms of the Notes and Article IX hereof and such conversion
Default is not cured or such conversion is not rescinded within five days after written notice of Default is given by registered mail to the Company by the Trustee or to the Company and the Trustee by the Holder of such Note; or 
  
 (g) default on the part of the Company in its obligation give notice to
Holders of their right to require the Company to repurchase Notes following the occurrence of a Fundamental Change within the time required to give such notice; or 
  

 60 

 (h) a court of competent jurisdiction shall enter an order for relief with respect to the Company or a
Subsidiary under the Bankruptcy Code or a court of competent jurisdiction shall enter a judgment, order or decree adjudging the Company or a Subsidiary a bankrupt or insolvent, or enter an order for relief for reorganization, arrangement, adjustment
or composition of or in respect of the Company under the Bankruptcy Code or applicable state insolvency law and the continuance of any such judgment, order or decree is unstayed and in effect for a period of 60 consecutive days; or 
  
 (i) the Company or a Subsidiary shall institute proceedings for entry of an
order for relief with respect to the Company or a Subsidiary under the Bankruptcy Code or for an adjudication of insolvency, or shall consent to the institution of bankruptcy or insolvency proceedings against it, or shall file a petition seeking, or
seek or consent to reorganization, arrangement, composition or relief under the Bankruptcy Code or any applicable state law, or shall consent to filing of such petition or to the appointment of a receiver, custodian, liquidator, assignee, trustee,
sequestrator or similar official (other than a custodian pursuant to 8 Delaware Code § 226 or any similar statute under other state laws) of the Company or of substantially all of its property, or the Company or a Subsidiary shall make a
general assignment for the benefit of creditors as recognized under the Bankruptcy Code. 
  
 If an Event of Default with respect to the Notes then outstanding occurs and is continuing (other than an Event of Default specified in Section 10.1(h) or Section 10.1(i)), then and in each and every such case, unless
the principal of all of the Notes shall have already become due and payable, either the Trustee or the Holders of not less than 25% in aggregate principal amount of the Notes then outstanding, by notice in writing to the Company (and to the Trustee
if given by Holders), may declare the principal of all the Notes and the interest and Contingent Interest, if any, accrued thereon and Liquidated Damages, if any, thereon to be due and payable immediately, and upon any such declaration the same
shall become and shall be immediately due and payable, anything in this Indenture or in the Notes contained to the contrary notwithstanding. This provision, however, is subject to the condition that if at any time after the principal (or such
specified amount) of the Notes shall have been so declared due and payable and before any judgment or decree for the payment of the moneys due shall have been obtained or entered as hereinafter provided, the Company shall pay or shall deposit with
the Trustee a sum sufficient to pay all matured installments of interest and Contingent Interest, if any, and Liquidated Damages, if any, upon all of the Notes and the principal of any and all Notes, which shall have become due otherwise than by
acceleration (with interest on overdue installments of interest (including Contingent Interest), if any, to the extent that payment of such interest is enforceable under applicable law and on such principal at the rate borne by the Notes to the date
of such payment or deposit) and shall pay the reasonable compensation, disbursements, expenses and advances of the Trustee, and any and all Defaults under this Indenture, other than the nonpayment of principal of and accrued interest, if any,
Contingent Interest, if any, and Liquidated Damages, if any, on the Notes, which shall have become due solely by reason of the acceleration, shall have been cured or shall have been waived in accordance with this Indenture, then and in every such
case the declaration of acceleration shall be automatically annulled and rescinded; but no such rescission and annulment shall extend to or shall affect any subsequent Default, or shall impair any right consequent thereon. If any Event of Default
with respect to the Company specified in Section 10.1(h) or 10.1(i) occurs, all unpaid principal and accrued interest, Contingent Interest and Liquidated Damages, if any, on all Notes then outstanding shall ipso facto become 

  

 61 

 
and be immediately due and payable without any declaration or other act by the Trustee or any Holder. 
  
 If the Trustee shall have proceeded to enforce any right under this Indenture
and such proceedings shall have been discontinued or abandoned because of such rescission or annulment or for any other reason or shall have been determined adversely to the Trustee, then and in every such case the Company, the Trustee and the
Holders shall be restored respectively to their several positions and rights hereunder, and all rights, remedies and powers of the Company, the Trustee and the Holders shall continue as though no such proceeding had been taken. 
  
 In determining whether the Holders of the requisite aggregate principal
amount of the Notes outstanding have given any request, demand, authorization or consent under this Indenture, the principal amount of Notes that will be deemed to be outstanding will be the amount of the principal of the Notes that would be due and
payable as of the date of the determination upon a declaration of acceleration of the maturity of the Notes. 
  
 SECTION 10.2. Payment of Notes on Default; Suit Therefor. The Company covenants that (a) if a Default shall be made in the payment of any
installment of interest (including Contingent Interest) upon the Notes then outstanding as and when the same shall become due and payable, and such Default shall have continued for a period of 30 days, or (b) if a Default shall be made in the
payment of the principal of any of the Notes as and when the same shall have become due and payable, whether at maturity of the Notes or upon redemption or by declaration or otherwise, then, upon demand of the Trustee, the Company will pay to the
Trustee, for the benefit of the Holders of the Notes, the whole amount that then shall have become due and payable on all such Notes for principal or interest (including Contingent Interest), if any, or both, as the case may be, with interest
(including Contingent Interest) upon the overdue principal and (to the extent that payment of such interest is enforceable under applicable law) upon the overdue installments of interest (including Contingent Interest), if any, at the rate borne by
the Notes; and, in addition thereto, such further amount as shall be sufficient to cover the costs and expenses of collection, including the reasonable costs and expenses of the Trustee, its agents, attorneys and counsel and any expenses or
liabilities incurred by the Trustee hereunder other than through its negligence or bad faith. 
  
 If the Company shall fail forthwith to pay such amounts upon such demand, the Trustee, in its own name and as trustee of an express trust, shall be entitled and empowered to institute any actions or proceedings at law
or in equity for the collection of the sums so due and unpaid, and may prosecute any such action or proceeding to judgment or final decree, and may enforce any such judgment or final decree against the Company and collect in the manner provided by
law out of the property of the Company, wherever situated, the moneys adjudged or decreed to be payable. 
  
 If there shall be pending proceedings for the bankruptcy or for the reorganization of the Company under any bankruptcy, insolvency or other similar law
now or hereafter in effect, or if a receiver or trustee or similar official shall have been appointed for the property of the Company, or in the case of any other similar judicial proceedings relative to the Company, or to the creditors or property
of the Company, the Trustee, irrespective of whether the principal of the Notes shall then be due and payable as therein expressed or by declaration or otherwise and 

  

 62 

 
irrespective of whether the Trustee shall have made any demand pursuant to the provisions of this Section 10.2, shall be entitled and empowered by
intervention in such proceedings or otherwise to file and prove a claim or claims for the whole amount of principal and interest (including Contingent Interest), if any, owing and unpaid in respect of the Notes, and, in case of any judicial
proceedings, to file such proofs of claim and other papers or documents as may be necessary or advisable in order to have the claims of the Trustee and of the Holders allowed in such judicial proceedings relative to the Company, its creditors, or
its property, and to collect and receive any moneys or other property payable or deliverable on any such claims, and to distribute the same after the deduction of its reasonable expenses, and any receiver, assignee or trustee or similar official in
bankruptcy or reorganization is hereby authorized by each of the Holders to make such payments to the Trustee, and, if the Trustee shall consent to the making of such payments directly to the Holders, to pay to the Trustee any amount due it pursuant
to Section 11.7 hereof for reasonable expenses. To the extent that such payment of reasonable expenses out of the estate in any such proceedings shall be denied for any reason, payment of the same shall be secured by a lien on, and shall be paid out
of, any and all distributions, dividends, moneys, securities and other property which the Holders of the Notes may be entitled to receive in such proceedings, whether in liquidation or under any plan of reorganization or arrangement or otherwise.

  
 All rights of action and of asserting claims under this
Indenture, or under any of the Notes, may be enforced by the Trustee without the possession of any of the Notes, or the production thereof at any trial or other proceeding relative thereto, and any such suit or proceeding instituted by the Trustee
shall be brought in its own name as trustee of an express trust, and any recovery of judgment shall be for the ratable benefit of the Holders of the Notes in respect of which such judgment has been recovered. 
  
 SECTION 10.3. Application of Moneys Collected by Trustee . Any moneys
collected by the Trustee pursuant to Section 10.2 with respect to the Notes then outstanding shall be applied in the order following, at the date or dates fixed by the Trustee for the distribution of such moneys, upon presentation of the several
Notes, and stamping thereon the payment, if only partially paid, and upon surrender thereof, if fully paid: 
  
 FIRST: To the payment of all amounts due to the Trustee pursuant to Section 11.7 except as a result of its negligence or bad faith;

  
 SECOND: If the principal of the outstanding
Notes shall not have become due and be unpaid, to the payment of interest, Contingent Interest and Liquidated Damages, if any, on the Notes, in the order of the maturity of the installments of such interest, if any, with interest (to the extent that
such interest has been collected by the Trustee) upon the overdue installments of interest, Contingent Interest and Liquidated Damages, if any, at the rate borne by the Notes, such payment to be made ratably to the Persons entitled thereto;

  
 THIRD: If the principal of the outstanding
Notes shall have become due, by declaration or otherwise, to the payment of the whole amount then owing and unpaid upon the Notes for principal and interest (including Contingent Interest), if any, with interest on the overdue principal and (to the
extent that such interest has been collected by the Trustee) upon overdue installments of interest, if any, at the rate borne by the Notes; and 

  

 63 

 
in case such moneys shall be insufficient to pay in full the whole amounts so due and unpaid upon the Notes, then to the payment of such principal and
interest, Contingent Interest and Liquidated Damages, if any, without preference or priority of principal over interest, Contingent Interest and Liquidated Damages or of interest, Contingent Interest and Liquidated Damages over principal, or of any
installment of interest, Contingent Interest and Liquidated Damages over any other installment of interest, Contingent Interest and Liquidated Damages, or of any Note over any other Note, ratably to the aggregate of such principal and accrued and
unpaid interest (including Contingent Interest); and 
  
 FOURTH: To the payment of any surplus then remaining to the Company, its successors or assigns, or as a court of competent jurisdiction shall direct in writing. 
  
 SECTION 10.4. Proceedings by Holders. No Holder of any Notes then outstanding shall have any right by virtue of or by
availing of any provision of this Indenture to institute any suit, action or proceeding in equity or at law upon or under or with respect to this Indenture or the Notes or for the appointment of a receiver or trustee or similar official, or for any
other remedy hereunder or thereunder, unless (i) such Holder previously shall have given to the Trustee written notice of a continuing Event of Default, (ii) the Holders of at least 25% in aggregate principal amount of the Notes then outstanding
shall have made a written request to the Trustee to institute such action, suit or proceeding in its own name as Trustee hereunder, (iii) the Trustee, after its receipt of such notice, shall have neglected or refused to institute any such action,
suit or proceeding for 60 days, and (iv) during such 60-day period the Holders of a majority in aggregate principal amount of the outstanding Notes do not give the Trustee a direction inconsistent with the request, it being understood and intended,
and being expressly covenanted by the Holder of every Note with every other Holder and the Trustee, that no one or more Holders of the Notes shall have any right in any manner whatever by virtue of or by availing of any provision of this Indenture
or of the Notes to affect, disturb or prejudice the rights of any other Holder of such Notes or to obtain or seek to obtain priority over or preference as to any other such Holder, or to enforce any right under this Indenture or the Notes, except in
the manner herein provided and for the equal, ratable and common benefit of all Holders of Notes. 
  
 Notwithstanding any other provisions in this Indenture, the right of any Holder of any Note to receive payment of the principal of and interest, if any,
Contingent Interest, if any, and Liquidated Damages, if any, on such Note, on or after the respective due dates expressed in this Indenture and such Note, to institute suit for the enforcement of any such payment or any right to convert on or after
such respective dates or to convert its Notes in accordance with the Indenture is absolute and unconditional and shall not be impaired or affected without the consent of such Holder. 
  
 SECTION 10.5. Proceedings by Trustee. In case of an Event of Default hereunder, the Trustee may in its discretion
proceed to protect and enforce the rights vested in it by this Indenture by such appropriate judicial proceedings as the Trustee shall deem necessary to protect and enforce any of such rights, either by suit in equity or by action at law or by
proceedings in bankruptcy or otherwise, whether for the specific enforcement of any covenant or agreement contained in this Indenture or in aid of the exercise of any power granted in this Indenture, or to enforce any other legal or equitable right
vested in the Trustee by this Indenture or by law. 
  

 64 

 SECTION 10.6. Remedies Cumulative and Continuing. All powers and remedies given by this Article X
to the Trustee or to the Holders shall, to the extent permitted by law, be deemed cumulative and not exclusive of any thereof or of any other powers and remedies available to the Trustee or the Holders, by judicial proceedings or otherwise, to
enforce the performance or observance of the covenants and agreements contained in this Indenture, and no delay or omission of the Trustee or of any Holder to exercise any right or power accruing upon any Default occurring and continuing as
aforesaid shall impair any such right or power, or shall be construed to be a waiver of any such Default or an acquiescence therein; and, subject to the provisions of Section 10.4, every power and remedy given by this Article X or by law to the
Trustee or to the Holders may be exercised from time to time, and as often as shall be deemed expedient, by the Trustee or by the Holders, respectively. 
  
 SECTION 10.7. Direction of Proceedings; Waiver of Defaults by Majority of Holders. Subject to Sections 10.4 and 14.2, the Holders of a majority in
aggregate principal amount of the Notes then outstanding shall have the right to direct the time, method and place of conducting any proceeding for any remedy available to the Trustee, or exercising any trust or power conferred on the Trustee with
respect to the Notes; provided, however, that (subject to the provisions of Section 11.1) the Trustee shall have the right to decline to follow any such direction if the Trustee shall determine upon advice of counsel that the action or
proceeding so directed may not lawfully be taken or is in conflict with this Indenture or if the Trustee in good faith by its board of directors, its executive committee, or a trust committee of directors or Responsible Officers or both shall
determine that the action or proceeding so directed would involve the Trustee in personal liability or would be unduly prejudicial to the rights of the other Holders of the Notes. The Holders of a majority in aggregate principal amount of the Notes
then outstanding may on behalf of the Holders of all of the Notes waive any past Default or Event of Default hereunder and its consequences (including acceleration and any related payment Default from such acceleration) except a Default in the
payment of interest, Contingent Interest and Liquidated Damages, if any, on, or the principal of, the Notes or a Default in the compliance with any provision hereunder that cannot be amended or supplemented pursuant to Article XIV without the
consent of each Holder of Notes affected. For the avoidance of doubt, nothing in this Section 10.7 shall affect the annulment and rescission of acceleration under Section 10.1. Upon any such waiver the Company, the Trustee and the Holders of the
Notes shall be restored to their former positions and rights hereunder, respectively; but no such waiver shall extend to any subsequent or other Default or Event of Default or impair any right consequent thereon. Whenever any Default or Event of
Default hereunder shall have been waived as permitted by this Section 10.7, said Default or Event of Default shall for all purposes of the Notes and this Indenture be deemed to have been cured and to be not continuing.  
  
 SECTION 10.8. Notice of Defaults. The Trustee shall, within 90 days
after the occurrence of a Default or Event of Default, with respect to the Notes then outstanding, mail to all Holders of the Notes, as the names and the addresses of such Holders appear upon the Note Register, notice of all defaults known to the
Trustee with respect to the Notes, unless such defaults shall have been cured before the giving of such notice (the term “defaults” for the purpose of this Section 10.8 being hereby defined to be the events specified in clauses (a), (b),
(c), (d), (e), (f), (g), (h) and (i)of Section 10.1, not including periods of grace, if any, provided for therein and irrespective of the giving of the written notice specified in said clause (c), but in the case of any default of the character
specified in said clause (c) no such notice to Holders shall be given 

  

 65 

 
until at least 60 days after the giving of written notice thereof to the Company pursuant to said clause (c)); provided, however, that, except
in the case of default in the payment of the principal of or interest, Contingent Interest or Liquidated Damages, if any, on any of the Notes, the Trustee shall be protected in withholding such notice if and so long as the board of directors, the
executive committee, or a trust committee of directors or Responsible Officers or both of the Trustee in good faith determines that the withholding of such notice is in the best interests of the Holders. 
  
 SECTION 10.9. Undertaking to Pay Costs. All parties to this Indenture
agree, and each Holder of any Note by his acceptance thereof shall be deemed to have agreed, that any court may in its discretion require, in any suit for the enforcement of any right or remedy under this Indenture, or in any suit against the
Trustee for any action taken or omitted by it as Trustee, the filing by any party litigant in such suit of an undertaking to pay the cost of such suit, and that such court may in its discretion assess reasonable costs, including reasonable
attorneys’ fees and expenses, against any party litigant in such suit, having due regard to the merits and good faith of the claims or defenses made by such party litigant; but the provisions of this Section 10.9 shall not apply to any suit
instituted by the Trustee, to any suit instituted by any Holder or group of Holders, holding in the aggregate more than 10% in aggregate principal amount of the Notes then outstanding, or to any suit instituted by any Holders for the enforcement of
the payment of the principal of or interest (including Contingent Interest), if any, on any Note against the Company on or after the due date thereto expressed in such Note. 
  
 ARTICLE XI 
  
 TRUSTEE 
  
 SECTION 11.1. Duties of Trustee. 
  
 (a) If an Event of Default has occurred and is continuing, the Trustee shall exercise the rights and powers vested in it by this Indenture and use the
same degree of care and skill in their exercise as a prudent Person would exercise or use under the circumstances in the conduct of such Person’s own affairs; provided that if an Event of Default occurs and is continuing, the Trustee
will be under no obligation to exercise any of the rights or powers under this Indenture at the request or direction of any of the Holders unless such Holders have provided the Trustee indemnity or security reasonably satisfactory to the Trustee
against loss, liability or expense. 
  
 (b) Except during the
continuance of an Event of Default: 
  
 (i) the
Trustee undertakes to perform such duties and only such duties as are specifically set forth in this Indenture and no implied covenants or obligations shall be read into this Indenture against the Trustee; and 
  
 (ii) in the absence of bad faith on its part, the Trustee
may conclusively rely, as to the truth of the statements and the correctness of the opinions expressed therein, 

  

 66 

 
upon certificates, directions, notices or opinions furnished to the Trustee. However, in the case of any such certificates, directions, notices or opinions
which by any provisions hereof are specifically required to be furnished to the Trustee, the Trustee shall examine such certificates and opinions to determine whether or not they conform to the requirements of this Indenture (but need not confirm or
investigate the accuracy of mathematical calculations or other facts stated therein). 
  
 (c) The Trustee may not be relieved from liability for its own negligent action, its own negligent failure to act or its own willful misconduct, except that: 
  
 (i) this paragraph does not limit the effect of paragraph
(b) of this Section; 
  
 (ii) the Trustee shall
not be liable for any error of judgment made in good faith by a Responsible Officer unless it is proved that the Trustee was negligent in ascertaining the pertinent facts; and 
  
 (iii) the Trustee shall not be liable with respect to any action it takes or omits to take in good faith in
accordance with a direction received by it pursuant to Section 10.4. 
  
 (d) The Trustee shall not be liable for interest on any money received by it except as the Trustee may agree in writing with the Company. 
  
 (e) Money held in trust by the Trustee need not be segregated from other funds except to the extent required by law. 
  
 (f) No provision of this Indenture shall require the Trustee to expend or
risk its own funds or otherwise incur any financial liability in the performance of any of its duties hereunder or in the exercise of any of its rights or powers, if it shall have reasonable grounds to believe that repayment of such funds or
adequate indemnity against such risk or liability is not reasonably assured to it. 
  
 (g) Every provision of this Indenture relating to the conduct or affecting the liability of or affording protection to the Trustee shall be subject to the provisions of this Section 11.1 and to the provisions of the
TIA. 
  
 (h) The Trustee shall be under no obligation to exercise
any of the rights or powers vested in it by this Indenture at the request or direction of any of the Holders unless such Holders shall have provided to the Trustee security or indemnity reasonably satisfactory to it against the costs, expenses
(including reasonable attorneys’ fees and expenses) and liabilities that might be incurred by it in compliance with such request or direction. 
  
 SECTION 11.2. Rights of Trustee. 
  
 (a) The Trustee may conclusively rely and shall be protected in acting or refraining from acting upon any paper or document believed by it to be genuine
and to have been signed or presented by the proper Person or Persons. The Trustee need not investigate any fact or matter stated in the document. 
  

 67 

 (b) Before the Trustee acts or refrains from acting, it may require an Officers’ Certificate or an
Opinion of Counsel. The Trustee shall not be liable for any action it takes or omits to take in good faith in reliance on the Officers’ Certificate or Opinion of Counsel. 
  
 (c) The Trustee may act through its attorneys and agents and shall not be responsible for the misconduct or negligence of
any attorney or agent appointed with due care. 
  
 (d) The Trustee
shall not be liable for any action it takes or omits to take in good faith which it believes to be authorized or within its rights or powers; provided, however, that the Trustee’s conduct does not constitute willful misconduct or
negligence. 
  
 (e) The Trustee may consult with counsel of its
selection, and the advice or opinion of such counsel appointed with due care with respect to legal matters relating to this Indenture and the Notes shall be full and complete authorization and protection from liability in respect to any action
taken, omitted or suffered by it hereunder in good faith and in accordance with the advice or opinion of such counsel. 
  
 (f) The Trustee shall not be bound to make any investigation into the facts or matters stated in any resolution, certificate, statement, instrument,
opinion, notice, request, direction, consent, order, bond or other paper or document; but the Trustee, in its discretion, may make such further inquiry or investigation into such facts or matters as it may see fit and, if the Trustee shall determine
to make such further inquiry or investigation, it shall be entitled to examine the books, records and premises of the Company at reasonable times, in a reasonable manner and upon reasonable advance notice, personally or by agent or attorney at the
sole cost of the Company and shall incur no liability or additional liability of any kind by reason of such inquiry or investigation. 
  
 (g) The Trustee shall not be deemed to have knowledge of any Default or Event of Default except, (i) during any period it is serving as Registrar and
Paying Agent for the Notes, any Event of Default occurring pursuant to Sections 10.1(a), 10.1(b) or 10.1(e) or (ii) any Default or Event of Default of which a Responsible Officer shall have received written notification or obtained actual knowledge.
The term “actual knowledge” shall mean the actual fact or statement of knowing by a Responsible Officer without independent investigation with respect thereto. 
  
 (h) Delivery of the reports, information and documents to the Trustee is for informational purposes only and the
Trustee’s receipt of such shall not constitute constructive notice of any information contained therein or determinable from information contained therein, including the Company’s compliance with any of its covenants hereunder (as to which
the Trustee is entitled to rely exclusively on Officers’ Certificates). 
  
 (i) In no event shall the Trustee be responsible or liable for special, indirect, or consequential loss or damage of any kind whatsoever (including, but not limited to, loss of profit) irrespective of whether the
Trustee has been advised of the likelihood of such loss or damage and regardless of the form of action. 
  
 (j) The rights, privileges, protections, immunities and benefits given to the Trustee, including its right to be indemnified, are extended to, and shall
be enforceable by, the 

  

 68 

 
Trustee in each of its capacities hereunder, and each agent, custodian and other Person employed to act hereunder. 
  
 (k) The Trustee may request that the Company deliver an Officers’
Certificate setting forth the names of individuals and/or titles of officers authorized at such time to take specified actions pursuant to this Indenture, which Officers’ Certificate may be signed by any Person authorized to sign an
Officers’ Certificate, including any Person specified as so authorized in any such certificate previously delivered and not superseded. 
  
 SECTION 11.3. Individual Rights of Trustee. The Trustee in its individual or any other capacity may become the owner or pledgee of Notes and may
otherwise deal with the Company or its Affiliates with the same rights it would have if it were not Trustee. Any Paying Agent, Registrar, co-registrar or co-paying agent may do the same with like rights. However, the Trustee must comply with
Sections 11.10 and 11.11. In addition, the Trustee shall be permitted to engage in transactions with the Company; provided, however, that if the Trustee acquires any conflicting interest (as such term is defined in Section 310(b) of
the TIA) the Trustee must (i) eliminate such conflict within 90 days of acquiring such conflicting interest, (ii) apply to the Commission for permission to continue acting as Trustee or (iii) resign as Trustee hereunder. 
  
 SECTION 11.4. Trustee’s Disclaimer. The Trustee shall not be
responsible for and makes no representation as to the validity or adequacy of this Indenture or the Notes, it shall not be accountable for the Company’s use of the Notes or the proceeds from the Notes, and it shall not be responsible for any
statement of the Company in this Indenture or in any document issued or offering circular (or similar document) used in connection with the sale of the Notes or in the Notes other than the Trustee’s certificate of authentication or for the use
or application of any funds received by any Paying Agent other than the Trustee. 
  
 SECTION 11.5. Notice of Defaults. If a Default or Event of Default occurs and is continuing and if a Responsible Officer has actual knowledge thereof, the Trustee shall mail to each Holder notice of the Default
or Event of Default within 90 days after it occurs. Except in the case of a Default or Event of Default in payment of principal of, or interest (including Contingent Interest) on any Note (including payments pursuant to the required repurchase
provisions of such Note, if any), the Trustee may withhold the notice if and so long as its board of directors, a committee of its board of directors or a committee of its Responsible Officers and/or a Responsible Officer in good faith determines
that withholding the notice is in the interests of registered Holders. 
  
 SECTION 11.6. Reports by Trustee to Holders. As promptly as practicable after each May 15 beginning with the May 15 following the date of this Indenture, and in any event prior to December 15 in each year, the Trustee shall mail to
each Holder a brief report dated as of such May 15 that complies with TIA § 313(a), if and to the extent such report may be required by the TIA. The Trustee also shall comply with TIA § 313(b). The Trustee shall also transmit by mail all
reports required by TIA § 313(c). 
  
 A copy of each report
at the time of its mailing to Holders shall be filed with the Commission and each stock exchange (if any) on which the Notes are listed. The Company 

  

 69 

 
agrees to notify promptly the Trustee in writing whenever the Notes become listed on any stock exchange and of any delisting thereof. 
  
 SECTION 11.7. Compensation and Indemnity. The Company shall pay to the
Trustee from time to time such reasonable compensation for its services as the parties shall agree in writing from time to time. The Trustee’s compensation shall not be limited by any law on compensation of a trustee of an express trust. The
Company shall reimburse the Trustee upon written request for all reasonable and documented out-of-pocket expenses incurred or made by it, including, but not limited to, costs of collection, costs of preparing and reviewing reports, certificates and
other documents, costs of preparation and mailing of notices to Holders and reasonable costs of counsel retained by the Trustee in connection with the delivery of an Opinion of Counsel or otherwise, in addition to the compensation for its services.
Such expenses shall include the reasonable compensation and reasonable and documented out-of-pocket expenses, disbursements and advances of the Trustee’s agents, counsel, accountants and experts. The Company shall indemnify the Trustee, and
each of its officers, directors, counsel and agents, against any and all loss, liability or expense (including, but not limited to, reasonable attorneys’ fees and expenses) incurred by it in connection with the administration of this trust and
the performance of its duties hereunder, including the costs and expenses of enforcing this Indenture (including this Section 11.7) and of defending itself against any claims (whether asserted by any Holder, the Company or otherwise). The Trustee
shall notify the Company promptly of any claim of which a Responsible Officer receives written notice for which it may seek indemnity. Failure by the Trustee to so notify the Company shall not relieve the Company of its obligations hereunder except
to the extent the Company is prejudiced thereby. The Company shall defend the claim and the Trustee may have separate counsel and, if the Trustee determines in its reasonable judgment that a conflict of interest exists between the Trustee and the
Company, the Company shall pay the fees and expenses of such counsel. The Company need not reimburse any expense or indemnify against any loss, liability or expense incurred by the Trustee through the Trustee’s own willful misconduct,
negligence or bad faith, subject to the exceptions contained in Section 11.1(c) hereof. 
  
 To secure the Company’s payment obligations in this Section 11.7, the Trustee shall have a lien prior to the Notes on all money or property held or collected by the Trustee other than money or property held in
trust to pay principal of and interest (including Contingent Interest) on particular Notes. 
  
 The Company’s payment obligations pursuant to this Section and any lien arising hereunder shall survive the discharge of this Indenture and the resignation or removal of the Trustee. When the Trustee incurs
expenses after the occurrence of a Default specified in Section 10.1(g) or (h) with respect to the Company, the expenses are intended to constitute expenses of administration under the Bankruptcy Code. 
  
 SECTION 11.8. Replacement of Trustee. The Trustee may resign at any
time by so notifying the Company. The Holders of a majority in principal amount of the Notes may remove the Trustee by so notifying the Company and the Trustee in writing and the Company may appoint a successor Trustee. The Company shall remove the
Trustee if: 
  
 (i) the Trustee fails to comply
with Section 11.10; 
  

 70 

 (ii) the Trustee is adjudged bankrupt or insolvent; 
  
 (iii) a receiver or other public officer takes charge of the
Trustee or its property; or 
  
 (iv) the Trustee
otherwise becomes incapable of acting. 
  
 If the Trustee resigns
or is removed by the Company or by the Holders of a majority in principal amount of the Notes and the Company does not reasonably promptly appoint a successor Trustee, or if a vacancy exists in the office of Trustee for any reason (the Trustee in
such event being referred to herein as the retiring Trustee), the Holders of a majority in aggregate principal amount of the Notes may appoint a successor Trustee. 
  
 A successor Trustee shall deliver a written acceptance of its appointment to the retiring Trustee and to the Company.
Thereupon the resignation or removal of the retiring Trustee shall become effective, and the successor Trustee shall have all the rights, powers and duties of the Trustee under this Indenture. The successor Trustee shall mail a notice of its
succession to Holders. The retiring Trustee shall promptly transfer all property held by it as Trustee to the successor Trustee, subject to the lien provided for in Section 11.7. 
  
 If the Company has not appointed a successor Trustee within 60 days after the retiring Trustee resigns or is removed, the
retiring Trustee or the Holders of 10% in principal amount of the Notes may petition, at the expense of the Company, any court of competent jurisdiction for the appointment of a successor Trustee. 
  
 If the Trustee fails to comply with Section 11.10, unless the Trustee’s
duty to resign is stayed as provided in TIA § 310(b), any Holder may petition any court of competent jurisdiction for the removal of the Trustee and the appointment of a successor Trustee. 
  
 Notwithstanding the replacement of the Trustee pursuant to this Section 11.8,
the Company’s obligations under Section 11.7 shall continue for the benefit of the retiring Trustee. 
  
 SECTION 11.9. Successor Trustee by Merger. If the Trustee consolidates with, merges or converts into, or transfers all or substantially all its
corporate trust business or assets to, another corporation or banking association, the resulting, surviving or transferee corporation without any further act shall be the successor Trustee. 
  
 In case at the time such successor or successors by merger, conversion or
consolidation to the Trustee shall succeed to the trusts created by this Indenture, any of the Notes shall have been authenticated but not delivered, any such successor to the Trustee may adopt the certificate of authentication of any predecessor
trustee, and deliver such Notes so authenticated; and in case at that time any of the Notes shall not have been authenticated, any successor to the Trustee may authenticate such Notes either in the name of any predecessor hereunder or in the name of
the successor to the Trustee; and in all such cases such certificates shall have the full force which it is anywhere in the Notes or in this Indenture provided that the certificate of the Trustee shall have. 
  

 71 

 SECTION 11.10. Eligibility; Disqualification. The Trustee shall at all times satisfy the
requirements of TIA § 310(a). The Trustee shall have a combined capital and surplus of at least $50 million as set forth in its most recently filed annual report of condition. The Trustee shall comply with TIA § 310(b). 
  
 SECTION 11.11. Preferential Collection of Claims Against Company. If
and when the Trustee shall be or become a creditor of the Company, the Trustee shall comply with TIA § 311(a), excluding any creditor relationship listed in TIA § 311(b). A Trustee who has resigned or been removed shall be subject to TIA
§ 311(a) to the extent indicated. 
  
 ARTICLE XII

  
 CONTINGENT INTEREST 
  
 SECTION 12.1. Contingent Interest. The Company will pay Contingent
Interest to Holders during any six-month period from March 15 to September 14 or from September 15 to March 14 (“Interest Period”) beginning with the six-month period commencing on or after March 15, 2009, if the average Trading Price of
the Notes for the five Trading Day measurement period ending on the second Trading Day immediately preceding the first day of the applicable Interest Period (the “Measurement Period”) equals 120% or more of the principal amount of the
Notes as of the last day of the Measurement Period. The amount of Contingent Interest payable in any Interest Period pursuant to this Section 12.1 shall equal 0.25% of the average Trading Price of the Notes for the applicable Measurement Period.

  
 SECTION 12.2. Payment of Contingent Interest. The
Company shall pay Contingent Interest owed pursuant to Section 12.1 for any Interest Period on the Interest Payment Date immediately succeeding the applicable Interest Period, to Holders of Notes as of the Regular Record Date related to such
Interest Payment Date. 
  
 SECTION 12.3. Notice of Contingent
Interest. 
  
 (a) As soon as practicable following the first
Business Day of an Interest Period for which Contingent Interest will be payable pursuant to Section 12.1, the Company shall notify the Holders of the right of such Holders to receive Contingent Interest and shall issue a press release containing
this information and publish the information on its website. 
  
 (b) On any Interest Payment Date on which Contingent Interest is payable pursuant to this Article XII, the Company shall issue a press release stating the amount of such Contingent Interest and setting forth the manner in which such amount
was calculated, and publish such information on its website. 
  

 72 

 ARTICLE XIII 
  
 SATISFACTION AND DISCHARGE OF INDENTURE; UNCLAIMED MONEYS 
  
 SECTION 13.1. Satisfaction and Discharge of Indenture . If at any time
(a) the Company shall have paid or caused to be paid the principal of and interest, Contingent Interest and Liquidated Damages, if any, on all the Notes outstanding (other than Notes which have been destroyed, lost or stolen and which have been
replaced or paid as provided in Section 2.8) as and when the same shall have become due and payable, or (b) the Company shall have delivered to the Trustee for cancellation all Notes theretofore authenticated (other than Notes which have been
destroyed, lost or stolen and which have been replaced or paid as provided in Section 2.8); and if, in any such case, the Company shall also pay or cause to be paid all other sums payable hereunder by the Company, then this Indenture shall cease to
be of further effect, and the Trustee, on demand of the Company accompanied by an Officers’ Certificate and an Opinion of Counsel, each stating that all conditions precedent relating to the satisfaction and discharge contemplated by this
provision have been complied with, and at the cost and expense of the Company, shall execute proper instruments acknowledging such satisfaction and discharging this Indenture. The Company agrees to reimburse the Trustee for any costs or expenses
thereafter reasonably and properly incurred, and to compensate the Trustee for any services thereafter reasonably and properly rendered, by the Trustee in connection with this Indenture or the Notes. 
  
 If at any time the exact amount described in clause (ii) below can be
determined at the time of making the deposit referred to in such clause (ii), (i) all of the Notes not theretofore delivered to the Trustee for cancellation shall have become due and payable, or are by their terms to become due and payable within
one year or are to be called for redemption within one year under arrangements satisfactory to the Trustee for the giving of notice of redemption, and (ii) (a) the Company shall have irrevocably deposited or caused to be deposited with the Trustee
as funds in trust, specifically pledged as security for, and dedicated solely to, the benefit of the Holders of the Notes, cash in an amount (other than moneys repaid by the Trustee or any Paying Agent to the Company in accordance with Section 13.4)
or U.S. Government Obligations, maturing as to principal and interest (including Contingent Interest), if any, at such times and in such amounts as will insure the availability of cash or securities sufficient in the opinion of a nationally
recognized firm of independent public accountants expressed in a written certification thereof delivered to the Trustee, to pay the principal of and interest (including Contingent Interest), if any, on all of the Notes on each date that such
principal or interest (including Contingent Interest), if any, is due and payable in accordance with the terms of this Indenture and the Notes, and (b) the Company has paid or caused to be paid all other sums payable hereunder by the Company; then
the Company shall be deemed to have paid and discharged the entire indebtedness on all the Notes on the date of the deposit referred to in this clause (ii), and the provisions of this Indenture with respect to the Notes shall no longer be in effect
(except as to (i) rights of registration of transfer and exchange of Notes, (ii) substitution of mutilated, defaced, destroyed, lost or stolen Notes, (iii) rights of Holders of Notes to receive payments of principal thereof and interest (including
Contingent Interest), if any, thereon upon the original stated due dates therefor (but not upon acceleration), (iv) the rights, obligations, duties and immunities of the Trustee hereunder, (v) the rights of the Holders of Notes as beneficiaries
hereof with respect to the property so deposited with the Trustee payable to all or any of them (vi) rights of Holders of Notes to 

  

 73 

 
convert the Notes pursuant to Article IX and (vii) the obligations of the Company under Section 3.3 with respect to the Notes) and the Trustee, on demand of
the Company accompanied by an Officers’ Certificate and an Opinion of Counsel, each stating that all conditions precedent contemplated by this provision have been complied with, and at the cost and expense of the Company, shall execute proper
instruments acknowledging such satisfaction and discharging such Indebtedness. 
  
 SECTION 13.2. Application by Trustee of Funds Deposited for Payment of Notes. All moneys deposited with the Trustee or any Paying Agent shall be held in trust and applied by it to the payment, either directly
or through any Paying Agent (including the Company acting as its own paying agent), to the Holders of the Notes for the payment or redemption of which such moneys have been deposited with the Trustee, of all sums due and to become due thereon for
principal and interest (including Contingent Interest), if any, but such money need not be segregated from other funds except to the extent required by law. 
  
 SECTION 13.3. Repayment of Moneys Held by Paying Agent. In connection with the satisfaction and discharge of this Indenture with respect to the
Notes, all moneys then held by any Paying Agent under the provisions of this Indenture with respect to the Notes shall, upon demand of the Company, be repaid to it and thereupon such Paying Agent shall be released from all further liability with
respect to such moneys. 
  
 SECTION 13.4. Return of Moneys Held
by Trustee and Paying Agent Unclaimed for Two Years. Any moneys deposited with or paid to the Trustee or any Paying Agent for the payment of the principal of or interest (including Contingent Interest), if any, on the Notes and not applied but
remaining unclaimed for two years after the date upon which such principal or interest (including Contingent Interest), if any, shall have become due and payable, shall, upon the written request of the Company and unless otherwise required by
mandatory provisions of applicable escheat or abandoned or unclaimed property law, be repaid to the Company by the Trustee or such Paying Agent, and the Holder of the Notes shall, unless otherwise required by mandatory provisions of applicable
escheat or abandoned or unclaimed property laws, thereafter look only to the Company for any payment which such Holder may be entitled to collect, and all liability of the Trustee or any Paying Agent with respect to such moneys shall thereupon
cease; provided, however, that the Trustee or such Paying Agent, before being required to make any such repayment with respect to moneys deposited with it for any payment in respect of the Notes, shall, at the expense of the Company,
mail by first-class mail to Holders of the Notes at their addresses as they shall appear on the Note register notice that such moneys remain and that, after a date specified therein, which shall not be less than 30 days from the date of such mailing
or publication, any unclaimed balance of such money then remaining will be repaid to the Company. 
  
 SECTION 13.5. Indemnity for U.S. Government Obligations. The Company shall pay and indemnify the Trustee against any tax, fee or other charge
imposed on or assessed against the U.S. Government Obligations deposited pursuant to Section 13.1 or the principal or interest (including Contingent Interest) received in respect of such obligations. 
  

 74 

 ARTICLE XIV 
  
 AMENDMENTS 
  
 SECTION 14.1. Without Consent of Holders. The Company and the Trustee may amend this Indenture or the Notes without notice to or consent of any
Holder: 
  
 (a) to cure any ambiguity, omission, defect or
inconsistency; 
  
 (b) to provide for the assumption by a
Successor Company of the Company’s obligations under this Indenture and the Notes; 
  
 (c) to provide for uncertificated Notes in addition to or in place of certificated Notes; 
  
 (d) to secure the Notes or to provide guarantees of the Notes; 
  
 (e) to add covenants that would benefit the Holders of the Notes or to surrender any rights of the Company under this Indenture; 
  
 (f) to comply with any requirements to effect or maintain the qualification
of this Indenture under the TIA; 
  
 (g) to add Events of Default
with respect to the Notes; or 
  
 (h) to make any change that does
not adversely affect any outstanding Notes in any material respect. 
  
 After an amendment under this Section becomes effective, the Company shall prepare and cause the Trustee to mail to Holders, a notice briefly describing such amendment. The failure to give such notice to all Holders, or any defect therein,
shall not impair or affect the validity of an amendment under this Section. 
  
 SECTION 14.2. With Consent of Holders. The Company and the Trustee may amend this Indenture or the Notes without notice to any Holder but with the written consent of the Holders of at least a majority in
aggregate principal amount of the Notes then outstanding. However, without the consent of each Note then outstanding, an amendment, supplement or waiver may not: 
  
 (a) reduce the amount of Notes whose Holders must consent to an amendment, supplement or waiver; 
  
 (b) reduce the rate of accrual of interest, Contingent Interest or Liquidated
Damages or modify the method for calculating interest, Contingent Interest or Liquidated Damages or change the time for payment of interest, Contingent Interest or Liquidated Damages on the Notes; 
  

 75 

 (c) modify the provisions with respect to a Holder’s rights upon a Fundamental Change in a manner
adverse to the Holders of the Notes, including the Company’s obligations to repurchase the Notes following a Fundamental Change; 
  
 (d) reduce the principal amount of Notes or change their Stated Maturity; 
  
 (e) reduce the Redemption Price or Repurchase Price of the Notes or change the time at which the Notes may or must be
redeemed or repurchased; 
  
 (f) make payments on the Notes
payable in currency other than as originally stated in the Notes; 
  
 (g) impair the Holder’s right to institute suit for the enforcement of any payment on the Notes; 
  
 (h) make any change in the percentage of principal amount of Notes necessary to waive compliance with provisions of this Indenture or to make any change
to this Section 14.2 or Section 14.3; 
  
 (i) waive a continuing
Default or Event of Default regarding any payment on the Notes; or 
  
 (j) adversely affect the conversion or repurchase provisions of the Notes. 
  
 It shall not be necessary for the consent of the Holders under this Section 14.2 to approve the particular form of any proposed amendment, but it shall be sufficient if such consent approves the substance thereof.

  
 After an amendment under this Section 14.2 becomes effective,
the Company shall mail to Holders a notice briefly describing such amendment. The failure to give such notice to all Holders, or any defect therein, shall not impair or affect the validity of an amendment under this Section 14.2. 
  
 SECTION 14.3. Compliance with Trust Indenture Act. Every amendment to
this Indenture or the Notes shall comply with the TIA as then in effect. 
  
 SECTION 14.4. Revocation and Effect of Consents and Waivers. A consent to an amendment or a waiver by a Holder of a Note shall bind the Holder and every subsequent Holder of that Note or portion of the Note
that evidences the same debt as the consenting Holder’s Note, even if notation of the consent or waiver is not made on the Note. However, any such Holder or subsequent Holder may revoke the consent or waiver as to such Holder’s Note or
portion of the Note if the Trustee receives the notice of revocation before the date the amendment or waiver becomes effective. After an amendment or waiver becomes effective, it shall bind every Holder. An amendment or waiver made pursuant to
Section 14.2 shall become effective upon receipt by the Trustee of the requisite number of written consents. 
  
 The Company may, but shall not be obligated to, fix a record date for the purpose of determining the Holders entitled to give their consent or take any
other action described above 

  

 76 

 
or required or permitted to be taken pursuant to this Indenture. If a record date is fixed, then notwithstanding the immediately preceding paragraph, those
Persons who were Holders at such record date (or their duly designated proxies), and only those Persons, shall be entitled to give such consent or to revoke any consent previously given or to take any such action, whether or not such Persons
continue to be Holders after such record date. No such consent shall become valid or effective more than 120 days after such record date. 
  
 SECTION 14.5. Notation on or Exchange of Notes. If an amendment changes the terms of a Note, the Trustee may require the Holder of the Note to
deliver it to the Trustee. The Trustee may place an appropriate notation on the Note regarding the changed terms and return it to the Holder. Alternatively, if the Company or the Trustee so determines, the Company in exchange for the Note shall
issue and the Trustee shall authenticate a new Note that reflects the changed terms. Failure to make the appropriate notation or to issue a new Note shall not affect the validity of such amendment. 
  
 SECTION 14.6. Trustee To Sign Amendments. The Trustee shall sign any
amendment authorized pursuant to this Article XIV if the amendment does not adversely affect the rights, duties, liabilities or immunities of the Trustee. If it does, the Trustee may but need not sign it. In signing such amendment the Trustee shall
be provided with, and (subject to Section 11.1) shall be fully protected in relying upon, an Officers’ Certificate and an Opinion of Counsel stating that such amendment is authorized or permitted by this Indenture. 
  
 ARTICLE XV 
  
 MISCELLANEOUS 
  
 SECTION 15.1. Trust Indenture Act Controls. If any provision of this
Indenture limits, qualifies or conflicts with another provision which is required to be included in this Indenture by the TIA, the provision required by the TIA shall control. 
  
 SECTION 15.2. Notices. Any notice or communication shall be in writing and delivered in person or mailed by
first-class mail addressed as follows: 
  
 If to
the Company: 
  
 PSS World Medical, Inc.

 4345 Southpoint Blvd. 
 Jacksonville, FL 32216 
 Attention: David D. Klarner 
 Facsimile No.: (904) 332-3214 
  

 77 

 With copies to: 
  
 Alston & Bird LLP 
 601 Pennsylvania Avenue, N.W. 
 North Building, 10th Floor 
 Washington, DC 20004 
 Attention: David E. Brown, Jr. 
 Facsimile No.: (202) 756-3333 
  
 If to the Trustee: 
  
 Wachovia Bank, National Association 
 225 Water Street 
 Jacksonville, FL 32202 
 Attention: John Speichert 
 Facsimile No.: (904) 489-5410 
  
 The Company or the Trustee by notice to the other may designate additional or different addresses for subsequent notices or communications. 
  
 Any notice or communication mailed to a Holder shall be mailed to the Holder
at the Holder’s address as it appears on the Note Register and shall be sufficiently given if so mailed within the time prescribed. Notices shall be deemed to have been given as of the date of mailing. 
  
 Failure to mail a notice or communication to a Holder or any defect in it
shall not affect its sufficiency with respect to other Holders. If a notice or communication is mailed in the manner provided above, it is duly given, whether or not the addressee receives it. 
  
 SECTION 15.3. Communication by Holders with Other Holders. Holders may
communicate pursuant to TIA § 312(b) with other Holders with respect to their rights under this Indenture or the Notes. The Trustee shall comply with TIA § 312(b). The Company, the Trustee, the Registrar and anyone else shall have the
protection of TIA § 312(c). 
  
 SECTION 15.4. Certificate
and Opinion as to Conditions Precedent. Upon any request or application by the Company to the Trustee to take or refrain from taking any action under this Indenture, the Company shall furnish to the Trustee such certificates and opinions as may
be required under the TIA. Each such certificate or opinion shall be given in the form of one or more Officers’ Certificates, if to be given by an Officer, or an Opinion of Counsel, if to be given by counsel, and shall comply with the
requirements of the TIA and any other requirements set forth in this Indenture. Notwithstanding the foregoing, in the case of any such request or application as to which the furnishing of any Officers’ Certificate or Opinion of Counsel is
specifically required by any provision of this Indenture relating to such particular request or application, no additional certificate or opinion need be furnished. 
  
 SECTION 15.5. Statements Required in Certificate or Opinion. Each certificate or opinion with respect to compliance
with a covenant or condition provided for in this Indenture (except for certificates provided for in Section 4.1(c)) shall include: 
  
 (1) a statement that the individual making such certificate or opinion has read such covenant or condition; 
  

 78 

 (2) a brief statement as to the nature and scope of the examination or investigation upon
which the statements or opinions contained in such certificate or opinion are based; 
  
 (3) a statement that, in the opinion of such individual, he has made such examination or investigation as is necessary to enable him to
express an informed opinion as to whether or not such covenant or condition has been complied with; and 
  
 (4) a statement as to whether or not, in the opinion of such individual, such covenant or condition has been complied with. 
  
 In giving an Opinion of Counsel, counsel may rely as to factual matters on an
Officers’ Certificate or such other certificates of Officer(s) as it may deem appropriate and on certificates of public officials. 
  
 SECTION 15.6. When Notes Disregarded. In determining whether the Holders of the required principal amount of Notes have concurred in any direction,
waiver or consent, Notes owned by the Company or by any Person directly or indirectly controlling or controlled by or under direct or indirect common control with the Company shall be disregarded and deemed not to be outstanding, except that, for
the purpose of determining whether the Trustee shall be protected in relying on any such direction, waiver or consent, only Notes which a Responsible Officer of the Trustee actually knows are so owned shall be so disregarded. Also, subject to the
foregoing, only Notes outstanding at the time shall be considered in any such determination. 
  
 SECTION 15.7. Rules by Trustee, Paying Agent and Registrar. The Trustee may make reasonable rules for action by, or a meeting of, Holders. The Registrar and the Paying Agent may make reasonable rules for their
functions. 
  
 SECTION 15.8. Governing Law. This Indenture
and the Notes shall be governed by, and construed in accordance with, the laws of the State of New York. 
  
 SECTION 15.9. No Recourse Against Others. No recourse for the payment of the principal of, or interest (including Contingent Interest and
Liquidated Damages, if any) on any Note and no recourse under or upon any obligation, covenant, agreement of the Company in this Indenture, the Notes or in any supplemental indenture, or because of the creation of any Indebtedness represented
thereby, shall be had against any incorporator, stockholder, employee, agent, officer, director, or subsidiary, past, present or future, of the Company or of any successor corporation or entity, whether by virtue of any constitution, statute or rule
of law, or by the enforcement of any assessment or penalty or otherwise, it being understood that all such liability is hereby waived and released as a condition to, and as a consideration for, the execution and delivery of this Indenture and the
issue of the Notes. 
  

 79 

 SECTION 15.10. Successors. All agreements of the Company in this Indenture and the Notes shall
bind its successors. All agreements of the Trustee in this Indenture shall bind its successors. 
  
 SECTION 15.11. Multiple Originals. The parties may sign any number of copies of this Indenture. Each signed copy shall be an original, but all of
them together represent the same agreement. One signed copy is enough to prove this Indenture. 
  
 SECTION 15.12. Variable Provisions. The Company initially appoints the Trustee as Paying Agent and Registrar and custodian with respect to any Global Notes. 
  
 SECTION 15.13. Qualification of Indenture. The Company shall qualify
this Indenture under the TIA in accordance with the terms and conditions of the Registration Rights Agreement and shall pay all reasonable costs and expenses (including attorneys’ fees and expenses for the Company and the Trustee) incurred in
connection therewith, including, but not limited to, costs and expenses of qualification of the Indenture and the Notes and printing this Indenture and the Notes. The Trustee shall be entitled to receive from the Company any such Officers’
Certificates, Opinions of Counsel or other documentation as it may reasonably request in connection with any such qualification of this Indenture under the TIA. 
  

 80 

 SIGNATURES 
  

IN WITNESS WHEREOF, the parties hereto have caused this Indenture to be duly executed, all as of the date first written above. 
  

			
	PSS WORLD MEDICAL, INC., as Issuer
		
	By:	 	/s/    DAVID D. KLARNER        
	 	 	

	 Name:
	 	David D. Klarner
	 Title:
	 	Vice President

  

			
	 WACHOVIA BANK, National Association, as Trustee

		
	By:	 	/s/    JOHN C. STEPHENS III        
	 	 	

	 Name:
	 	John C. Stephens III
	 Title:
	 	Vice President

  

 S-1 

 EXHIBIT A 
  

[FORM OF FACE OF SECURITY] 
  
 THIS NOTE AND ANY COMMON STOCK ISSUABLE UPON THE CONVERSION OF THIS NOTE HAVE NOT BEEN REGISTERED UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES
ACT”), AND MAY NOT BE SOLD OR OTHERWISE TRANSFERRED IN THE ABSENCE OF SUCH REGISTRATION OR AN APPLICABLE EXEMPTION THEREFROM. EACH PURCHASER OF THIS NOTE IS HEREBY NOTIFIED THAT THE SELLER OF THIS NOTE MAY BE RELYING ON THE EXEMPTION FROM THE
PROVISIONS OF SECTION 5 OF THE SECURITIES ACT PROVIDED BY RULE 144A THEREUNDER. 
  
 THIS NOTE AND ANY COMMON STOCK ISSUABLE UPON THE CONVERSION OF THIS NOTE MAY NOT BE OFFERED, SOLD, PLEDGED OR OTHERWISE TRANSFERRED EXCEPT (A) (1) TO A PERSON WHO THE TRANSFEROR REASONABLY BELIEVES IS A QUALIFIED INSTITUTIONAL BUYER WITHIN
THE MEANING OF RULE 144A UNDER THE SECURITIES ACT ACQUIRING FOR ITS OWN ACCOUNT OR FOR THE ACCOUNT OF A QUALIFIED INSTITUTIONAL BUYER IN A TRANSACTION MEETING THE REQUIREMENTS OF RULE 144A, (2) PURSUANT TO AN EXEMPTION FROM REGISTRATION UNDER THE
SECURITIES ACT PROVIDED BY RULE 144 THEREUNDER (IF AVAILABLE), (3) TO AN INSTITUTIONAL INVESTOR THAT IS AN ACCREDITED INVESTOR WITHIN THE MEANING OF RULE 501(a)(1), (2), (3) OR (7) OF REGULATION D UNDER THE SECURITIES ACT PURSUANT TO AN EXEMPTION
FROM REGISTRATION UNDER THE SECURITIES ACT (IF AVAILABLE) OR (4) PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT, AND (B) IN ACCORDANCE WITH ALL APPLICABLE SECURITIES LAWS OF THE STATES OF THE UNITED STATES AND OTHER
JURISDICTIONS. 
  
 THIS NOTE, ANY SHARES OF COMMON STOCK ISSUABLE UPON ITS
CONVERSION AND ANY RELATED DOCUMENTATION MAY BE AMENDED OR SUPPLEMENTED FROM TIME TO TIME TO MODIFY THE RESTRICTIONS ON RESALES AND OTHER TRANSFERS OF THIS NOTE AND ANY SUCH SHARES TO REFLECT ANY CHANGE IN APPLICABLE LAW OR REGULATION (OR THE
INTERPRETATION THEREOF) OR IN PRACTICES RELATING TO THE RESALE OR TRANSFER OF RESTRICTED SECURITIES GENERALLY. THE HOLDER OF THIS NOTE AND SUCH SHARES OF COMMON STOCK SHALL BE DEEMED BY THE ACCEPTANCE OF THIS NOTE AND ANY SUCH SHARES TO HAVE AGREED
TO ANY SUCH AMENDMENT OR SUPPLEMENT. 
  

 A-1 

 THIS SECURITY IS A GLOBAL SECURITY WITHIN THE MEANING OF THE INDENTURE HEREINAFTER REFERRED TO AND IS REGISTERED IN THE
NAME OF THE DEPOSITORY TRUST COMPANY, A NEW YORK CORPORATION (“DEPOSITARY”), OR A NOMINEE OF THE DEPOSITARY, WHICH MAY BE TREATED BY THE COMPANY, THE TRUSTEE AND ANY AGENT THEREOF AS THE OWNER AND HOLDER OF THIS SECURITY FOR ALL PURPOSES.
UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITARY TO THE COMPANY OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE & CO. OR IN SUCH
OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITARY (AND ANY PAYMENT IS MADE TO CEDE & CO. OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITARY), ANY TRANSFER, PLEDGE, OR OTHER USE
HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL INASMUCH AS THE REGISTERED OWNER HEREOF, CEDE & CO., HAS AN INTEREST HEREIN. 
  
 TRANSFERS OF THIS GLOBAL SECURITY SHALL BE LIMITED TO TRANSFERS IN WHOLE, BUT NOT IN PART, BY THE DEPOSITARY TO A NOMINEE OF THE DEPOSITARY OR BY A NOMINEE OF THE
DEPOSITARY TO THE DEPOSITARY OR ANOTHER NOMINEE OF THE DEPOSITARY OR BY THE DEPOSITARY OR ANY SUCH NOMINEE TO A SUCCESSOR DEPOSITARY OR A NOMINEE OF SUCH SUCCESSOR DEPOSITARY, AND TRANSFERS OF PORTIONS OF THIS GLOBAL SECURITY SHALL BE LIMITED TO
TRANSFERS MADE IN ACCORDANCE WITH THE RESTRICTIONS SET FORTH IN THE INDENTURE REFERRED TO ON THE REVERSE HEREOF. 
  

 A-2 

			
	No. 1	 	 Principal Amount $150,000,000,
 as revised by the Schedule of Increases
 and Decreases in the Global Note attached hereto

  
 CUSIP NO. 69366A AA 8

  
 PSS World Medical, Inc. 
  
 2.25% Convertible Senior Notes due March 15, 2024 
  
 PSS World Medical, Inc., a Florida corporation, promises to pay to Cede &
Co., or registered assigns, the principal sum of $150,000,000 Dollars, as revised by the Schedule of Increases and Decreases in the Global Note attached hereto, on March 15, 2024. 
  
 Interest Payment Dates: March 15, and September 15. 
  
 Regular Record Dates: March 1 and September 1. 
  
 Additional provisions of this Note are set forth on the other side of this Note. 
  

			
	PSS WORLD MEDICAL, INC.
		
	By:	 	 
	 	 	

  

			
	 TRUSTEE’S CERTIFICATE OF AUTHENTICATION
  
 Dated:
  
 WACHOVIA BANK, National Association, as Trustee,
certifies that this is one of the Notes referred to in the within-mentioned Indenture.

		
	By:	 	 
	 	 	

	 	 	Authorized Signatory

  

 A-3 

 [FORM OF REVERSE SIDE OF NOTE] 
  
 2.25% Convertible Senior Notes due March 15, 2024 
  

	1.	Interest 

  
 PSS World Medical, Inc., a Florida corporation (such corporation, and its successors and assigns under the Indenture hereinafter referred to, being herein
called the “Company”), promises to pay interest on the principal amount of this Note at the rate per annum shown above. The Company will pay interest semiannually on March 15 and September 15 of each year. Interest on the Notes will accrue
from the most recent date to which interest has been paid on the Notes or, if no interest has been paid, from March 8, 2004. The Company shall, to the fullest extent permitted by law, pay interest on overdue principal and overdue installments of
interest, if any and Contingent Interest, if any (plus interest on such interest to the extent lawful), at the rate borne by the Notes, which interest shall be payable upon demand. Interest will be computed on the basis of a 360-day year of twelve
30-day months. 
  

	2.	Contingent Interest 

  
 From and after March 15, 2009, the Company will pay Contingent Interest on this Note under the circumstances and in the amounts described in Article 12 of
the Indenture. Such Contingent Interest, if any, shall be payable semi-annually in arrears on each Interest Payment Date. Contingent Interest, if any, will be computed on the basis of a 360-day year of twelve 30-day months. 
  

	3.	Method of Payment 

  
 By no later than 11:00 a.m. (New York City time) on the date on which any principal of or interest (including Contingent Interest, if any) on any Note is
due and payable, the Company shall irrevocably deposit with the Trustee or the Paying Agent money sufficient to pay such principal and/or interest. The Company will pay interest (except Defaulted Interest) on the principal amount of the Notes on
each March 15 and September 15 to the Persons who are registered Holders of Notes at the close of business on the March 1 and September 1 next preceding the Interest Payment Date even if Notes are canceled or repurchased after the Regular Record
Date and on or before the Interest Payment Date. Holders must surrender Notes to a Paying Agent to collect principal payments. The Company will pay principal and interest (including Contingent Interest, if any) in money of the United States that at
the time of payment is legal tender for payment of public and private debts. The Company will make all payments in respect of a Definitive Note (including principal and interest) in U.S. dollars at the office of the Trustee. At the Company’s
option, however, the Company may make such payments by mailing a check to the registered address of each Holder thereof as such address shall appear on the Note Register or, with respect to Notes represented by a Global Note, by wire transfer of
immediately available funds to the accounts specified by the Depositary. If a payment date is a date other than a Business Day, payment may be made at that place on the next succeeding day that is a Business Day and no interest shall accrue for the
intervening period. 
  

 A-4 

	4.	Paying Agent, Conversion Agent and Registrar 

  
 Initially, Wachovia Bank, National Association (“Trustee”) will act as Paying Agent, Conversion Agent and Registrar. The Company may appoint and
change any Paying Agent, Conversion Agent, Registrar or co-registrar without notice to any Holder. The Company or any of its domestically incorporated Subsidiaries may act as Paying Agent, Conversion Agent, Registrar or co-registrar. 
  

	5.	Indenture 

  
 The Company issued the Notes under an Indenture dated as of March 8, 2004 (as it may be amended or supplemented from time to time in accordance with the
terms thereof, the “Indenture”), among the Company and the Trustee. The terms of the Notes include those stated in the Indenture and those made part of the Indenture by reference to the Trust Indenture Act of 1939 (15 U.S.C. §§
77aaa-77bbbb) as in effect from time to time (the “Act”). Capitalized terms used herein and not defined herein have the meanings ascribed thereto in the Indenture. The Notes are subject to all such terms, and Holders are referred to the
Indenture and the Act for a statement of those terms. To the extent permitted by applicable law, in the event of any inconsistency between the terms of this Note and the terms of the Indenture, the terms of the Indenture shall control. 

 
 The Notes are senior unsecured obligations of the Company limited to
$150,000,000 aggregate principal amount. 
  

	6.	Redemption at the Option of the Company 

  
 No sinking fund is provided for the Notes. The Notes are redeemable for cash in whole, or in part, at any time on or after March 15, 2009 at the option of
the Company at a redemption price (“Redemption Price”) equal to 100% of the principal amount of the Notes, plus any accrued and unpaid interest (including Contingent Interest and Liquidated Damages, if any) to, but not including, the
Redemption Date. 
  

	7.	Notice of Redemption at the Option of the Company 

  
 Notice of redemption at the option of the Company shall be mailed at least 30 days but not more than 60 days before a Redemption Date to the Trustee, the
Paying Agent and each Holder of Notes to be redeemed at the Holder’s registered address. If money sufficient to pay the Redemption Price of all Notes (or portions thereof) to be redeemed on the Redemption Date is deposited with the Paying Agent
prior to or on the Redemption Date, on and after the Redemption Date, interest (including Contingent Interest and Liquidated Damages, if any), if any, shall cease to accrue on such Notes or portions thereof. Notes in denominations larger than $1,000
principal amount may be redeemed in part but only in integral multiples of $1,000 principal amount. 
  

	8.	Repurchase by the Company at the Option of the Holder 

  
 Subject to the terms and conditions of the Indenture, a Holder shall have the option to require the Company to purchase the Notes held by such Holder on
March 15, 2009, 

  

 A-5 

 
March 15, 2014 and March 15, 2019 (each, a “Repurchase Date”) at a purchase price (the “Repurchase Price”) equal to 100% of the principal
amount of the Notes to be purchased plus any accrued and unpaid interest, if any (including Contingent Interest and Liquidated Damages, if any), to but not including such Repurchase Date, upon delivery of a Repurchase Notice containing the
information set forth in the Indenture from the opening of business on the date that is 20 Business Days prior to such Repurchase Date until the close of business on the Business Day immediately prior to such Repurchase Date and upon delivery of the
Notes to the Paying Agent by the Holder as set forth in the Indenture. The Company will pay the Repurchase Price in cash with respect each Repurchase Date. 
  
 Notes in denominations larger than $1,000 principal amount may be purchased in part, but only in integral multiples of $1,000 principal amount.

  

	9.	Repurchase at the Option of the Holder Upon a Fundamental Change 

  
 If a Fundamental Change shall occur, each Holder shall have the right, at such Holder’s option and subject to the terms and conditions of the
Indenture, to require the Company to purchase any or all of such Holder’s Notes or any portion of the principal amount thereof that is equal to $1,000 or an integral multiple of $1,000 on the day that is no less than 20 days and no more than 35
days after the date of the Company Notice of the occurrence of the Fundamental Change (subject to extension to comply with applicable law) for a Fundamental Change Repurchase Price equal to 100% of the principal amount of Notes purchased plus
accrued and unpaid interest (including Contingent Interest and Liquidated Damages, if any) to but not including the Fundamental Change Repurchase Date, which Fundamental Change Repurchase Price shall be paid in cash. 
  
 Holders have the right to withdraw any Repurchase Notice or Fundamental
Change Repurchase Notice, as the case may be, by delivery to the Paying Agent of a written notice of withdrawal in accordance with the provisions of the Indenture. 
  

	10.	Conversion 

  
 Subject to the procedures set forth in the Indenture, a Holder may convert Notes into Common Stock on or before the close of business on March 14, 2024
during the periods and upon satisfaction of the conditions set forth in the Indenture. 
  
 Notes in respect of which a Holder has delivered a notice of exercise of the option to require the Company to purchase such Notes pursuant to Article VI or VII of the Indenture may be converted only if the notice of
exercise is withdrawn in accordance with the terms of the Indenture. 
  
 The initial Conversion Rate is 58.4949 shares of Common Stock per $1,000 principal amount, subject to adjustment in certain events described in the Indenture. The Company may, at its option, deliver in lieu of shares of Common Stock, cash
or a combination of cash and shares of Common Stock. 
  
 To
convert the Notes a Holder must (1) complete and manually sign the irrevocable conversion notice on the back of the Notes (or complete and manually sign a facsimile of 

  

 A-6 

 
such notice) and deliver such notice to the Conversion Agent at the office maintained by the Conversion Agent for such purpose, (2) surrender the Notes to
the Conversion Agent, (3) furnish appropriate endorsements and transfer documents if required by the Conversion Agent, the Company or the Trustee and (4) pay any transfer or similar tax, if required. 
  

	11.	Denominations; Transfer; Exchange 

  
 The Notes are in registered form without coupons in denominations of principal amount of $1,000 and whole multiples of $1,000. A Holder may transfer or
exchange Notes in accordance with the Indenture. The Registrar may require a Holder, among other things, to furnish appropriate endorsements or transfer documents and to pay any taxes and fees required by law or permitted by the Indenture. The
Registrar need not register the transfer of or exchange any Notes (A) for a period beginning at the opening of business 15 days before any selection of Notes for redemption or repurchase and ending at the close of business on the day notice of such
redemption or repurchase is deemed to have been given to all Holders of Notes to be so redeemed or repurchased or (B) selected for redemption or repurchase in whole or in part, except for the transfer of the unredeemed portion of any Note being
redeemed in part. 
  

	12.	Persons Deemed Owners 

  
 The registered Holder of this Note may be treated as the owner of this Note for all purposes. 
  

	13.	Unclaimed Money 

  
 If money for the payment of the principal of, or interest (including Contingent Interest, if any) on the Note remains unclaimed for two years, the Trustee
or Paying Agent shall pay the money back to the Company at its written request unless an abandoned property law designates another Person. After any such payment, Holders entitled to the money must look only to the Company and not to the Trustee for
payment. 
  

	14.	Amendment, Waiver 

  
 Subject to certain exceptions set forth in the Indenture, (i) the Indenture and the Notes may be amended with the written consent of the Holders of at
least a majority in aggregate principal amount of the then outstanding Notes (including, without limitation, consents obtained in connection with a purchase of, or tender offer or exchange offer for, Notes) and (ii) any default (other than with
respect to nonpayment) or noncompliance with any provision may be waived with the written consent of the Holders of a majority in aggregate principal amount of the then outstanding Notes (including, without limitation, consents obtained in
connection with a purchase of, or tender offer or exchange offer for, Notes). 
  

	15.	Defaulted Interest 

  
 Except as otherwise specified with respect to the Notes, any Defaulted Interest on any Note shall forthwith cease to be payable to the registered Holder
thereof on the relevant Regular Record Date or accrual date, as the case may be, by virtue of having been such Holder, 

  

 A-7 

 
and such Defaulted Interest may be paid by the Company as provided for in Section 2.12 of the Indenture. 
  

	16.	No Recourse Against Others 

  
 No recourse for the payment of the principal of or interest (or including Contingent Interest and Liquidated Damages, if any) on this Note and no recourse
under or upon any obligation, covenant or agreement of the Company in the Indenture, this Note or in any supplemental indenture, or because of the creation of any Indebtedness represented thereby, shall be had against any incorporator, stockholder,
employee, agent, officer, director, or subsidiary, past, present or future, of the Company or of any successor corporation or entity, whether by virtue of any constitution, statute or rule of law, or by the enforcement of any assessment or penalty
or otherwise, it being understood that all such liability is hereby waived and released as a condition to, and as a consideration for, the execution and delivery of the Indenture and the issue of this Note. 
  

	17.	Authentication 

  
 This Note shall not be valid until an authorized signatory of the Trustee (or an authenticating agent acting on its behalf) manually signs the certificate
of authentication on the other side of this Note. 
  

	18.	Abbreviations 

  
 Customary abbreviations may be used in the name of a Holder or an assignee, such as TEN COM (=tenants in common), TEN ENT (=tenants by the entirety), JT
TEN (=joint tenants with rights of survivorship and not as tenants in common), CUST (=custodian) and U/G/M/A (=Uniform Gift to Minors Act). 
  

	19.	CUSIP Numbers 

  
 Pursuant to a recommendation promulgated by the Committee on Uniform Security Identification Procedures the Company has caused CUSIP numbers to be printed
on the Notes. No representation is made as to the accuracy of such numbers as printed on the Notes and reliance may be placed only on the other identification numbers placed thereon. 
  

	20.	Governing Law 

  
 This Note shall be governed by, and construed in accordance with, the laws of the State of New York applicable to contracts made and to be performed
entirely in such state, without regard to principles of conflicts of law. 
  

 A-8 

 The Company will furnish to any Holder upon written request and without charge to the Holder a copy of
the Indenture which has in it the text of this Note. Requests may be made to: 
  
 PSS World Medical, Inc. 
 4345 Southpoint Blvd. 
 Jacksonville, FL 32216 
 Attention: David D.
Klarner 
 Facsimile No.: (904) 332-3214 
  

 A-9 

 ASSIGNMENT FORM 
  

To assign this Note, fill in the form below: 
  
 I or we assign and transfer this Note to 
  
 ____________________________________________________________ 
 (Print or type assignee’s name, address and zip code) 
  
 _______________________________________________ 
 (Insert assignee’s soc. sec. or tax I.D. No.)

  
 and irrevocably appoint
                     agent to transfer this Note on the books of the Company. The agent may substitute another to act for him. 
  

  

			
	 Date:                    
	  	Your
Signature:                                

  

			
		
	Signature Guarantee:	 	 
	 	 	

	 	 	(Signature must be guaranteed)

  

 Sign exactly as your name appears on the other side of this Note. 
  
 The signature(s) should be guaranteed by an eligible guarantor institution (banks, stockbrokers, savings and loan associations and credit unions with membership in an approved signature guarantee medallion program),
pursuant to S.E.C. Rule 17Ad-15. 
  
 In connection with any transfer or exchange
of any of the Notes evidenced by this certificate occurring prior to the date that is two years after the later of the date of original issuance of such Notes and the last date, if any, on which such Notes were owned by the Company or any Affiliate
of the Company, the undersigned confirms that such Notes are being: 
  
 CHECK ONE
BOX BELOW: 
  

					
	 1.
	 	 ̈	 	acquired for the undersigned’s own account, without transfer; or
	 2.
	 	 ̈	 	transferred to the Company; or
	 3.
	 	 ̈	 	transferred pursuant to and in compliance with Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”); or
	 4.
	 	 ̈	 	transferred pursuant to an effective registration statement under the Securities Act; or
	 5.
	 	 ̈	 	transferred to an institutional accredited investor (as defined in Rule 501(a)(1), (2), (3) or (7) under the Securities Act), that has furnished to the Trustee a signed letter containing certain
representations and agreements (the form of which letter appears as Section 2.7 of the Indenture); or
	 6.
	 	 ̈	 	transferred pursuant to another available exemption from the registration requirements of the Securities Act of 1933.

  

 A-10 

 Unless one of the boxes is checked, the Trustee will refuse to register any of the Notes evidenced by this certificate in
the name of any person other than the registered Holder thereof; provided, however, that if box (5) or (6) is checked, the Trustee or the Company may require, prior to registering any such transfer of the Notes, in their sole
discretion, such legal opinions, certifications and other information as the Trustee or the Company may reasonably request to confirm that such transfer is being made pursuant to an exemption from, or in a transaction not subject to, the
registration requirements of the Securities Act, such as the exemption provided by Rule 144 under such Act. 
  

					
			
	  	 	 	 	  
	 	 	 	 	

	 	 	 	 	 Signature

	 Signature Guarantee:
	 	 	 	 
			
	  	 	 	 	  
	
	 	 	 	

	 (Signature must be guaranteed)
	 	 	 	 Signature

	

  
 The signature(s) should be guaranteed
by an eligible guarantor institution (banks, stockbrokers, savings and loan associations and credit unions with membership in an approved signature guarantee medallion program), pursuant to S.E.C. Rule 17Ad-15. 
  
 TO BE COMPLETED BY PURCHASER IF (1) OR (3) ABOVE IS CHECKED. 
  
 The undersigned represents and warrants that it is purchasing this Note for
its own account or an account with respect to which it exercises sole investment discretion and that it and any such account is a qualified institutional buyer within the meaning of Rule 144A under the Securities Act, as amended, and is aware that
the sale to it is being made in reliance on Rule 144A and acknowledges that it has received such information regarding the Company as the undersigned has requested pursuant to Rule 144A or has determined not to request such information and that it
is aware that the transferor is relying upon the undersigned’s foregoing representations in order to claim the exemption from registration provided by Rule 144A. 
  

									
	 Dated:
	 	 	 	 NOTICE: To be executed by an executive officer

			
	 	 	 	 	 [INSERT NAME OF ASSIGNOR]

					
	 	 	 	 	 	 	By:	 	 
	 	 	 	 	 	 	 	 	

	 	 	 	 	 	 	 	 	 Name:
 Title:

  

 A-11 

 SCHEDULE OF INCREASES OR DECREASES IN GLOBAL SECURITY 
  
 The following increases or decreases in this Global Note have been made:

  

									
	Date of
Exchange

	 	Amount of decrease in Principal
Amount of this Global Note

	 	Amount of increase in Principal
Amount of this Global Note

	 	Principal Amount of this
Global Note following such
decrease or increase

	 	Signature of authorized
signatory of Trustee or Notes
Custodian

  

 A-12 

 OPTION OF HOLDER TO ELECT REPURCHASE 
  
 If you want to elect to have this Note purchased by the Company pursuant to Section 7.1 or Article VI of the Indenture,
check the box:  ̈ 
  
 If you want to elect to have only part of this Note purchased by the Company pursuant to Section 7.1 or Article VI of the Indenture, state the amount in
principal amount (must be an integral multiple of $1,000): $                    . 
  

					
			
	 Date:                            
	 	 Your Signature:
	 	  
	 	 	 	 	

	 	 	 	 	(Sign exactly as your name appears on the other side of this Note)

  

			
		
	Signature Guarantee:	 	 
	 	 	

	 	 	(Signature must be guaranteed)

  
 The signature(s) should be guaranteed
by an eligible guarantor institution (banks, stockbrokers, savings and loan associations and credit unions with membership in an approved signature guarantee medallion program), pursuant to S.E.C. Rule 17Ad-15. 
  

 A-13 

 FORM OF CERTIFICATE TO BE DELIVERED UPON EXCHANGE 
 OR REGISTRATION OF TRANSFER OF SECURITIES 
  

	 	Re:	2.25% Convertible Senior Notes due March 15, 2024 of PSS World Medical, Inc. (the “Company”). 

  
 This Certificate relates to
$                                        
             principal amount of Notes held in *                 book-entry or
*                 definitive form by
                                        
             (the “Transferor”). 
  
 The Transferor has requested the Trustee by written order to exchange or register the transfer of a Note or Notes. 
  
 In connection with such request and in respect of each such Note, the
Transferor does hereby certify that the Transferor is familiar with the Indenture, dated as of March 8, 2004 (as amended or supplemented to date, the “Indenture”), between the Company and Wachovia Bank, National Association, as trustee
(the “Trustee”), relating to the above-captioned Notes and that the transfer of this Note does not require registration under the Securities Act (as defined below) because:* 
  
  ̈ Such Note is
being acquired for the Transferor’s own account without transfer. 
  
  ̈ Such Note is being transferred to a “qualified institutional buyer” (as defined in Rule 144A under the Securities Act of
1933, as amended (the “Securities Act”)), in accordance with Rule 144A under the Securities Act. 
  
  ̈ Such Note is being transferred (i) pursuant to
an exemption from registration in accordance with Rule 144 under the Securities Act (and based upon an opinion of counsel if the Company or the Trustee so requests) or (ii) pursuant to an effective registration statement under the Securities Act.

  
  ̈ Such Note is being transferred in reliance on and in compliance with another exemption from the registration requirements of the Securities Act (and based upon an opinion of counsel
if the Company or the Trustee so requests). 

	*	Fill in blank or check appropriate box, as applicable. 

  

 A-14 

 You are entitled to rely upon this certificate and you are irrevocably authorized to produce this
certificate or a copy hereof to any interested party in any administrative or legal proceeding or official inquiry with respect to the matters covered hereby. 
  

			
	 [INSERT NAME OF TRANSFEROR]

		
	 By:
	 	 
	 	 	

	 	 	Name:
	 	 	Title:
	 	 	Address:
		
	 	 	 Date:

  

 A-15 

 CONVERSION NOTICE 
  

To convert this Note into Common Stock of the Company, check the box: 
  
  ̈ 
  
 To convert only part of this Note, state the principal amount to be converted (must be in integral multiples of $1,000): 
  

			
		
	$	 	 
	 	 	

  
 If you want the stock certificate made
out in another person’s name, fill in the form below: 
  

	
	
	  

 (Insert other person’s soc.
sec. or tax I.D. no.)

	
	 
	

	
	 
	

	
	 
	

	
	 
	

	(Print or type other person’s name, address and zip code)

  

	
	 
	

  

									
				
	 Date:
	 	 	 	Signature(s):	 	 
	 	 	
	 	 	 	 	

					
	 	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	

	 	 	 	 	 	 	(Signatures must be guaranteed by an “eligible guarantor institution” meeting the requirements of the Registrar, which requirements include membership or
participation in the Security Transfer Agent Medallion Program (“STAMP”) or such other “signature guarantee program” as may be determined by the Registrar in addition to, or in substitution for, STAMP, all in accordance with the
Securities Exchange Act of 1934, as amended.)

  

 A-16 

									
	 	 	 	 	 
					
	 Signature(s) guaranteed by:
	 	 	 	 	 	 	 	 
	 	 	

	 	 	(Signatures must be guaranteed by an “eligible guarantor institution” meeting the requirements of the Registrar, which requirements include membership or participation in
the Security Transfer Agent Medallion Program (“STAMP”) or such other “signature guarantee program” as may be determined by the Registrar in addition to, or in substitution for, STAMP, all in accordance with the Securities
Exchange Act of 1934, as amended.)

  

 A-17 

 EXHIBIT B 
  
 FORM OF TRANSFER CERTIFICATE FOR TRANSFER 
 OF RESTRICTED COMMON STOCK 
  
 [NAME AND ADDRESS
OF COMMON STOCK TRANSFER AGENT] 
  

	 	Re:	PSS World Medical, Inc. 2.25% Convertible Senior Notes Due March 15, 2024 (the “Notes”) 

  
 Reference is hereby made to the Indenture dated as of March 8, 2004 between the Company and the Trustee (collectively, the
“Indenture”). Capitalized terms used but not defined herein shall have the meanings given them in the Indenture. 
  
 This letter relates to                  shares of Common Stock
represented by the accompanying certificate(s) that were issued upon conversion of Notes and which are held in the name of [name of transferor] (the “Transferor”) to effect the transfer of such Common Stock. 
  
 In connection with the transfer of such shares of Common Stock, the
undersigned confirms that such shares of Common Stock are being transferred and do not require registration under the Securities Act (as defined below) because: 
  

CHECK ONE BOX BELOW: 
  
  ̈ Such Common Stock is being acquired for the
Transferor’s own account without transfer. 
  
  ̈ Such Common Stock is being transferred to a “qualified institutional buyer” (as defined in Rule 144A under the Securities Act of 1933, as amended
(the “Securities Act”)), in accordance with Rule 144A under the Securities Act. 
  
  ̈ Such Common Stock is being transferred (i) pursuant to an exemption from registration in accordance with Rule
144 under the Securities Act (and based upon an opinion of counsel if the Company or the Trustee so requests) or (ii) pursuant to an effective registration statement under the Securities Act. 
  
  ̈ Such Common Stock is being transferred in reliance on and in compliance with another exemption from the registration requirements of the Securities Act (and based upon an opinion of counsel if the Company or the
Trustee so requests). 
  

 B-1 

 Unless one of the boxes is checked, the transfer agent will refuse to register any of the Common Stock
evidenced by this certificate in the name of any person other than the registered holder thereof; provided, however, that if box (2), (3) or (4) is checked, the transfer agent may require, prior to registering any such transfer of the
Common Stock such certifications and other information, including opinions of counsel, as the Company has reasonably requested in writing, by delivery to the transfer agent of a standing letter of instruction, to confirm that such transfer is being
made pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act. 
  

			
	[Name of Transferor],
		
	By:	 	 
	 	 	

	 	 	 Name:

	 	 	 Title:

		
	 Dated:
	 	 

  

 B-2 

 ANNEX A 
  
 Projected Payment Schedule* 
  

							
	 Semi-Annual
 Period

	  	Date

	  	Total Projected
Payment

	 
	 0
	  	3/8/2004	  	$	(1,000.00	)
	 1
	  	9/15/2004	  	$	11.25	 
	 2
	  	3/15/2005	  	$	11.25	 
	 3
	  	9/15/2005	  	$	11.25	 
	 4
	  	3/15/2006	  	$	11.25	 
	 5
	  	9/15/2006	  	$	11.25	 
	 6
	  	3/15/2007	  	$	11.25	 
	 7
	  	9/15/2007	  	$	11.25	 
	 8
	  	3/15/2008	  	$	11.25	 
	 9
	  	9/15/2008	  	$	11.25	 
	 10
	  	3/15/2009	  	$	11.25	 
	 11
	  	9/15/2009	  	$	11.25	 
	 12
	  	3/15/2010	  	$	14.36	 
	 13
	  	9/15/2010	  	$	14.53	 
	 14
	  	3/15/2011	  	$	14.71	 
	 15
	  	9/15/2011	  	$	14.90	 
	 16
	  	3/15/2012	  	$	15.10	 
	 17
	  	9/15/2012	  	$	15.31	 
	 18
	  	3/15/2013	  	$	15.53	 
	 19
	  	9/15/2013	  	$	15.77	 
	 20
	  	3/15/2014	  	$	16.02	 
	 21
	  	9/15/2014	  	$	16.28	 
	 22
	  	3/15/2015	  	$	16.56	 
	 23
	  	9/15/2015	  	$	16.85	 
	 24
	  	3/15/2016	  	$	17.16	 
	 25
	  	9/15/2016	  	$	17.48	 
	 26
	  	3/15/2017	  	$	17.82	 
	 27
	  	9/15/2017	  	$	18.19	 
	 28
	  	3/15/2018	  	$	18.57	 
	 29
	  	9/15/2018	  	$	18.97	 
	 30
	  	3/15/2019	  	$	19.40	 
	 31
	  	9/15/2019	  	$	19.84	 
	 32
	  	3/15/2020	  	$	20.32	 
	 33
	  	9/15/2020	  	$	20.81	 
	 34
	  	3/15/2021	  	$	21.34	 
	 35
	  	9/15/2021	  	$	21.90	 
	 36
	  	3/15/2022	  	$	22.48	 
	 37
	  	9/15/2022	  	$	23.10	 
	 38
	  	3/15/2023	  	$	23.75	 
	 39
	  	9/15/2023	  	$	24.44	 
	 40
	  	3/15/2024	  	$	3,241.86	 

	*	The comparable yield means the annual yield the Company would pay, as of the date of issue of a Note, on a fixed-rate nonconvertible debt security with no contingent payments,
but with terms and conditions otherwise comparable to those of the Notes, and the schedule of projected payments has been determined on the basis of an assumption of linear growth of the stock price and a constant dividend yield and has not been
determined for any purpose other than for the determination of interest accruals and adjustments thereof in respect of the Notes for United States federal income tax purposes. The comparable yield and the schedule of projected payments do not
constitute a projection or representation regarding the amounts payable on Notes. 

  

 B-3

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00061-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00061-of-00352.parquet"}]]